Abstract
Background
Type 1 diabetes (T1D) is a serious threat to childhood life and has fairly complicated pathogenesis. Profound attempts have been made to enlighten the pathogenesis, but the molecular mechanisms of T1D are still not well known.
Methods
To identify the candidate genes in the progression of T1D, expression profiling by high throughput sequencing dataset GSE123658 was downloaded from Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were identified, and gene ontology (GO) and pathway enrichment analyses were performed. The protein-protein interaction network (PPI), modules, target gene - miRNA regulatory network and target gene - TF regulatory network analysis were constructed and analyzed using HIPPIE, miRNet, NetworkAnalyst and Cytoscape. Finally, validation of hub genes was conducted by using ROC (Receiver operating characteristic) curve and RT-PCR analysis. A molecular docking study was performed.
Results
A total of 284 DEGs were identified, consisting of 142 up regulated genes and 142 down regulated genes. The gene ontology (GO) and pathways of the DEGs include cell-cell signaling, vesicle fusion, plasma membrane, signaling receptor activity, lipid binding, signaling by GPCR and innate immune system. Four hub genes were identified and biological process analysis revealed that these genes were mainly enriched in cell-cell signaling, cytokine signaling in immune system, signaling by GPCR and innate immune system. ROC curve and RT-PCR analysis showed that EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN might be involved in the advancement of T1D. Molecular docking studies showed high docking score.
Conclusions
DEGs and hub genes identified in the present investigation help us understand the molecular mechanisms underlying the advancement of T1D, and provide candidate targets for diagnosis and treatment of T1D.
Keywords: bioinformatics, type 1 diabetes, differentially expressed genes, enrichment analysis, pathways
Introduction
Type 1 diabetes (T1D) (insulin-dependent) is a core challenge for endocrine research around the world [1]. Approximately 5 to 10% of the childhood population is affected with T1D worldwide [2]. T1D affects the eyes, kidneys, heart, peripheral and autonomic nervous systems [3]. Pancreatic cells, particularly β-cells, play a key role in the occurrence and progression of T1D [4]. Treatment for T1D includes targeting β-cells and β-cells regeneration [5]. However, T1D is a complex disease and its biology remains poorly understood [6].
There are several important risk factors for T1D, such as genetic and environmental factors [7, 8]. Previous studies identified aspects of the molecular mechanism of T1D advancement. T1D has been genetically associated with genes and signaling pathways, CTLA-4 [9], SUMO4 [10], CYP27B1 [11], PD-1 [12], KIAA0350 [13], tumor necrosis factor alpha signaling pathways [14], NLRP3 and NLRP1 inflammasomes signaling pathways [15], HIF-1/VEGF signaling pathway [16], l-arginine/NO pathway [17], and CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway [18]. Next-generation sequencing (NGS) has drastically increased the understanding mechanism of T1D, and analyses of these data can provide insight into effective diagnostic and therapeutic T1D treatments [19]. Thus, identifying key molecular biomarkers is essential for early diagnosis, prevention, and treatment of T1D.
It worth a lot of money and time to identify disease related molecular biomarkers by experiment alone. With the wide application of expression profiling by high throughput sequencing data, there were huge genomics data deposited in public databases [20]. The progression of computational tools gives us an alternative method to diagnose novel molecular biomarkers.
In this investigation, we employed the bioinformatics approach to discover the differentially expressed genes between T1D patients and healthy donors. Original expression profiling by high throughput sequencing dataset GSE123658 was downloaded. 39 T1D patients’ samples and 43 healthy donors’ samples were analyzed in our investigation. Commonly altered DEGs were isolated from integrated data. Additionally, GO/ REACTOME pathway analysis, construction of protein–protein interaction network, modules, target gene - miRNA regulatory network and target gene - TF regulatory network analysis were performed to analyze these data. Four hub genes (EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN) were identified. ROC (receiver operating characteristic) curve and RT-PCR analysis were used to verify clinically relevant hub genes. The aim of this investigation was to gain a better understanding of the underlying molecular mechanisms and to discover molecular biomarkers for T1D.
Material and methods
Data resources
Expression profiling by high throughput sequencing dataset GSE123658 was downloaded from the GEO database (http://www.ncbi.nlm.nih.gov/geo/) [21]. CPM count normalization performed on the original dataset GSE123658 from GEO databse using package edgeR package [22], voom function [23], and Limma [24] of R software. The data was produced using a GPL18573 Illumina NextSeq 500 (Homo sapiens). The GSE123658 dataset contained data from 82 samples, including 39 T1D patients’ samples and 43 healthy donors’ samples.
Identification of DEGs
The identification of DEGs between 39 T1D patients’ samples and 43 healthy donors’ samples was performed using Limma package in R bioconductor. lmFit function in the limma package to construct linear model for individual gene [25]. makeContrasts function in the limma package to compose similarity between T1D and healthy donors groups (log fold-changes) are obtained as contrasts of these fitted linear model. eBayes is a function in limma package which figure out empirical Bayes predicts of DEGs [26]. topTable function in limma package to obtain a table of the most significant Up and down regulated genes from a eBayes model fit. To correct the discovery of statistically important molecular biomarkers and limitations of false-positives, we using the adjusted P-value and Benjamini and Hochberg false discovery rate method [27]. Fold-change (FC) and adjust p-values were used to found DEGs. A |log2FC| > 0.94 for up regulated genes, |log2FC| -0.39 for down regulated genes and P-value < 0.05 were used as considered statistically significant. The volcano plot was implemented using ggplot2 package [28], and the heat map was established using gplots package in R language.
Gene Ontology (GO) and pathway enrichment analyses of DEGs
Gene Ontology (GO) (http://www.geneontology.org) analysis is a routine analysis for annotating genes and determining biological component, including biological process (BP), cellular component (CC) and molecular function (MF) [29]. REACTOME (https://reactome.org/) [30] pathway database is applied for classification by correlating gene sets into their respective pathways. The ToppGene (ToppFun) (https://toppgene.cchmc.org/enrichment.jsp) [31] is a gene functional classification tool that objective to provide a extensive set of functional annotation tools for authors to recognize the biological explanation behind large lists of genes. P < 0.05 was find statistically significant.
PPI network construction and module analysis
The online Human Integrated Protein-Protein Interaction rEference (HIPPIE) (http://cbdm.uni-mainz.de/hippie/) [32] online database was using to predicted the PPI network information. Analyzing the interactions and functions between DEGs may provide information about the mechanisms of generation and development of disease (PPI score > 0.4). Cytoscape 3.8.0 (http://www.cytoscape.org/) [33] is a bioinformatics platform for constructing and visualizing molecular interaction networks. The Network Analyzer Cytoscape plug-in was used to find hub genes were screened using highest node degree [34], betweenness centrality [35], stress centrality [36] and closeness centrality [37] methods and hub genes were further analyzed for pathway and GO enrichment analysis. The plug-in PEWCC1 (http://apps.cytoscape.org/apps/PEWCC1) [38] of Cytoscape was applied to detect densely connected regions in PPI networks. The PPI networks were constructed using Cytoscape and the most key module in the PPI networks was preferred using PEWCC1. The criteria for selection were set as follows: Max depth = 100, degree cut-off = 2, Node score cut-off = 0.2, PEWCC1 scores >5, and K-score = 2.
Construction of miRNA - target regulatory network
miRNet database (https://www.mirnet.ca/) [39] online database was used to predict miRNAs that targeted the DEGs associated with T1D. The DEGs were selected according to the screening criterion of P value <0.05. The results were exported into the Cytoscape software for analysis. The target genes - miRNA regulatory network was constructed through network topology prosperities. The node degree was determined using the Network analysis plugin, and miRNAs with a node degree >12.
Construction of TF - target regulatory network
NetworkAnalyst database (https://www.networkanalyst.ca/) [40] online database was used to predict TFs that targeted the DEGs associated with T1D. The DEGs were selected according to the screening criterion of P value <0.05. The results were exported into the Cytoscape software for analysis. The target genes - TF regulatory network was constructed through network topology prosperities. The node degree was determined using the Network analysis plugin, and TFs with a node degree >12.
Validation of hub genes
Receiver operating characteristic (ROC) curve analysis [41] was implemented to calculate the sensitivity and specificity of the DEGs for T1D diagnosis using the R package by using the generalized linear model (GLM) in machine learning algorithms [42]. An area under the curve (AUC) value was determined and used to label the ROC effect. The RIN-m5F (ATCC CRL-11605) cell line procured from ATCC for T1D. RINm5F cell line was grown in RPMI-1640 medium added with 10% fetal bovine serum and penicillin/streptomycin. Incubate this cell line at 37 °C in a 5% CO2 in humidified cell culture incubator. The HITT15 (ATCC CRL1777) cell line procured from ATCC for normal. CRL-1777 cell line was grown in Ham’s F12K medium added with 10% fetal bovine serum,87.5%; dialyzedhorse serum, 2 mM Lglutamine, 1.5 g/L sodium bicarbonate, and penicillin/streptomycin. Incubate the this cell line at 37 °C in a 5% CO2 in humidified cell culture incubator. In RT-PCR analysis, total RNA was isolated from in vitro cultured cells of diabetics and normal using a TRI Reagent (Sigma, USA). cDNA was synthesized using 2.0 μg of total RNA with the FastQuant RT kit (with gDNase; Tiangen Biotech Co., Ltd.). The relative mRNA expression was measured in the QuantStudio 7 Flex real-time PCR system (Thermo Fisher Scientific, Waltham, MA, USA). The relative expression levels were determined by the 2-ΔΔCt method and normalized to internal control β-actin [42]. All RT-PCR reactions were performed in triplicate. The primers used to explore mRNA expression of ten hub genes were shown in Table 1.
Table 1.
The sequences of primers for quantitative RT-PCR
| Genes | Primers | Length of target fragment, bp |
|---|---|---|
| EGFR |
F: AGGCACGAGTAACAAGCTCAC R: ATGAGGACATAACCAGCCACC |
21 21 |
| GRIN2B |
F: TCTGACCGGAAGATCCAGGG R: TCCATGATGTTGAGCATTACGG |
20 22 |
| GJA1 |
F: GGTGACTGGAGCGCCTTAG R: GCGCACATGAGAGATTGGGA |
19 20 |
| CAP2 |
F: CCCTGCCCTTGGATGGATAG R: ACGCTGATACTGTGGATGCTA |
20 21 |
| MIF |
F: CTCTCCGAGCTCACCCAGCAG R: CGCGTTCATGTCGTAATAGTT |
21 21 |
| POLR2A |
F: GGGTGGCATCAAATACCCAGA R: AGACACAGCGCAAAACTTTCA |
21 21 |
| PRKACA |
F: AGCCCACTTGGATCAGTTTGA R: GTTCCCGGTCTCCTTGTGT |
21 19 |
| GABARAP |
F: AGAAGAGCATCCGTTCGAGAA R: CCAGGTCTCCTATCCGAGCTT |
21 21 |
| TLN1 |
F: GACGATGCAGTTTGAGCCG R: GGTCATCATCTGACAGAAAGAG |
19 23 |
| PXN |
F: CTGCTGGAACTGAACGCTGTA R: GGGGCTGTTAGTCTCTGGGA |
21 20 |
F Forward Primers, R Reverse Primers
Molecular Docking studies
The surflex-docking studies of the designed molecule, standard on over expressed genes of PDB protein were performed using SYBYL-X 2.0 perpetual software. All the designed molecules and standard were outlined using ChemDraw Software, imported and saved in sdf. templet using open babel free software. The protein structures of EGFR (epidermal growth factor receptor) and its co-crystallised protein of PDB code 2XYJ, 2XYX and GRIN2B its co-crystallised protein of PDB code and its co-crystallised protein of PDB code 5EWL, 6E7V were extracted from Protein Data Bank [43–46]. Together with the TRIPOS force field, GasteigerHuckel (GH) charges were added to all designed molecules and standard for the structure optimization process. Additionally, using MMFF94s and MMFF94 algorithm methods, energy minimization was done. The protein preparation was carried out after incorporation of protein. The co-crystallized ligand and all water molecules were removed from the crystal structure; more hydrogen’s were added and the side chain was set. TRIPOS force field was used for the minimization of structure. The compounds’ interaction efficiency with the receptor was represented by the Surflex-Dock score in kcal / mol units. The interaction between the protein and the ligand, the best pose was incorporated into the molecular area. The visualization of ligand interaction with receptor is done by using discovery studio visualizer.
Results
Identification of DEGs
With a threshold of P-value <0.05 and absolute value of |log2FC| > 0.94 for up regulated genes, |log2FC| -0.39 for down regulated genes, DEGs were identified from dataset. 284 DEGs were screened from the GSE123658 dataset, which consisted of 142 up regulated genes and 142 down regulated genes and only top ten up regulated genes and down regulated genes are listed in Table 2. Volcano plots were used to visualize differential expression of genes between the T1D group and healthy donors group (Fig.1). A heat map showed expression profiling of DEGs in the analysis result (Fig.2).
Table 2.
The statistical metrics for key differentially expressed genes (DEGs)
| GeneSymbol | logFC | p Value | adj. P.Val | t value | Regulations | GeneName | |
|---|---|---|---|---|---|---|---|
| ARMS2 | 1.105122 | 3.28E-07 | 0.000198 | 5.53328 | Up | age-related maculopathy susceptibility 2 | |
| PRSS46P | 1.005863 | 1.59E-06 | 0.000459 | 5.153257 | Up | serine protease 46, pseudogene | |
| MYH13 | 1.03327 | 1.64E-06 | 0.00046 | 5.144666 | Up | myosin heavy chain 13 | |
| RAD21L1 | 1.367492 | 2.87E-06 | 0.000592 | 5.007555 | Up | RAD21 cohesin complex component like 1 | |
| AS3MT | 1.172185 | 2.97E-06 | 0.000593 | 4.998809 | Up | arsenitemethyltransferase | |
| UPK1B | 1.142189 | 4.25E-06 | 0.000663 | 4.909531 | Up | uroplakin 1B | |
| CRHR2 | 1.057435 | 4.66E-06 | 0.000686 | 4.886267 | Up | corticotropin releasing hormone receptor 2 | |
| KRT20 | 1.041956 | 5.47E-06 | 0.000738 | 4.845569 | Up | keratin 20 | |
| CYP2F1 | 0.996571 | 5.49E-06 | 0.000738 | 4.844967 | Up | cytochrome P450 family 2 subfamily F member 1 | |
| TBX20 | 0.915545 | 6.65E-06 | 0.000852 | 4.796325 | Up | T-box transcription factor 20 | |
| TEX15 | 1.040483 | 6.7E-06 | 0.000852 | 4.794446 | Up | testis expressed 15, meiosis and synapsis associated | |
| REN | 0.918655 | 7.4E-06 | 0.00091 | 4.769059 | Up | renin | |
| RDH8 | 1.031642 | 8.2E-06 | 0.000925 | 4.743027 | Up | retinol dehydrogenase 8 | |
| PADI3 | 1.004196 | 8.23E-06 | 0.000925 | 4.742198 | Up | peptidyl arginine deiminase 3 | |
| RIMS4 | 1.005408 | 8.44E-06 | 0.000925 | 4.735751 | Up | regulating synaptic membrane exocytosis 4 | |
| MS4A5 | 0.988204 | 8.45E-06 | 0.000925 | 4.735279 | Up | membrane spanning 4-domains A5 | |
| HFM1 | 1.083591 | 1.04E-05 | 0.001038 | 4.683383 | Up | helicase for meiosis 1 | |
| EGFR | 1.045618 | 1.16E-05 | 0.001078 | 4.655195 | Up | epidermal growth factor receptor | |
| C10orf113 | 0.984302 | 1.27E-05 | 0.001122 | 4.629975 | Up | chromosome 10 open reading frame 113 | |
| RGS4 | 0.968679 | 1.28E-05 | 0.001122 | 4.629106 | Up | regulator of G protein signaling 4 | |
| C2orf73 | 0.965222 | 1.29E-05 | 0.001122 | 4.626793 | Up | chromosome 2 open reading frame 73 | |
| ACSBG2 | 1.181896 | 1.27E-05 | 0.001122 | 4.631273 | Up | acyl-CoA synthetasebubblegum family member 2 | |
| BTBD18 | 0.963267 | 1.41E-05 | 0.001181 | 4.604073 | Up | BTB domain containing 18 | |
| DPPA5 | 0.954617 | 1.44E-05 | 0.001195 | 4.598614 | Up | developmental pluripotency associated 5 | |
| OR10J3 | 0.985446 | 1.56E-05 | 0.001237 | 4.578119 | Up | olfactory receptor family 10 subfamily J member 3 | |
| KCNK4 | 1.033357 | 1.57E-05 | 0.001237 | 4.575705 | Up | potassium two pore domain channel subfamily K member 4 | |
| LRAT | 0.925599 | 1.61E-05 | 0.001259 | 4.568727 | Up | lecithin retinol acyltransferase | |
| IL17B | 0.958598 | 1.72E-05 | 0.001302 | 4.551641 | Up | interleukin 17B | |
| FBXO10 | 1.012141 | 1.76E-05 | 0.001319 | 4.545579 | Up | F-box protein 10 | |
| LRRC74A | 0.894289 | 1.78E-05 | 0.001319 | 4.54289 | Up | leucine rich repeat containing 74A | |
| TM4SF5 | 0.988935 | 1.86E-05 | 0.001335 | 4.531217 | Up | transmembrane 4 L six family member 5 | |
| OR2T29 | 0.956232 | 1.89E-05 | 0.001335 | 4.527962 | Up | olfactory receptor family 2 subfamily T member 29 | |
| RNF180 | 1.050934 | 1.89E-05 | 0.001335 | 4.526775 | Up | ring finger protein 180 | |
| MYOT | 0.998153 | 1.9E-05 | 0.001335 | 4.525922 | Up | myotilin | |
| SLC22A25 | 0.905085 | 2.1E-05 | 0.001407 | 4.499193 | Up | solute carrier family 22 member 25 | |
| CMA1 | 0.871927 | 2.12E-05 | 0.001407 | 4.497403 | Up | chymase 1 | |
| PCDHB10 | 1.017337 | 2.14E-05 | 0.001407 | 4.494598 | Up | protocadherin beta 10 | |
| HRCT1 | 0.931584 | 2.16E-05 | 0.001407 | 4.492152 | Up | histidine rich carboxyl terminus 1 | |
| TRHR | 0.967196 | 2.17E-05 | 0.001407 | 4.491435 | Up | thyrotropin releasing hormone receptor | |
| NACA2 | 1.235555 | 2.15E-05 | 0.001407 | 4.494057 | Up | nascent polypeptide associated complex subunit alpha 2 | |
| CCL19 | 1.05675 | 2.17E-05 | 0.001407 | 4.490985 | Up | C-C motif chemokine ligand 19 | |
| DMRTA2 | 0.919949 | 2.31E-05 | 0.001446 | 4.474549 | Up | DMRT like family A2 | |
| NRAP | 0.970444 | 2.42E-05 | 0.001479 | 4.46211 | Up | nebulin related anchoring protein | |
| DNAH3 | 0.948597 | 2.46E-05 | 0.001483 | 4.458656 | Up | dynein axonemal heavy chain 3 | |
| CCL13 | 1.008793 | 2.46E-05 | 0.001483 | 4.458373 | Up | C-C motif chemokine ligand 13 | |
| OSR1 | 0.99949 | 2.47E-05 | 0.001483 | 4.456576 | Up | odd-skipped related transcription factor 1 | |
| TMEM145 | 0.966024 | 2.46E-05 | 0.001483 | 4.457613 | Up | transmembrane protein 145 | |
| AVP | 0.940076 | 2.5E-05 | 0.00149 | 4.453465 | Up | arginine vasopressin | |
| CSHL1 | 0.84012 | 2.55E-05 | 0.001496 | 4.44882 | Up | chorionic somatomammotropin hormone like 1 | |
| LHFPL3 | 1.029874 | 2.56E-05 | 0.001497 | 4.44723 | Up | LHFPL tetraspan subfamily member 3 | |
| SNAP91 | 1.023292 | 2.57E-05 | 0.001497 | 4.446795 | Up | synaptosome associated protein 91 | |
| SOX18 | 1.029443 | 2.6E-05 | 0.001504 | 4.44371 | Up | SRY-box transcription factor 18 | |
| CAP2 | 1.0769 | 2.63E-05 | 0.001511 | 4.440701 | Up | cyclase associated actin cytoskeleton regulatory protein 2 | |
| C1orf146 | 0.912546 | 2.69E-05 | 0.001529 | 4.434806 | Up | chromosome 1 open reading frame 146 | |
| PDE6C | 0.880944 | 2.82E-05 | 0.001574 | 4.421773 | Up | phosphodiesterase 6C | |
| CRYAA | 0.894932 | 2.89E-05 | 0.001596 | 4.41523 | Up | crystallin alpha A | |
| NR0B2 | 0.903675 | 2.9E-05 | 0.001596 | 4.414618 | Up | nuclear receptor subfamily 0 group B member 2 | |
| ANKRD30B | 0.953544 | 2.93E-05 | 0.001599 | 4.411547 | Up | ankyrin repeat domain 30B | |
| CST6 | 0.946705 | 3.04E-05 | 0.001632 | 4.401733 | Up | cystatin E/M | |
| CAMK1G | 0.956887 | 3.05E-05 | 0.001632 | 4.401395 | Up | calcium/calmodulin dependent protein kinase IG | |
| CYP39A1 | 0.879266 | 3.08E-05 | 0.001632 | 4.399046 | Up | cytochrome P450 family 39 subfamily A member 1 | |
| ZNF214 | 0.948008 | 3.14E-05 | 0.001653 | 4.393435 | Up | zinc finger protein 214 | |
| MRGPRF | 0.936902 | 3.18E-05 | 0.001666 | 4.390434 | Up | MAS related GPR family member F | |
| PTPRT | 1.102577 | 3.22E-05 | 0.001674 | 4.386782 | Up | protein tyrosine phosphatase receptor type T | |
| KRT39 | 1.081629 | 3.21E-05 | 0.001674 | 4.387502 | Up | keratin 39 | |
| PHF21B | 0.897853 | 3.26E-05 | 0.001681 | 4.383695 | Up | PHD finger protein 21B | |
| ABRA | 0.967897 | 3.26E-05 | 0.001681 | 4.383147 | Up | actin binding Rho activating protein | |
| ADGRF4 | 0.958187 | 3.3E-05 | 0.001693 | 4.380467 | Up | adhesion G protein-coupled receptor F4 | |
| ABCC12 | 0.932702 | 3.35E-05 | 0.001709 | 4.376353 | Up | ATP binding cassette subfamily C member 12 | |
| SLC16A8 | 0.908131 | 3.38E-05 | 0.001712 | 4.374274 | Up | solute carrier family 16 member 8 | |
| ATP6V1G2-DDX39B | 0.990995 | 3.4E-05 | 0.001715 | 4.372164 | Up | ATP6V1G2-DDX39B readthrough (NMD candidate) | |
| LEMD1 | 0.846889 | 3.51E-05 | 0.001738 | 4.363856 | Up | LEM domain containing 1 | |
| KPNA7 | 0.953213 | 3.51E-05 | 0.001738 | 4.363815 | Up | karyopherin subunit alpha 7 | |
| MYH6 | 0.952519 | 3.56E-05 | 0.001753 | 4.359936 | Up | myosin heavy chain 6 | |
| FRMPD2 | 0.957963 | 3.68E-05 | 0.001757 | 4.351517 | Up | FERM and PDZ domain containing 2 | |
| SULT6B1 | 0.965243 | 3.69E-05 | 0.001757 | 4.350796 | Up | sulfotransferase family 6B member 1 | |
| HSD3B2 | 0.933208 | 3.7E-05 | 0.001757 | 4.3496 | Up | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | |
| SULF1 | 0.9309 | 3.71E-05 | 0.001757 | 4.349307 | Up | sulfatase 1 | |
| G6PC | 1.038462 | 3.71E-05 | 0.001757 | 4.349175 | Up | glucose-6-phosphatase catalytic subunit | |
| MTRNR2L6 | 1.015308 | 3.72E-05 | 0.001757 | 4.348247 | Up | MT-RNR2 like 6 | |
| IZUMO1 | 0.863468 | 3.73E-05 | 0.001757 | 4.347643 | Up | izumo sperm-egg fusion 1 | |
| CFAP77 | 0.854205 | 3.75E-05 | 0.001757 | 4.346388 | Up | cilia and flagella associated protein 77 | |
| GPR37 | 0.969013 | 3.75E-05 | 0.001757 | 4.346128 | Up | G protein-coupled receptor 37 | |
| OR6C70 | 0.996132 | 3.78E-05 | 0.001757 | 4.344383 | Up | olfactory receptor family 6 subfamily C member 70 | |
| URGCP-MRPS24 | 0.929538 | 3.8E-05 | 0.001759 | 4.342672 | Up | URGCP-MRPS24 readthrough | |
| SLC26A3 | 0.912109 | 3.84E-05 | 0.001766 | 4.33951 | Up | solute carrier family 26 member 3 | |
| ITGBL1 | 0.89074 | 3.88E-05 | 0.001766 | 4.337347 | Up | integrin subunit beta like 1 | |
| LOC102725072 | 0.93312 | 3.88E-05 | 0.001766 | 4.336863 | Up | Putative uncharacterized protein DKFZp434K191 | |
| BLACE | 0.837756 | 3.94E-05 | 0.001771 | 4.332862 | Up | B cell acute lymphoblastic leukemia expressed | |
| LOC100131496 | 0.873058 | 3.96E-05 | 0.001771 | 4.331895 | Up | uncharacterized LOC100131496 | |
| LIPF | 0.971728 | 3.97E-05 | 0.001771 | 4.331252 | Up | lipase F, gastric type | |
| FNDC8 | 0.897073 | 4E-05 | 0.001771 | 4.3287 | Up | fibronectin type III domain containing 8 | |
| LOC389199 | 0.873159 | 4.1E-05 | 0.001785 | 4.322016 | Up | uncharacterized LOC389199 | |
| OR2K2 | 0.856644 | 4.28E-05 | 0.001834 | 4.310597 | Up | olfactory receptor family 2 subfamily K member 2 | |
| FABP6 | 0.940984 | 4.31E-05 | 0.001842 | 4.308644 | Up | fatty acid binding protein 6 | |
| SPATA16 | 0.946274 | 4.37E-05 | 0.001845 | 4.305413 | Up | spermatogenesis associated 16 | |
| SMCO1 | 1.042857 | 4.36E-05 | 0.001845 | 4.305897 | Up | single-pass membrane protein with coiled-coil domains 1 | |
| PCDHB2 | 1.169306 | 4.41E-05 | 0.001855 | 4.302798 | Up | protocadherin beta 2 | |
| FAM243A | 0.902671 | 4.49E-05 | 0.001866 | 4.29812 | Up | family with sequence similarity 243 member A | |
| HOXB8 | 0.886424 | 4.51E-05 | 0.001866 | 4.296412 | Up | homeobox B8 | |
| LMO1 | 0.892873 | 4.53E-05 | 0.00187 | 4.29529 | Up | LIM domain only 1 | |
| MAS1L | 0.89613 | 4.56E-05 | 0.001876 | 4.293436 | Up | MAS1 proto-oncogene like, G protein-coupled receptor | |
| GLYATL3 | 0.90734 | 4.59E-05 | 0.001876 | 4.291841 | Up | glycine-N-acyltransferase like 3 | |
| UGT2A1 | 0.870199 | 4.69E-05 | 0.001883 | 4.286149 | Up | UDP glucuronosyltransferase family 2 member A1 complex locus | |
| RERG | 0.939549 | 4.69E-05 | 0.001883 | 4.286306 | Up | RAS like estrogen regulated growth inhibitor | |
| CELA2A | 0.924629 | 4.7E-05 | 0.001883 | 4.285588 | Up | chymotrypsin like elastase 2A | |
| LRFN5 | 0.946274 | 4.8E-05 | 0.001915 | 4.279702 | Up | leucine rich repeat and fibronectin type III domain containing 5 | |
| PAX3 | 0.826938 | 4.83E-05 | 0.001921 | 4.27827 | Up | paired box 3 | |
| KIF1A | 0.973095 | 4.86E-05 | 0.001927 | 4.276802 | Up | kinesin family member 1A | |
| MRGPRE | 0.86341 | 4.93E-05 | 0.001952 | 4.272623 | Up | MAS related GPR family member E | |
| NPY | 0.877892 | 4.99E-05 | 0.001962 | 4.269525 | Up | neuropeptide Y | |
| EFS | 1.003465 | 5E-05 | 0.001962 | 4.269001 | Up | embryonal Fyn-associated substrate | |
| ZSCAN1 | 0.921942 | 5.02E-05 | 0.001962 | 4.26778 | Up | zinc finger and SCAN domain containing 1 | |
| MEIOB | 0.971239 | 5.03E-05 | 0.001962 | 4.267016 | Up | meiosis specific with OB-fold | |
| TMPRSS15 | 0.884284 | 5.02E-05 | 0.001962 | 4.267806 | Up | transmembrane serine protease 15 | |
| DRD2 | 0.861436 | 5.04E-05 | 0.001962 | 4.266826 | Up | dopamine receptor D2 | |
| CNMD | 0.959271 | 5.05E-05 | 0.001963 | 4.266074 | Up | chondromodulin | |
| AMBP | 0.883904 | 5.08E-05 | 0.001966 | 4.264596 | Up | alpha-1-microglobulin/bikunin precursor | |
| C8orf34 | 0.874882 | 5.16E-05 | 0.00198 | 4.260541 | Up | chromosome 8 open reading frame 34 | |
| EGR4 | 0.93485 | 5.19E-05 | 0.001987 | 4.25858 | Up | early growth response 4 | |
| LGALS7 | 0.958985 | 5.24E-05 | 0.001987 | 4.255983 | Up | galectin 7 | |
| INHA | 0.858348 | 5.23E-05 | 0.001987 | 4.256562 | Up | inhibin subunit alpha | |
| MNX1 | 0.845332 | 5.28E-05 | 0.00199 | 4.254289 | Up | motor neuron and pancreas homeobox 1 | |
| SLC10A1 | 0.889098 | 5.41E-05 | 0.002017 | 4.247721 | Up | solute carrier family 10 member 1 | |
| NPBWR1 | 0.965049 | 5.42E-05 | 0.002017 | 4.246995 | Up | neuropeptides B and W receptor 1 | |
| PMF1-BGLAP | 0.976467 | 5.45E-05 | 0.002025 | 4.245385 | Up | PMF1-BGLAP readthrough | |
| LHCGR | 0.897295 | 5.57E-05 | 0.002041 | 4.239485 | Up | luteinizing hormone/choriogonadotropin receptor | |
| NT5C1A | 0.86506 | 5.59E-05 | 0.002041 | 4.238871 | Up | 5′-nucleotidase, cytosolic IA | |
| ASCL1 | 0.918002 | 5.6E-05 | 0.002041 | 4.238038 | Up | achaete-scute family bHLH transcription factor 1 | |
| CCDC140 | 0.969595 | 5.61E-05 | 0.002041 | 4.237583 | Up | coiled-coil domain containing 140 | |
| NEUROG3 | 0.951564 | 5.79E-05 | 0.002073 | 4.229287 | Up | neurogenin 3 | |
| TMC2 | 1.236136 | 5.62E-05 | 0.002041 | 4.237443 | Up | transmembrane channel like 2 | |
| MINDY4B | 1.034321 | 5.81E-05 | 0.002073 | 4.228387 | Up | MINDY family member 4B | |
| COL3A1 | 0.899332 | 5.86E-05 | 0.002073 | 4.226076 | Up | collagen type III alpha 1 chain | |
| SLCO6A1 | 0.920379 | 5.89E-05 | 0.002073 | 4.224473 | Up | solute carrier organic anion transporter family member 6A1 | |
| THRSP | 0.891603 | 5.93E-05 | 0.002073 | 4.222727 | Up | thyroid hormone responsive | |
| DBX2 | 0.883726 | 5.93E-05 | 0.002073 | 4.222452 | Up | developing brain homeobox 2 | |
| OR52N5 | 0.874656 | 5.94E-05 | 0.002073 | 4.221942 | Up | olfactory receptor family 52 subfamily N member 5 | |
| ANO4 | 0.891458 | 5.95E-05 | 0.002073 | 4.22163 | Up | anoctamin 4 | |
| RPRML | 1.013736 | 5.96E-05 | 0.002073 | 4.22104 | Up | reprimo like | |
| LIPM | 0.857463 | 5.97E-05 | 0.002073 | 4.220906 | Up | lipase family member M | |
| EFCAB3 | 0.930354 | 5.98E-05 | 0.002073 | 4.220334 | Up | EF-hand calcium binding domain 3 | |
| LRRC2-AS1 | 0.891603 | 5.99E-05 | 0.002073 | 4.220002 | Up | LRRC2 antisense RNA 1 | |
| GJA1 | 0.940111 | 5.94E-05 | 0.002073 | 4.222116 | Up | gap junction protein alpha 1 | |
| OR51E1 | 0.966601 | 6.13E-05 | 0.002103 | 4.21374 | Up | olfactory receptor family 51 subfamily E member 1 | |
| ANP32D | 0.855187 | 6.14E-05 | 0.002103 | 4.213256 | Up | acidic nuclear phosphoprotein 32 family member D | |
| FMC1-LUC7L2 | 0.914577 | 6.21E-05 | 0.002109 | 4.21018 | Up | FMC1-LUC7L2 readthrough | |
| PRLHR | 0.905404 | 6.26E-05 | 0.002114 | 4.207869 | Up | prolactin releasing hormone receptor | |
| PPFIA2 | 0.962581 | 6.28E-05 | 0.002114 | 4.206985 | Up | PTPRF interacting protein alpha 2 | |
| IRX5 | 0.930915 | 6.35E-05 | 0.002124 | 4.203899 | Up | iroquoishomeobox 5 | |
| CSRNP3 | 0.893691 | 6.37E-05 | 0.002125 | 4.20305 | Up | cysteine and serine rich nuclear protein 3 | |
| DAND5 | 0.869683 | 6.39E-05 | 0.002125 | 4.20215 | Up | DAN domain BMP antagonist family member 5 | |
| NKAIN4 | 0.986106 | 6.38E-05 | 0.002125 | 4.202648 | Up | sodium/potassium transporting ATPase interacting 4 | |
| TMPRSS11B | 0.859699 | 6.45E-05 | 0.002126 | 4.19958 | Up | transmembrane serine protease 11B | |
| GULP1 | 0.98403 | 6.48E-05 | 0.002126 | 4.198514 | Up | GULP PTB domain containing engulfment adaptor 1 | |
| ADGRL4 | 0.967777 | 6.53E-05 | 0.002135 | 4.196582 | Up | adhesion G protein-coupled receptor L4 | |
| HOXD8 | 0.897017 | 6.6E-05 | 0.002143 | 4.193495 | Up | homeobox D8 | |
| OR52N1 | 0.839763 | 6.66E-05 | 0.002154 | 4.191133 | Up | olfactory receptor family 52 subfamily N member 1 | |
| LINC01555 | 0.897816 | 6.66E-05 | 0.002154 | 4.190957 | Up | long intergenic non-protein coding RNA 1555 | |
| CA10 | 1.011486 | 6.89E-05 | 0.002212 | 4.181597 | Up | carbonic anhydrase 10 | |
| CYP2W1 | 0.875193 | 7.07E-05 | 0.002224 | 4.174858 | Up | cytochrome P450 family 2 subfamily W member 1 | |
| CCDC27 | 0.885529 | 7.08E-05 | 0.002224 | 4.174477 | Up | coiled-coil domain containing 27 | |
| MYH7 | 0.885529 | 7.08E-05 | 0.002224 | 4.174477 | Up | myosin heavy chain 7 | |
| GNAT1 | 0.885529 | 7.08E-05 | 0.002224 | 4.174477 | Up | G protein subunit alpha transducin 1 | |
| NPPC | 0.964362 | 7.36E-05 | 0.002263 | 4.163694 | Up | natriuretic peptide C | |
| CBLC | 0.891165 | 7.5E-05 | 0.002292 | 4.158584 | Up | Cbl proto-oncogene C | |
| TRIM55 | 0.945582 | 7.46E-05 | 0.002284 | 4.160085 | Up | tripartite motif containing 55 | |
| EEF1G | 0.83887 | 7.57E-05 | 0.002293 | 4.155878 | Up | eukaryotic translation elongation factor 1 gamma | |
| ADCYAP1R1 | 0.896389 | 7.58E-05 | 0.002293 | 4.155685 | Up | ADCYAP receptor type I | |
| TAFA4 | 0.838908 | 7.58E-05 | 0.002293 | 4.155485 | Up | TAFA chemokine like family member 4 | |
| OVOL1 | 0.884916 | 7.57E-05 | 0.002293 | 4.156118 | Up | ovo like transcriptional repressor 1 | |
| EFEMP1 | 0.913807 | 7.67E-05 | 0.002304 | 4.152284 | Up | EGF containing fibulin extracellular matrix protein 1 | |
| SLC36A2 | 0.897775 | 7.69E-05 | 0.002304 | 4.151795 | Up | solute carrier family 36 member 2 | |
| SPINK13 | 0.860333 | 7.76E-05 | 0.002322 | 4.149133 | Up | serine peptidase inhibitor, Kazal type 13 (putative) | |
| CCDC158 | 0.832487 | 7.97E-05 | 0.002364 | 4.141709 | Up | coiled-coil domain containing 158 | |
| RBAK-RBAKDN | 0.916027 | 8.11E-05 | 0.002396 | 4.137123 | Up | RBAK-RBAKDN readthrough | |
| CCL17 | 0.896315 | 8.25E-05 | 0.002434 | 4.132223 | Up | C-C motif chemokine ligand 17 | |
| SELE | 0.850167 | 8.29E-05 | 0.002443 | 4.130829 | Up | selectin E | |
| GOLGA6B | 0.9457 | 8.37E-05 | 0.002446 | 4.128465 | Up | golgin A6 family member B | |
| IGFL4 | 0.850147 | 8.44E-05 | 0.002452 | 4.125895 | Up | IGF like family member 4 | |
| CNTFR | 0.883786 | 8.48E-05 | 0.002457 | 4.124845 | Up | ciliaryneurotrophic factor receptor | |
| C1orf141 | 0.949302 | 8.51E-05 | 0.00246 | 4.123621 | Up | chromosome 1 open reading frame 141 | |
| NOS1 | 0.932437 | 8.63E-05 | 0.002471 | 4.119973 | Up | nitric oxide synthase 1 | |
| REG1B | 0.893055 | 8.76E-05 | 0.002495 | 4.115883 | Up | regenerating family member 1 beta | |
| CAPSL | 0.894376 | 8.79E-05 | 0.002501 | 4.114845 | Up | calcyphosine like | |
| C1QTNF7 | 0.883655 | 8.86E-05 | 0.002513 | 4.112561 | Up | C1q and TNF related 7 | |
| RHBDL2 | 0.883638 | 8.88E-05 | 0.002513 | 4.111975 | Up | rhomboid like 2 | |
| TEAD4 | 0.893342 | 8.91E-05 | 0.002513 | 4.111195 | Up | TEA domain transcription factor 4 | |
| PRRX1 | 0.923623 | 8.93E-05 | 0.002513 | 4.110382 | Up | paired related homeobox 1 | |
| SERPINB12 | 0.833849 | 8.95E-05 | 0.002513 | 4.109731 | Up | serpin family B member 12 | |
| TBX10 | 0.833115 | 9E-05 | 0.002513 | 4.108444 | Up | T-box transcription factor 10 | |
| COL6A5 | 0.920311 | 9.01E-05 | 0.002513 | 4.108069 | Up | collagen type VI alpha 5 chain | |
| KLK4 | 0.837318 | 9.03E-05 | 0.002513 | 4.107393 | Up | kallikrein related peptidase 4 | |
| GRIN2B | 0.950071 | 9.06E-05 | 0.002513 | 4.106573 | Up | glutamate ionotropic receptor NMDA type subunit 2B | |
| RGS20 | 0.900519 | 9.07E-05 | 0.002513 | 4.106097 | Up | regulator of G protein signaling 20 | |
| ZNF728 | 0.883605 | 9.14E-05 | 0.002515 | 4.103954 | Up | zinc finger protein 728 | |
| SIX4 | 0.85187 | 9.18E-05 | 0.002518 | 4.102815 | Up | SIX homeobox 4 | |
| NPFFR2 | 0.929088 | 9.21E-05 | 0.002521 | 4.101991 | Up | neuropeptide FF receptor 2 | |
| ANKRD62 | 0.899096 | 9.23E-05 | 0.002521 | 4.101348 | Up | ankyrin repeat domain 62 | |
| CLLU1 | 1.132069 | 9.03E-05 | 0.002513 | 4.10742 | Up | chronic lymphocytic leukemia up-regulated 1 | |
| CNTNAP4 | 0.914215 | 9.32E-05 | 0.002528 | 4.09853 | Up | contactin associated protein like 4 | |
| COL12A1 | 0.912316 | 9.56E-05 | 0.002587 | 4.091597 | Up | collagen type XII alpha 1 chain | |
| EBF3 | 0.839069 | 9.7E-05 | 0.002604 | 4.087742 | Up | EBF transcription factor 3 | |
| GRIA4 | 0.979336 | 9.8E-05 | 0.002614 | 4.084733 | Up | glutamate ionotropic receptor AMPA type subunit 4 | |
| PTHLH | 0.963725 | 9.8E-05 | 0.002614 | 4.08484 | Up | parathyroid hormone like hormone | |
| SLC9A2 | 0.881992 | 9.82E-05 | 0.002614 | 4.084262 | Up | solute carrier family 9 member A2 | |
| HEPHL1 | 0.882607 | 9.86E-05 | 0.002619 | 4.083035 | Up | hephaestin like 1 | |
| SCG3 | 0.893171 | 9.91E-05 | 0.00262 | 4.081758 | Up | secretogranin III | |
| SIX1 | 0.921197 | 9.92E-05 | 0.00262 | 4.081507 | Up | SIX homeobox 1 | |
| TSPYL6 | 0.891306 | 9.97E-05 | 0.002628 | 4.07987 | Up | TSPY like 6 | |
| IRGC | 0.839346 | 0.0001 | 0.002634 | 4.078065 | Up | immunity related GTPase cinema | |
| GPR6 | 0.930096 | 0.000101 | 0.00264 | 4.076739 | Up | G protein-coupled receptor 6 | |
| SCN3B | 0.832646 | 0.000101 | 0.00264 | 4.076478 | Up | sodium voltage-gated channel beta subunit 3 | |
| EMILIN3 | 0.967257 | 0.000102 | 0.002653 | 4.074049 | Up | elastin microfibrilinterfacer 3 | |
| EPN3 | 0.914055 | 0.000104 | 0.002683 | 4.068937 | Up | epsin 3 | |
| PDLIM4 | 0.933994 | 0.000104 | 0.002683 | 4.068455 | Up | PDZ and LIM domain 4 | |
| DCC | 1.037614 | 0.000106 | 0.002705 | 4.06329 | Up | DCC netrin 1 receptor | |
| IL9 | 0.854817 | 0.000107 | 0.002723 | 4.060443 | Up | interleukin 9 | |
| GRM5 | 0.826169 | 0.000108 | 0.002744 | 4.057559 | Up | glutamate metabotropic receptor 5 | |
| ODF3L2 | 0.894219 | 0.000108 | 0.002744 | 4.057227 | Up | outer dense fiber of sperm tails 3 like 2 | |
| C5orf60 | 0.929657 | 0.000113 | 0.002843 | 4.044374 | Up | chromosome 5 open reading frame 60 | |
| LRRC3B | 0.885916 | 0.000114 | 0.002843 | 4.042437 | Up | leucine rich repeat containing 3B | |
| NLRP14 | 0.859959 | 0.000114 | 0.002843 | 4.043418 | Up | NLR family pyrin domain containing 14 | |
| SLC25A51P4 | 0.889805 | 0.000117 | 0.002902 | 4.035322 | Up | SLC25A51 pseudogene 4 | |
| FOXD4L4 | 0.839378 | 0.00012 | 0.002931 | 4.028918 | Up | forkhead box D4 like 4 | |
| PGR | 0.831922 | 0.00012 | 0.002931 | 4.028878 | Up | progesterone receptor | |
| PRL | 1.125879 | 0.000118 | 0.002906 | 4.034159 | Up | prolactin | |
| C3orf79 | 0.857368 | 0.000121 | 0.00294 | 4.025807 | Up | chromosome 3 open reading frame 79 | |
| SERPIND1 | 0.906509 | 0.000121 | 0.002937 | 4.0271 | Up | serpin family D member 1 | |
| S100A7A | 0.847703 | 0.000122 | 0.002953 | 4.023133 | Up | S100 calcium binding protein A7A | |
| EN1 | 0.9169 | 0.000124 | 0.002964 | 4.018471 | Up | engrailed homeobox 1 | |
| KRT38 | 1.042088 | 0.000125 | 0.002971 | 4.016678 | Up | keratin 38 | |
| LINC02108 | 0.846143 | 0.000126 | 0.002975 | 4.014499 | Up | long intergenic non-protein coding RNA 2108 | |
| GPR158 | 0.831736 | 0.000126 | 0.002975 | 4.013975 | Up | G protein-coupled receptor 158 | |
| ACSM6 | 0.908554 | 0.000128 | 0.002993 | 4.011439 | Up | acyl-CoA synthetase medium chain family member 6 | |
| ASPA | 0.871659 | 0.000129 | 0.003 | 4.007633 | Up | aspartoacylase | |
| SH3GL2 | 0.918924 | 0.000132 | 0.003024 | 4.001385 | Up | SH3 domain containing GRB2 like 2, endophilin A1 | |
| HAO1 | 0.826311 | 0.000133 | 0.00303 | 4.000253 | Up | hydroxyacid oxidase 1 | |
| PDPN | 0.889264 | 0.000134 | 0.003031 | 3.996743 | Up | podoplanin | |
| CWH43 | 0.839103 | 0.000135 | 0.003032 | 3.996334 | Up | cell wall biogenesis 43 C-terminal homolog | |
| OR6S1 | 0.835524 | 0.000135 | 0.003042 | 3.994961 | Up | olfactory receptor family 6 subfamily S member 1 | |
| OR51B4 | 0.827743 | 0.000137 | 0.003053 | 3.992138 | Up | olfactory receptor family 51 subfamily B member 4 | |
| NPBWR2 | 0.868277 | 0.000138 | 0.003069 | 3.989344 | Up | neuropeptides B and W receptor 2 | |
| THSD4 | 0.846128 | 0.000138 | 0.003069 | 3.988521 | Up | thrombospondin type 1 domain containing 4 | |
| ADAMTS9 | 0.834461 | 0.000139 | 0.003069 | 3.988039 | Up | ADAM metallopeptidase with thrombospondin type 1 motif 9 | |
| FOXQ1 | 1.443796 | 0.000136 | 0.003044 | 3.993401 | Up | forkhead box Q1 | |
| PLN | 0.949551 | 0.000139 | 0.00307 | 3.986876 | Up | phospholamban | |
| MAP3K19 | 0.87061 | 0.000141 | 0.00309 | 3.982479 | Up | mitogen-activated protein kinase kinasekinase 19 | |
| CSNK1A1L | 1.098186 | 0.000141 | 0.00309 | 3.983183 | Up | casein kinase 1 alpha 1 like | |
| BARX2 | 0.902302 | 0.000142 | 0.003091 | 3.981995 | Up | BARX homeobox 2 | |
| ISY1-RAB43 | 0.930431 | 0.000143 | 0.003092 | 3.980065 | Up | ISY1-RAB43 readthrough | |
| NELL1 | 0.869267 | 0.000146 | 0.003138 | 3.972653 | Up | neural EGFL like 1 | |
| WT1 | 0.833065 | 0.000148 | 0.003154 | 3.968739 | Up | WT1 transcription factor | |
| CTCFL | 0.834806 | 0.000151 | 0.003178 | 3.963845 | Up | CCCTC-binding factor like | |
| REG1A | 0.848322 | 0.000151 | 0.003178 | 3.962989 | Up | regenerating family member 1 alpha | |
| CELA2B | 0.861666 | 0.000153 | 0.003182 | 3.960649 | Up | chymotrypsin like elastase 2B | |
| PRELP | 0.854017 | 0.000153 | 0.003182 | 3.960358 | Up | proline and arginine rich end leucine rich repeat protein | |
| CNTN2 | 0.848239 | 0.000154 | 0.003184 | 3.958439 | Up | contactin 2 | |
| CRP | 0.836218 | 0.000154 | 0.003184 | 3.958316 | Up | C-reactive protein | |
| GGTLC2 | 0.890003 | 0.000157 | 0.003207 | 3.953599 | Up | gamma-glutamyltransferase light chain 2 | |
| FSD2 | 0.856494 | 0.000156 | 0.003207 | 3.953925 | Up | fibronectin type III and SPRY domain containing 2 | |
| MYH4 | 0.862217 | 0.000157 | 0.003207 | 3.953188 | Up | myosin heavy chain 4 | |
| TUBA3C | 0.881504 | 0.00016 | 0.003247 | 3.947266 | Up | tubulin alpha 3c | |
| HSD11B2 | 0.865869 | 0.000164 | 0.003268 | 3.941252 | Up | hydroxysteroid 11-beta dehydrogenase 2 | |
| MKRN2OS | 0.852903 | 0.000164 | 0.003273 | 3.940266 | Up | MKRN2 opposite strand | |
| SYT4 | 0.859298 | 0.000164 | 0.003275 | 3.939713 | Up | synaptotagmin 4 | |
| TM4SF20 | 0.900136 | 0.000167 | 0.003292 | 3.934626 | Up | transmembrane 4 L six family member 20 | |
| LRP2 | 0.963595 | 0.000167 | 0.003292 | 3.935053 | Up | LDL receptor related protein 2 | |
| ADAM7 | 0.872506 | 0.00017 | 0.00331 | 3.930757 | Up | ADAM metallopeptidase domain 7 | |
| GPR15 | 0.902774 | 0.000212 | 0.003705 | 3.867416 | Up | G protein-coupled receptor 15 | |
| SMTNL2 | 0.867183 | 0.000173 | 0.00334 | 3.92602 | Up | smoothelin like 2 | |
| APOH | 0.921926 | 0.000173 | 0.00334 | 3.924941 | Up | apolipoprotein H | |
| FCAMR | 0.946932 | 0.000174 | 0.003343 | 3.924287 | Up | Fc fragment of IgA and IgM receptor | |
| TRPA1 | 0.914295 | 0.000175 | 0.003346 | 3.922484 | Up | transient receptor potential cation channel subfamily A member 1 | |
| WIF1 | 0.847809 | 0.000176 | 0.00336 | 3.919958 | Up | WNT inhibitory factor 1 | |
| CLDN20 | 0.883524 | 0.000177 | 0.003361 | 3.919207 | Up | claudin 20 | |
| OPRM1 | 0.913422 | 0.000177 | 0.003361 | 3.919346 | Up | opioid receptor mu 1 | |
| CCDC198 | 0.938346 | 0.000177 | 0.003364 | 3.918639 | Up | coiled-coil domain containing 198 | |
| FREM3 | 0.956335 | 0.000182 | 0.003437 | 3.910621 | Up | FRAS1 related extracellular matrix 3 | |
| ANKRD18B | 1.013694 | 0.000183 | 0.003441 | 3.908794 | Up | ankyrin repeat domain 18B | |
| AMY1A | 0.94182 | 0.000183 | 0.003441 | 3.908943 | Up | amylase alpha 1A | |
| C2orf80 | 0.907847 | 0.000188 | 0.003491 | 3.902387 | Up | chromosome 2 open reading frame 80 | |
| SP9 | 0.90324 | 0.000188 | 0.003492 | 3.901414 | Up | Sp9 transcription factor | |
| SLCO1C1 | 0.9077 | 0.000194 | 0.003562 | 3.89294 | Up | solute carrier organic anion transporter family member 1C1 | |
| RFX6 | 0.897237 | 0.000195 | 0.003562 | 3.891995 | Up | regulatory factor X6 | |
| MRO | 0.892061 | 0.000195 | 0.003563 | 3.891612 | Up | maestro | |
| THSD7B | 0.829227 | 0.000196 | 0.003567 | 3.890001 | Up | thrombospondin type 1 domain containing 7B | |
| C11orf44 | 0.825633 | 0.000197 | 0.003573 | 3.888583 | Up | chromosome 11 open reading frame 44 | |
| PDE11A | 0.882109 | 0.0002 | 0.003608 | 3.88364 | Up | phosphodiesterase 11A | |
| BTC | 0.842319 | 0.000202 | 0.003619 | 3.881898 | Up | betacellulin | |
| C14orf39 | 0.852061 | 0.000202 | 0.003625 | 3.881117 | Up | chromosome 14 open reading frame 39 | |
| KCNIP1 | 0.831954 | 0.000203 | 0.003634 | 3.879927 | Up | potassium voltage-gated channel interacting protein 1 | |
| DDC | 0.899141 | 0.000205 | 0.003655 | 3.876928 | Up | dopa decarboxylase | |
| KRTAP10–5 | 0.83581 | 0.000206 | 0.003664 | 3.875023 | Up | keratin associated protein 10–5 | |
| B3GALT1 | 0.865828 | 0.000207 | 0.003672 | 3.874106 | Up | beta-1,3-galactosyltransferase 1 | |
| KCNT2 | 0.882533 | 0.000209 | 0.003692 | 3.871085 | Up | potassium sodium-activated channel subfamily T member 2 | |
| OTOGL | 1.017886 | 0.000211 | 0.003705 | 3.868493 | Up | otogelin like | |
| ELAVL3 | 0.837778 | 0.000213 | 0.00371 | 3.86572 | Up | ELAV like RNA binding protein 3 | |
| CFHR1 | 0.865906 | 0.000214 | 0.003716 | 3.864405 | Up | complement factor H related 1 | |
| PLA2G5 | 0.83062 | 0.000216 | 0.00373 | 3.862104 | Up | phospholipase A2 group V | |
| FOLH1 | 0.917208 | 0.000217 | 0.003735 | 3.861207 | Up | folate hydrolase 1 | |
| LPA | 0.875646 | 0.000221 | 0.003777 | 3.856187 | Up | lipoprotein(a) | |
| LOC100130449 | 0.831124 | 0.000221 | 0.003777 | 3.855362 | Up | uncharacterized LOC100130449 | |
| LINC00923 | 0.918504 | 0.000222 | 0.003777 | 3.854828 | Up | long intergenic non-protein coding RNA 923 | |
| TERB2 | 0.876286 | 0.000222 | 0.003777 | 3.854536 | Up | telomere repeat binding bouquet formation protein 2 | |
| HHIP | 0.825721 | 0.000222 | 0.003777 | 3.854168 | Up | hedgehog interacting protein | |
| DRGX | 0.842289 | 0.000228 | 0.003835 | 3.846389 | Up | dorsal root ganglia homeobox | |
| SERPINA9 | 0.84755 | 0.000228 | 0.003835 | 3.846199 | Up | serpin family A member 9 | |
| PRKAA2 | 0.894063 | 0.000233 | 0.003871 | 3.840763 | Up | protein kinase AMP-activated catalytic subunit alpha 2 | |
| MMP27 | 0.867836 | 0.000236 | 0.003895 | 3.837287 | Up | matrix metallopeptidase 27 | |
| NPNT | 0.90569 | 0.000236 | 0.003899 | 3.836429 | Up | nephronectin | |
| SLC51B | 0.839976 | 0.000238 | 0.003904 | 3.834684 | Up | solute carrier family 51 beta subunit | |
| C3orf80 | 0.904281 | 0.000236 | 0.003895 | 3.836993 | Up | chromosome 3 open reading frame 80 | |
| SOX2 | 0.869644 | 0.000238 | 0.003904 | 3.834656 | Up | SRY-box transcription factor 2 | |
| EYA1 | 1.078018 | 0.000237 | 0.003901 | 3.835456 | Up | EYA transcriptional coactivator and phosphatase 1 | |
| SI | 0.880135 | 0.00024 | 0.003926 | 3.831805 | Up | sucrase-isomaltase | |
| TIMP4 | 0.90339 | 0.000241 | 0.00393 | 3.83074 | Up | TIMP metallopeptidase inhibitor 4 | |
| LARP6 | 0.890316 | 0.00024 | 0.003926 | 3.831332 | Up | La ribonucleoprotein 6, translational regulator | |
| MOGAT2 | 0.833587 | 0.000243 | 0.003943 | 3.828618 | Up | monoacylglycerol O-acyltransferase 2 | |
| OR1L3 | 0.835533 | 0.000243 | 0.003943 | 3.82828 | Up | olfactory receptor family 1 subfamily L member 3 | |
| CACNA1G | 0.912907 | 0.000243 | 0.003943 | 3.828145 | Up | calcium voltage-gated channel subunit alpha1 G | |
| CRX | 0.89157 | 0.000243 | 0.003944 | 3.8278 | Up | cone-rod homeobox | |
| PPP2R2C | 0.882852 | 0.000247 | 0.00397 | 3.824007 | Up | protein phosphatase 2 regulatory subunit Bgamma | |
| SLC30A3 | 0.892961 | 0.000248 | 0.003978 | 3.822534 | Up | solute carrier family 30 member 3 | |
| RHOJ | 0.860054 | 0.000252 | 0.004016 | 3.81792 | Up | ras homolog family member J | |
| KCNJ13 | 0.853986 | 0.000256 | 0.004054 | 3.813553 | Up | potassium inwardly rectifying channel subfamily J member 13 | |
| HAS2 | 0.882356 | 0.000257 | 0.004062 | 3.812592 | Up | hyaluronan synthase 2 | |
| KRTAP10–6 | 0.879999 | 0.000257 | 0.004062 | 3.811877 | Up | keratin associated protein 10–6 | |
| FFAR1 | 0.88097 | 0.000257 | 0.004062 | 3.812033 | Up | free fatty acid receptor 1 | |
| FGF6 | 0.835818 | 0.000259 | 0.004077 | 3.810292 | Up | fibroblast growth factor 6 | |
| OTX2 | 1.0534 | 0.000267 | 0.004169 | 3.800608 | Up | orthodenticlehomeobox 2 | |
| CLRN2 | 0.823406 | 0.000269 | 0.004182 | 3.798898 | Up | clarin 2 | |
| C19orf81 | 0.847143 | 0.000272 | 0.004205 | 3.795697 | Up | chromosome 19 open reading frame 81 | |
| NUPR2 | 0.908781 | 0.000272 | 0.004205 | 3.796129 | Up | nuclear protein 2, transcriptional regulator | |
| CCN1 | 0.860705 | 0.000276 | 0.00423 | 3.791036 | Up | cellular communication network factor 1 | |
| HECW1 | 0.933254 | 0.000278 | 0.004243 | 3.789303 | Up | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | |
| PTGER1 | 0.840067 | 0.000279 | 0.004243 | 3.788337 | Up | prostaglandin E receptor 1 | |
| CDH15 | 0.86729 | 0.00028 | 0.004248 | 3.787447 | Up | cadherin 15 | |
| CLVS2 | 0.851515 | 0.000281 | 0.004253 | 3.786814 | Up | clavesin 2 | |
| LY6G6F-LY6G6D | 0.856601 | 0.000281 | 0.004261 | 3.78581 | Up | LY6G6F-LY6G6D readthrough | |
| CYP4X1 | 0.824815 | 0.000288 | 0.004307 | 3.779012 | Up | cytochrome P450 family 4 subfamily X member 1 | |
| MYOG | 0.879018 | 0.000289 | 0.004307 | 3.778098 | Up | myogenin | |
| RFPL4AL1 | 1.159429 | 0.000295 | 0.00436 | 3.772636 | Up | ret finger protein like 4A like 1 | |
| LRRC8E | 0.830259 | 0.0003 | 0.004418 | 3.767782 | Up | leucine rich repeat containing 8 VRAC subunit E | |
| NXPE1 | 0.860153 | 0.000302 | 0.004436 | 3.765215 | Up | neurexophilin and PC-esterase domain family member 1 | |
| KIF25 | 0.853635 | 0.000304 | 0.004441 | 3.763906 | Up | kinesin family member 25 | |
| CBLN2 | 0.966722 | 0.000305 | 0.004454 | 3.762634 | Up | cerebellin 2 precursor | |
| AREG | 0.901451 | 0.000308 | 0.004485 | 3.759795 | Up | amphiregulin | |
| SPATA8 | 0.878422 | 0.000311 | 0.004508 | 3.7569 | Up | spermatogenesis associated 8 | |
| GCGR | 0.86834 | 0.000311 | 0.004508 | 3.756813 | Up | glucagon receptor | |
| OR51E2 | 1.003339 | 0.000313 | 0.004529 | 3.754696 | Up | olfactory receptor family 51 subfamily E member 2 | |
| RPE65 | 0.835844 | 0.000315 | 0.004549 | 3.752653 | Up | retinoid isomerohydrolase RPE65 | |
| LAMA4 | 0.925931 | 0.000318 | 0.004572 | 3.750191 | Up | laminin subunit alpha 4 | |
| GABRA4 | 0.9215 | 0.000322 | 0.004599 | 3.747009 | Up | gamma-aminobutyric acid type A receptor alpha4 subunit | |
| MFAP2 | 0.972218 | 0.000324 | 0.004611 | 3.74445 | Up | microfibril associated protein 2 | |
| WFDC5 | 0.84266 | 0.000328 | 0.004639 | 3.740917 | Up | WAP four-disulfide core domain 5 | |
| IGSF21 | 0.851515 | 0.000331 | 0.004652 | 3.738722 | Up | immunoglobin superfamily member 21 | |
| C17orf102 | 0.839208 | 0.000332 | 0.004669 | 3.737396 | Up | chromosome 17 open reading frame 102 | |
| A2ML1 | 0.846661 | 0.000334 | 0.004675 | 3.73642 | Up | alpha-2-macroglobulin like 1 | |
| PLA2G3 | 0.828347 | 0.000334 | 0.004675 | 3.73607 | Up | phospholipase A2 group III | |
| C1orf229 | 0.851752 | 0.000335 | 0.004681 | 3.735201 | Up | chromosome 1 open reading frame 229 | |
| PLA2G10 | 0.831528 | 0.000345 | 0.004783 | 3.726918 | Up | phospholipase A2 group X | |
| UTF1 | 0.940212 | 0.000346 | 0.004796 | 3.725564 | Up | undifferentiated embryonic cell transcription factor 1 | |
| CELF4 | 0.871614 | 0.00035 | 0.004827 | 3.722421 | Up | CUGBP Elav-like family member 4 | |
| BTBD16 | 0.859346 | 0.000354 | 0.004868 | 3.71863 | Up | BTB domain containing 16 | |
| TMPRSS12 | 0.87545 | 0.000356 | 0.004868 | 3.717707 | Up | transmembrane serine protease 12 | |
| SPRY4 | 0.899144 | 0.000369 | 0.004997 | 3.707011 | Up | sprouty RTK signaling antagonist 4 | |
| FUT6 | 0.88066 | 0.000369 | 0.004997 | 3.706933 | Up | fucosyltransferase 6 | |
| LINC01551 | 0.87545 | 0.000372 | 0.005023 | 3.704451 | Up | long intergenic non-protein coding RNA 1551 | |
| GNG12 | 0.937701 | 0.000372 | 0.005023 | 3.704226 | Up | G protein subunit gamma 12 | |
| RD3 | 0.880776 | 0.000374 | 0.005038 | 3.703076 | Up | retinal degeneration 3, GUCY2D regulator | |
| DKK1 | 0.950344 | 0.000383 | 0.005138 | 3.695639 | Up | dickkopf WNT signaling pathway inhibitor 1 | |
| NUTM2F | 0.890116 | 0.000384 | 0.005147 | 3.694933 | Up | NUT family member 2F | |
| NPAP1 | 0.841125 | 0.000385 | 0.00515 | 3.694524 | Up | nuclear pore associated protein 1 | |
| PDE10A | 0.838498 | 0.000402 | 0.005283 | 3.681647 | Up | phosphodiesterase 10A | |
| BDKRB2 | 0.859999 | 0.000401 | 0.005283 | 3.681948 | Up | bradykinin receptor B2 | |
| HES5 | 0.898473 | 0.000404 | 0.005292 | 3.680429 | Up | hes family bHLH transcription factor 5 | |
| SCEL | 0.834584 | 0.000413 | 0.005347 | 3.673264 | Up | sciellin | |
| TMIGD1 | 0.827595 | 0.000413 | 0.005347 | 3.673264 | Up | transmembrane and immunoglobulin domain containing 1 | |
| PDE1A | 0.866557 | 0.000413 | 0.005347 | 3.673886 | Up | phosphodiesterase 1A | |
| GOLGA8G | 1.023375 | 0.000419 | 0.005389 | 3.669375 | Up | golgin A8 family member G | |
| C12orf77 | 0.836295 | 0.000436 | 0.005501 | 3.657361 | Up | chromosome 12 open reading frame 77 | |
| PRSS12 | 0.917236 | 0.000437 | 0.005502 | 3.65691 | Up | serine protease 12 | |
| RBM46 | 0.951241 | 0.000438 | 0.005502 | 3.6564 | Up | RNA binding motif protein 46 | |
| KRT78 | 0.835349 | 0.000439 | 0.005502 | 3.655735 | Up | keratin 78 | |
| TAC4 | 0.866135 | 0.00044 | 0.005508 | 3.654937 | Up | tachykinin precursor 4 | |
| KRBOX1 | 0.865226 | 0.000439 | 0.005502 | 3.655612 | Up | KRAB box domain containing 1 | |
| PERM1 | 0.85926 | 0.000442 | 0.005508 | 3.6534 | Up | PPARGC1 and ESRR induced regulator, muscle 1 | |
| CAPN9 | 0.968118 | 0.000455 | 0.005612 | 3.644617 | Up | calpain 9 | |
| MAS1 | 0.874605 | 0.000469 | 0.005723 | 3.635607 | Up | MAS1 proto-oncogene, G protein-coupled receptor | |
| ALDOB | 0.840212 | 0.000481 | 0.005821 | 3.628603 | Up | aldolase, fructose-bisphosphate B | |
| FAM131C | 0.843355 | 0.000483 | 0.005829 | 3.627366 | Up | family with sequence similarity 131 member C | |
| FAM71D | 1.002051 | 0.000482 | 0.005825 | 3.628064 | Up | family with sequence similarity 71 member D | |
| TMEM72 | 0.847662 | 0.000505 | 0.005976 | 3.613798 | Up | transmembrane protein 72 | |
| GSX2 | 0.884597 | 0.000505 | 0.005976 | 3.613792 | Up | GS homeobox 2 | |
| RASA4B | 1.064804 | 0.000499 | 0.005946 | 3.617563 | Up | RAS p21 protein activator 4B | |
| HSPB2 | 0.843999 | 0.000508 | 0.005984 | 3.611888 | Up | heat shock protein family B (small) member 2 | |
| FSTL5 | 0.877677 | 0.000523 | 0.006098 | 3.603482 | Up | follistatin like 5 | |
| RAX2 | 0.84501 | 0.000525 | 0.006112 | 3.60243 | Up | retina and anterior neural fold homeobox 2 | |
| BCO1 | 0.833952 | 0.000536 | 0.006202 | 3.59581 | Up | beta-carotene oxygenase 1 | |
| GPR62 | 0.86578 | 0.000536 | 0.006202 | 3.595965 | Up | G protein-coupled receptor 62 | |
| CDH18 | 0.829682 | 0.00054 | 0.006224 | 3.593699 | Up | cadherin 18 | |
| HSPE1-MOB4 | 0.902692 | 0.000545 | 0.006264 | 3.590982 | Up | HSPE1-MOB4 readthrough | |
| MEGF10 | 0.828489 | 0.000545 | 0.006264 | 3.590973 | Up | multiple EGF like domains 10 | |
| RASSF9 | 0.833952 | 0.000582 | 0.006473 | 3.571637 | Up | Ras association domain family member 9 | |
| PALM2AKAP2 | 0.841084 | 0.000608 | 0.006683 | 3.558351 | Up | PALM2 and AKAP2 fusion | |
| ZFPM2 | 0.83487 | 0.000614 | 0.00671 | 3.555258 | Up | zinc finger protein, FOG family member 2 | |
| IL21 | 0.872983 | 0.00063 | 0.006805 | 3.547506 | Up | interleukin 21 | |
| TCHH | 0.913257 | 0.000641 | 0.006828 | 3.542218 | Up | trichohyalin | |
| DNAI1 | 0.825247 | 0.000645 | 0.006844 | 3.540376 | Up | dynein axonemal intermediate chain 1 | |
| LHX2 | 0.825638 | 0.000664 | 0.006981 | 3.531404 | Up | LIM homeobox 2 | |
| TCIM | 0.880336 | 0.000669 | 0.007015 | 3.529277 | Up | transcriptional and immune response regulator | |
| CHKB-CPT1B | 0.908843 | 0.000671 | 0.007024 | 3.52834 | Up | CHKB-CPT1B readthrough (NMD candidate) | |
| FAXC | 0.832545 | 0.000693 | 0.007167 | 3.518441 | Up | failed axon connections homolog, metaxin like GST domain containing | |
| SPECC1L-ADORA2A | 0.828726 | 0.000728 | 0.00737 | 3.503843 | Up | SPECC1L-ADORA2A readthrough (NMD candidate) | |
| DPP10 | 0.834719 | 0.000736 | 0.007433 | 3.500365 | Up | dipeptidyl peptidase like 10 | |
| AMER2 | 0.854851 | 0.000749 | 0.00752 | 3.494939 | Up | APC membrane recruitment protein 2 | |
| SPATA22 | 1.255195 | 0.000761 | 0.007595 | 3.490127 | Up | spermatogenesis associated 22 | |
| TMEM151A | 0.881109 | 0.000781 | 0.007713 | 3.482345 | Up | transmembrane protein 151A | |
| ATP1A4 | 1.689421 | 0.000778 | 0.007691 | 3.483567 | Up | ATPase Na+/K+ transporting subunit alpha 4 | |
| HOXB7 | 0.989446 | 0.000781 | 0.007714 | 3.482117 | Up | homeobox B7 | |
| CCDC169 | 0.897611 | 0.000815 | 0.007946 | 3.469141 | Up | coiled-coil domain containing 169 | |
| SPINK4 | 0.843362 | 0.000821 | 0.007979 | 3.466965 | Up | serine peptidase inhibitor, Kazal type 4 | |
| LKAAEAR1 | 1.056911 | 0.000821 | 0.007979 | 3.467037 | Up | LKAAEAR motif containing 1 | |
| BPIFC | 0.838473 | 0.000822 | 0.007982 | 3.466596 | Up | BPI fold containing family C | |
| EIF4E1B | 0.823457 | 0.000847 | 0.008124 | 3.457562 | Up | eukaryotic translation initiation factor 4E family member 1B | |
| COX8C | 0.823798 | 0.000853 | 0.008147 | 3.455114 | Up | cytochrome c oxidase subunit 8C | |
| MIF | 1.110365 | 0.000941 | 0.008696 | 3.425057 | Up | macrophage migration inhibitory factor | |
| LRRC71 | 0.833583 | 0.000886 | 0.008347 | 3.443592 | Up | leucine rich repeat containing 71 | |
| EPB41L4B | 1.108212 | 0.000896 | 0.008413 | 3.440042 | Up | erythrocyte membrane protein band 4.1 like 4B | |
| MYRIP | 0.847925 | 0.000903 | 0.008457 | 3.437595 | Up | myosin VIIA and Rab interacting protein | |
| CORO7-PAM16 | 0.904171 | 0.000939 | 0.008696 | 3.425726 | Up | CORO7-PAM16 readthrough | |
| ZSWIM2 | 0.880153 | 0.000983 | 0.008909 | 3.411475 | Up | zinc finger SWIM-type containing 2 | |
| TPPP2 | 0.85002 | 0.000983 | 0.008909 | 3.411351 | Up | tubulin polymerization promoting protein family member 2 | |
| PTPN20 | 0.978815 | 0.000982 | 0.008909 | 3.411957 | Up | protein tyrosine phosphatase non-receptor type 20 | |
| CST8 | 0.828046 | 0.000998 | 0.008992 | 3.40695 | Up | cystatin 8 | |
| KCNH5 | 0.840209 | 0.001002 | 0.009002 | 3.405458 | Up | potassium voltage-gated channel subfamily H member 5 | |
| WFDC1 | 0.88007 | 0.001062 | 0.009383 | 3.387406 | Up | WAP four-disulfide core domain 1 | |
| OR3A1 | 0.842916 | 0.001063 | 0.009383 | 3.387314 | Up | olfactory receptor family 3 subfamily A member 1 (gene/pseudogene) | |
| EXOC3L4 | 0.847958 | 0.001109 | 0.009648 | 3.374087 | Up | exocyst complex component 3 like 4 | |
| GHSR | 0.849126 | 0.001113 | 0.009673 | 3.372795 | Up | growth hormone secretagogue receptor | |
| GDA | 0.889672 | 0.001119 | 0.009709 | 3.371151 | Up | guanine deaminase | |
| SHISA8 | 0.861981 | 0.001118 | 0.009704 | 3.371469 | Up | shisa family member 8 | |
| ZSCAN10 | 0.86053 | 0.001192 | 0.01015 | 3.351508 | Up | zinc finger and SCAN domain containing 10 | |
| GDPD4 | 0.825987 | 0.001228 | 0.010386 | 3.342107 | Up | glycerophosphodiesterphosphodiesterase domain containing 4 | |
| C4orf48 | 0.963154 | 0.001242 | 0.010457 | 3.338544 | Up | chromosome 4 open reading frame 48 | |
| SPDEF | 0.881194 | 0.001231 | 0.010399 | 3.341393 | Up | SAM pointed domain containing ETS transcription factor | |
| PMCH | 0.938262 | 0.001273 | 0.010644 | 3.330774 | Up | pro-melanin concentrating hormone | |
| TMEM121 | 1.161269 | 0.001281 | 0.010665 | 3.328878 | Up | transmembrane protein 121 | |
| ESRP2 | 0.86225 | 0.001323 | 0.010867 | 3.318668 | Up | epithelial splicing regulatory protein 2 | |
| GOLGA6L9 | 0.913468 | 0.001369 | 0.011101 | 3.30796 | Up | golgin A6 family like 9 | |
| LRRTM2 | 0.922665 | 0.001414 | 0.011348 | 3.297763 | Up | leucine rich repeat transmembrane neuronal 2 | |
| RFX4 | 0.831273 | 0.001445 | 0.011513 | 3.290825 | Up | regulatory factor X4 | |
| FAP | 0.99642 | 0.001437 | 0.011476 | 3.292583 | Up | fibroblast activation protein alpha | |
| CTAGE6 | 0.885238 | 0.001484 | 0.011748 | 3.282458 | Up | CTAGE family member 6 | |
| GPC6 | 0.897005 | 0.001603 | 0.012397 | 3.257934 | Up | glypican 6 | |
| BOLA2B | 1.348547 | 0.001587 | 0.012335 | 3.261001 | Up | bolA family member 2B | |
| ANGPT4 | 0.829222 | 0.001678 | 0.012731 | 3.24332 | Up | angiopoietin 4 | |
| GLYATL1 | 0.859167 | 0.001744 | 0.013066 | 3.230845 | Up | glycine-N-acyltransferase like 1 | |
| ALPI | 0.83854 | 0.001782 | 0.013284 | 3.223964 | Up | alkaline phosphatase, intestinal | |
| LINC02312 | 0.846436 | 0.00182 | 0.013468 | 3.217256 | Up | long intergenic non-protein coding RNA 2312 | |
| MAGI1 | 0.834329 | 0.001979 | 0.014332 | 3.190204 | Up | membrane associated guanylate kinase, WW and PDZ domain containing 1 | |
| LOC105377590 | 0.827061 | 0.002067 | 0.014767 | 3.176133 | Up | uncharacterized LOC105377590 | |
| UGT2A3 | 1.084825 | 0.002072 | 0.014775 | 3.175415 | Up | UDP glucuronosyltransferase family 2 member A3 | |
| SEMA6B | 0.97473 | 0.002148 | 0.015121 | 3.163707 | Up | semaphorin 6B | |
| RFPL4A | 1.618683 | 0.002173 | 0.015241 | 3.159916 | Up | ret finger protein like 4A | |
| P2RX2 | 0.823852 | 0.002237 | 0.015538 | 3.150517 | Up | purinergic receptor P2X 2 | |
| COL1A2 | 0.873234 | 0.002262 | 0.015671 | 3.14683 | Up | collagen type I alpha 2 chain | |
| CDKL2 | 0.900439 | 0.002301 | 0.015857 | 3.141203 | Up | cyclin dependent kinase like 2 | |
| CLUL1 | 0.934087 | 0.002373 | 0.016257 | 3.131195 | Up | clusterin like 1 | |
| MIPOL1 | 0.862616 | 0.002732 | 0.017911 | 3.084864 | Up | mirror-image polydactyly 1 | |
| PKNOX2 | 0.859428 | 0.002743 | 0.017952 | 3.083472 | Up | PBX/knotted 1 homeobox 2 | |
| TRHDE | 0.950234 | 0.002983 | 0.019018 | 3.05568 | Up | thyrotropin releasing hormone degrading enzyme | |
| BCAR1 | 0.894146 | 0.002995 | 0.019072 | 3.054351 | Up | BCAR1 scaffold protein, Cas family member | |
| ZPLD1 | 0.83027 | 0.003108 | 0.019559 | 3.042048 | Up | zonapellucida like domain containing 1 | |
| ECM2 | 0.881103 | 0.003166 | 0.019806 | 3.035863 | Up | extracellular matrix protein 2 | |
| C8B | 0.83507 | 0.003179 | 0.019849 | 3.034511 | Up | complement C8 beta chain | |
| ZSCAN4 | 0.824589 | 0.003335 | 0.020502 | 3.018496 | Up | zinc finger and SCAN domain containing 4 | |
| DUSP15 | 0.835463 | 0.003583 | 0.021602 | 2.994384 | Up | dual specificity phosphatase 15 | |
| FSIP2 | 1.051501 | 0.003654 | 0.021884 | 2.987718 | Up | fibrous sheath interacting protein 2 | |
| GYPA | 0.838823 | 0.003832 | 0.022535 | 2.971603 | Up | glycophorin A (MNS blood group) | |
| MICU3 | 0.836643 | 0.004058 | 0.023381 | 2.952197 | Up | mitochondrial calcium uptake family member 3 | |
| ABCB5 | 0.828852 | 0.00415 | 0.023751 | 2.944524 | Up | ATP binding cassette subfamily B member 5 | |
| MTRNR2L1 | 2.018372 | 0.004535 | 0.025279 | 2.914228 | Up | MT-RNR2 like 1 | |
| TRAPPC5 | 0.871477 | 0.004667 | 0.025812 | 2.904327 | Up | trafficking protein particle complex 5 | |
| MYT1L | 1.20911 | 0.004898 | 0.026721 | 2.88766 | Up | myelin transcription factor 1 like | |
| DKK2 | 0.89525 | 0.005299 | 0.028207 | 2.860463 | Up | dickkopf WNT signaling pathway inhibitor 2 | |
| SRXN1 | 1.018618 | 0.005734 | 0.029851 | 2.832953 | Up | sulfiredoxin 1 | |
| HBZ | 1.056697 | 0.005869 | 0.030365 | 2.824809 | Up | hemoglobin subunit zeta | |
| GABRB3 | 0.916767 | 0.005973 | 0.030651 | 2.818616 | Up | gamma-aminobutyric acid type A receptor beta3 subunit | |
| TDRD15 | 0.860035 | 0.006628 | 0.033041 | 2.781952 | Up | tudor domain containing 15 | |
| 0.908183 | 0.00747 | 0.036155 | 2.739388 | Up | peptide deformylase, mitochondrial | ||
| CCDC144A | 1.387575 | 0.007676 | 0.036885 | 2.729663 | Up | coiled-coil domain containing 144A | |
| MRPL12 | 1.043343 | 0.011635 | 0.049872 | 2.57764 | Up | mitochondrial ribosomal protein L12 | |
| SIRPB2 | −0.47534 | 8.44E-09 | 4.63E-05 | −6.37763 | Down | signal regulatory protein beta 2 | |
| RNF122 | −0.40229 | 1.36E-08 | 4.63E-05 | −6.26932 | Down | ring finger protein 122 | |
| SYK | −0.32942 | 2.38E-08 | 6.66E-05 | −6.1427 | Down | spleen associated tyrosine kinase | |
| LASP1 | −0.39444 | 7.15E-08 | 0.000109 | −5.89021 | Down | LIM and SH3 protein 1 | |
| SLC44A2 | −0.3592 | 1.09E-07 | 0.000141 | −5.79236 | Down | solute carrier family 44 member 2 | |
| C5AR2 | −0.45692 | 1.58E-07 | 0.000165 | −5.70624 | Down | complement component 5a receptor 2 | |
| PRKACA | −0.49178 | 2.12E-07 | 0.000197 | −5.63649 | Down | protein kinase cAMP-activated catalytic subunit alpha | |
| TP53INP2 | −0.59653 | 2.35E-07 | 0.000198 | −5.61183 | Down | tumor protein p53 inducible nuclear protein 2 | |
| F11R | −0.37662 | 3.27E-07 | 0.000198 | −5.53422 | Down | F11 receptor | |
| INKA2 | −0.4438 | 3.25E-07 | 0.000198 | −5.5354 | Down | inka box actin regulator 2 | |
| GABARAP | −0.49797 | 3.53E-07 | 0.000205 | −5.5156 | Down | GABA type A receptor-associated protein | |
| CRTC2 | −0.48092 | 3.66E-07 | 0.000205 | −5.50724 | Down | CREB regulated transcription coactivator 2 | |
| RXRB | −0.3761 | 4.52E-07 | 0.00023 | −5.45685 | Down | retinoid X receptor beta | |
| CASP9 | −0.27139 | 5.84E-07 | 0.000258 | −5.39557 | Down | caspase 9 | |
| C6orf136 | −0.3863 | 7.96E-07 | 0.000297 | −5.321 | Down | chromosome 6 open reading frame 136 | |
| CTDSP2 | −0.32959 | 7.48E-07 | 0.000288 | −5.3362 | Down | CTD small phosphatase 2 | |
| DPEP2 | −0.41998 | 7.56E-07 | 0.000288 | −5.33349 | Down | dipeptidase 2 | |
| TMEM234 | −0.38446 | 8.95E-07 | 0.000313 | −5.29278 | Down | transmembrane protein 234 | |
| TMEM179B | −0.27682 | 9.14E-07 | 0.000313 | −5.28769 | Down | transmembrane protein 179B | |
| SNX11 | −0.32558 | 9.47E-07 | 0.000318 | −5.27902 | Down | sorting nexin 11 | |
| AGAP9 | −1.41788 | 4.42E-07 | 0.00023 | −5.46256 | Down | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | |
| FAM219A | −0.45019 | 1.17E-06 | 0.000376 | −5.22858 | Down | family with sequence similarity 219 member A | |
| CSNK2B | −0.29639 | 1.41E-06 | 0.00043 | −5.18303 | Down | casein kinase 2 beta | |
| TMEM127 | −0.34378 | 1.43E-06 | 0.00043 | −5.1782 | Down | transmembrane protein 127 | |
| MEFV | −0.52752 | 1.62E-06 | 0.00046 | −5.14816 | Down | MEFV innate immuity regulator, pyrin | |
| KCTD21 | −0.31051 | 1.92E-06 | 0.000504 | −5.1065 | Down | potassium channel tetramerization domain containing 21 | |
| TMBIM1 | −0.32832 | 1.86E-06 | 0.0005 | −5.11415 | Down | transmembrane BAX inhibitor motif containing 1 | |
| IL17RA | −0.4439 | 1.99E-06 | 0.000507 | −5.09788 | Down | interleukin 17 receptor A | |
| RAB37 | −0.31838 | 2.04E-06 | 0.00051 | −5.09207 | Down | RAB37, member RAS oncogene family | |
| GAB2 | −0.44824 | 2.15E-06 | 0.000532 | −5.07836 | Down | GRB2 associated binding protein 2 | |
| BLOC1S3 | −0.28757 | 2.43E-06 | 0.000544 | −5.04845 | Down | biogenesis of lysosomal organelles complex 1 subunit 3 | |
| APOL2 | −0.46372 | 2.38E-06 | 0.000544 | −5.05359 | Down | apolipoprotein L2 | |
| KIAA0319L | −0.35586 | 2.4E-06 | 0.000544 | −5.05141 | Down | KIAA0319 like | |
| SIPA1L1 | −0.37533 | 2.84E-06 | 0.000592 | −5.00972 | Down | signal induced proliferation associated 1 like 1 | |
| ARF3 | −0.39406 | 2.86E-06 | 0.000592 | −5.00779 | Down | ADP ribosylation factor 3 | |
| CASC3 | −0.28443 | 2.89E-06 | 0.000592 | −5.00572 | Down | CASC3 exon junction complex subunit | |
| ARHGAP30 | −0.2905 | 3.04E-06 | 0.000593 | −4.99258 | Down | Rho GTPase activating protein 30 | |
| TOP3A | −0.35048 | 3.21E-06 | 0.000593 | −4.97967 | Down | DNA topoisomerase III alpha | |
| C16orf54 | −0.26747 | 3.24E-06 | 0.000593 | −4.97743 | Down | chromosome 16 open reading frame 54 | |
| BEST1 | −0.50351 | 3.37E-06 | 0.000593 | −4.96756 | Down | bestrophin 1 | |
| C6orf89 | −0.28041 | 3.39E-06 | 0.000593 | −4.96553 | Down | chromosome 6 open reading frame 89 | |
| SUSD6 | −0.37933 | 3.37E-06 | 0.000593 | −4.96707 | Down | sushi domain containing 6 | |
| STAT6 | −0.386 | 3.46E-06 | 0.000594 | −4.96042 | Down | signal transducer and activator of transcription 6 | |
| SH3D21 | −0.62962 | 4.05E-06 | 0.000648 | −4.92115 | Down | SH3 domain containing 21 | |
| FAM214B | −0.36064 | 3.72E-06 | 0.000615 | −4.94269 | Down | family with sequence similarity 214 member B | |
| AGPAT1 | −0.37351 | 3.97E-06 | 0.000641 | −4.92639 | Down | 1-acylglycerol-3-phosphate O-acyltransferase 1 | |
| CPSF7 | −0.33791 | 4.39E-06 | 0.00067 | −4.90105 | Down | cleavage and polyadenylation specific factor 7 | |
| EGLN2 | −0.33487 | 4.97E-06 | 0.00072 | −4.86981 | Down | egl-9 family hypoxia inducible factor 2 | |
| VAMP2 | −0.32282 | 5.23E-06 | 0.000738 | −4.85729 | Down | vesicle associated membrane protein 2 | |
| ARHGAP1 | −0.46187 | 5.32E-06 | 0.000738 | −4.85289 | Down | Rho GTPase activating protein 1 | |
| CPT2 | −0.30399 | 6.25E-06 | 0.00082 | −4.81205 | Down | carnitinepalmitoyltransferase 2 | |
| OSCAR | −0.4824 | 7.26E-06 | 0.000909 | −4.77404 | Down | osteoclast associated Ig-like receptor | |
| EXTL3 | −0.44258 | 7.37E-06 | 0.00091 | −4.77025 | Down | exostosin like glycosyltransferase 3 | |
| NOMO2 | −0.58975 | 8.27E-06 | 0.000925 | −4.74093 | Down | NODAL modulator 2 | |
| PIK3R5 | −0.28302 | 8.01E-06 | 0.000925 | −4.74887 | Down | phosphoinositide-3-kinase regulatory subunit 5 | |
| IGF2R | −0.52404 | 8.21E-06 | 0.000925 | −4.74277 | Down | insulin like growth factor 2 receptor | |
| EPHX1 | −0.55423 | 9.97E-06 | 0.001014 | −4.6931 | Down | epoxide hydrolase 1 | |
| MAPKAPK2 | −0.29705 | 8.55E-06 | 0.000925 | −4.73251 | Down | MAPK activated protein kinase 2 | |
| STAT3 | −0.36483 | 9.1E-06 | 0.000967 | −4.71639 | Down | signal transducer and activator of transcription 3 | |
| NPIPB3 | −0.96437 | 1.13E-05 | 0.001075 | −4.66109 | Down | nuclear pore complex interacting protein family member B3 | |
| RNF19B | −0.29623 | 1.04E-05 | 0.001038 | −4.681 | Down | ring finger protein 19B | |
| PBX2 | −0.36625 | 1.07E-05 | 0.001047 | −4.67424 | Down | PBX homeobox 2 | |
| MTMR3 | −0.30993 | 1.16E-05 | 0.001078 | −4.65496 | Down | myotubularin related protein 3 | |
| PI4KB | −0.32556 | 1.17E-05 | 0.001078 | −4.65218 | Down | phosphatidylinositol 4-kinase beta | |
| GLYR1 | −0.33045 | 1.23E-05 | 0.001111 | −4.63863 | Down | glyoxylatereductase 1 homolog | |
| TK2 | −0.30672 | 1.33E-05 | 0.001135 | −4.61837 | Down | thymidine kinase 2 | |
| RAF1 | −0.26209 | 1.34E-05 | 0.001139 | −4.61618 | Down | Raf-1 proto-oncogene, serine/threonine kinase | |
| PPP1R10 | −0.32024 | 1.44E-05 | 0.001195 | −4.59736 | Down | protein phosphatase 1 regulatory subunit 10 | |
| ARRB2 | −0.26361 | 1.45E-05 | 0.001195 | −4.59727 | Down | arrestin beta 2 | |
| ATP6V0D1 | −0.39381 | 1.45E-05 | 0.001196 | −4.59576 | Down | ATPase H+ transporting V0 subunit d1 | |
| SMAP2 | −0.35835 | 1.47E-05 | 0.001201 | −4.59347 | Down | small ArfGAP2 | |
| KDELR1 | −0.34331 | 1.53E-05 | 0.001232 | −4.58193 | Down | KDEL endoplasmic reticulum protein retention receptor 1 | |
| ATP6V0A1 | −0.3471 | 1.64E-05 | 0.00127 | −4.5643 | Down | ATPase H+ transporting V0 subunit a1 | |
| NDST1 | −0.51316 | 1.68E-05 | 0.001284 | −4.55772 | Down | N-deacetylase and N-sulfotransferase 1 | |
| SF3A1 | −0.36624 | 1.79E-05 | 0.001319 | −4.54121 | Down | splicing factor 3a subunit 1 | |
| TPCN2 | −0.41036 | 1.93E-05 | 0.001352 | −4.52153 | Down | two pore segment channel 2 | |
| TAPBP | −0.35224 | 1.89E-05 | 0.001335 | −4.52755 | Down | TAP binding protein | |
| TRPC4AP | −0.27784 | 1.95E-05 | 0.001354 | −4.51955 | Down | transient receptor potential cation channel subfamily C member 4 associated protein | |
| NDE1 | −0.3477 | 1.98E-05 | 0.001369 | −4.51459 | Down | nudE neurodevelopment protein 1 | |
| PIGS | −0.26132 | 2.15E-05 | 0.001407 | −4.49392 | Down | phosphatidylinositol glycan anchor biosynthesis class S | |
| TIFAB | −0.67622 | 2.29E-05 | 0.001441 | −4.47698 | Down | TIFA inhibitor | |
| DGKG | −0.35931 | 2.61E-05 | 0.001504 | −4.44284 | Down | diacylglycerol kinase gamma | |
| CYTH2 | −0.27 | 2.65E-05 | 0.001515 | −4.43896 | Down | cytohesin 2 | |
| PDZD3 | −1.1876 | 2.23E-05 | 0.001411 | −4.48422 | Down | PDZ domain containing 3 | |
| PXN | −0.40274 | 2.8E-05 | 0.00157 | −4.42421 | Down | paxillin | |
| MOB3A | −0.38776 | 2.99E-05 | 0.001621 | −4.40616 | Down | MOB kinase activator 3A | |
| CHKB | −0.69168 | 3.78E-05 | 0.001757 | −4.34418 | Down | choline kinase beta | |
| TMEM121B | −0.58616 | 3.6E-05 | 0.001757 | −4.35738 | Down | transmembrane protein 121B | |
| PEAK3 | −0.64308 | 3.86E-05 | 0.001766 | −4.33852 | Down | PEAK family member 3 | |
| APOL1 | −0.43281 | 3.39E-05 | 0.001712 | −4.3734 | Down | apolipoprotein L1 | |
| IRF1 | −0.27784 | 3.51E-05 | 0.001738 | −4.36395 | Down | interferon regulatory factor 1 | |
| MINDY1 | −0.37272 | 3.76E-05 | 0.001757 | −4.34574 | Down | MINDY lysine 48 deubiquitinase 1 | |
| RNF24 | −0.38862 | 3.8E-05 | 0.001759 | −4.34233 | Down | ring finger protein 24 | |
| PRCC | −0.26648 | 4.35E-05 | 0.001845 | −4.30641 | Down | proline rich mitotic checkpoint control factor | |
| BORCS8 | −0.36271 | 4.62E-05 | 0.001879 | −4.28997 | Down | BLOC-1 related complex subunit 8 | |
| ITGA5 | −0.35353 | 4.34E-05 | 0.001845 | −4.30671 | Down | integrin subunit alpha 5 | |
| SMPD2 | −0.28647 | 5.33E-05 | 0.001995 | −4.25178 | Down | sphingomyelinphosphodiesterase 2 | |
| SMARCD1 | −0.33626 | 5.11E-05 | 0.001972 | −4.26291 | Down | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | |
| SIK3 | −0.26974 | 5.36E-05 | 0.002002 | −4.25023 | Down | SIK family kinase 3 | |
| C9orf129 | −1.18267 | 5.01E-05 | 0.001962 | −4.26853 | Down | chromosome 9 open reading frame 129 | |
| SCAMP5 | −0.60055 | 7.19E-05 | 0.00225 | −4.17021 | Down | secretory carrier membrane protein 5 | |
| IP6K1 | −0.32228 | 5.67E-05 | 0.002052 | −4.23471 | Down | inositol hexakisphosphate kinase 1 | |
| TRANK1 | −0.42013 | 5.8E-05 | 0.002073 | −4.22853 | Down | tetratricopeptide repeat and ankyrin repeat containing 1 | |
| PRR14L | −0.29747 | 6.19E-05 | 0.002108 | −4.21102 | Down | proline rich 14 like | |
| SETDB1 | −0.28227 | 6.25E-05 | 0.002114 | −4.20826 | Down | SET domain bifurcated histone lysine methyltransferase 1 | |
| ZNFX1 | −0.32602 | 6.25E-05 | 0.002114 | −4.20844 | Down | zinc finger NFX1-type containing 1 | |
| GSK3A | −0.35215 | 6.47E-05 | 0.002126 | −4.19898 | Down | glycogen synthase kinase 3 alpha | |
| GPSM3 | −0.38027 | 6.28E-05 | 0.002114 | −4.20685 | Down | G protein signaling modulator 3 | |
| CLN3 | −0.31966 | 7.41E-05 | 0.002275 | −4.16164 | Down | CLN3 lysosomal/endosomaltransmembrane protein, battenin | |
| CYB561D1 | −0.30277 | 7.06E-05 | 0.002224 | −4.17511 | Down | cytochrome b561 family member D1 | |
| GBA2 | −0.26836 | 7.06E-05 | 0.002224 | −4.17523 | Down | glucosylceramidase beta 2 | |
| SEC14L1 | −0.31028 | 7.06E-05 | 0.002224 | −4.17493 | Down | SEC14 like lipid binding 1 | |
| KCTD2 | −0.28549 | 7.52E-05 | 0.002293 | −4.15781 | Down | potassium channel tetramerization domain containing 2 | |
| RGL3 | −0.75662 | 8.74E-05 | 0.002495 | −4.11629 | Down | ral guanine nucleotide dissociation stimulator like 3 | |
| DTX4 | −0.40937 | 9.03E-05 | 0.002513 | −4.1075 | Down | deltex E3 ubiquitin ligase 4 | |
| CLEC4C | −0.88455 | 0.000102 | 0.002653 | −4.07383 | Down | C-type lectin domain family 4 member C | |
| GTPBP1 | −0.41546 | 8.09E-05 | 0.002396 | −4.13758 | Down | GTP binding protein 1 | |
| RNF135 | −0.27712 | 8.49E-05 | 0.002457 | −4.12445 | Down | ring finger protein 135 | |
| ASF1B | −0.45437 | 9.24E-05 | 0.002521 | −4.10114 | Down | anti-silencing function 1B histone chaperone | |
| ARAP3 | −0.52053 | 8.66E-05 | 0.002477 | −4.11882 | Down | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 | |
| ST6GALNAC2 | −0.38956 | 9.6E-05 | 0.002588 | −4.09059 | Down | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | |
| VPS37C | −0.3927 | 0.000106 | 0.002705 | −4.0635 | Down | VPS37C subunit of ESCRT-I | |
| TNFRSF1B | −0.32737 | 9.6E-05 | 0.002588 | −4.09033 | Down | TNF receptor superfamily member 1B | |
| LY6G5B | −0.41293 | 0.000115 | 0.002866 | −4.03965 | Down | lymphocyte antigen 6 family member G5B | |
| PTAFR | −0.29634 | 9.8E-05 | 0.002614 | −4.08471 | Down | platelet activating factor receptor | |
| MYADM | −0.41938 | 0.000102 | 0.00266 | −4.07268 | Down | myeloid associated differentiation marker | |
| MBD6 | −0.55341 | 0.000105 | 0.002693 | −4.06584 | Down | methyl-CpG binding domain protein 6 | |
| RETREG2 | −0.2614 | 0.000107 | 0.002723 | −4.06108 | Down | reticulophagy regulator family member 2 | |
| LMBR1L | −0.27058 | 0.000114 | 0.002843 | −4.04291 | Down | limb development membrane protein 1 like | |
| BET1L | −0.32294 | 0.000118 | 0.002909 | −4.03319 | Down | Bet1 golgi vesicular membrane trafficking protein like | |
| SORT1 | −0.34943 | 0.000117 | 0.002904 | −4.03473 | Down | sortilin 1 | |
| MTF1 | −0.29397 | 0.000123 | 0.002957 | −4.02199 | Down | metal regulatory transcription factor 1 | |
| C19orf54 | −0.34173 | 0.000147 | 0.003138 | −3.97225 | Down | chromosome 19 open reading frame 54 | |
| CXCL16 | −0.35275 | 0.000124 | 0.002964 | −4.01814 | Down | C-X-C motif chemokine ligand 16 | |
| RUBCN | −0.3292 | 0.000126 | 0.002975 | −4.01499 | Down | rubicon autophagy regulator | |
| SNX27 | −0.26986 | 0.000124 | 0.002964 | −4.01952 | Down | sorting nexin 27 | |
| RAB11FIP1 | −0.29163 | 0.000123 | 0.002964 | −4.02057 | Down | RAB11 family interacting protein 1 | |
| LGALS9 | −0.3923 | 0.000126 | 0.002975 | −4.01527 | Down | galectin 9 | |
| PTPN18 | −0.27467 | 0.000129 | 0.003 | −4.00738 | Down | protein tyrosine phosphatase non-receptor type 18 | |
| SIRPA | −0.2873 | 0.00013 | 0.003 | −4.00656 | Down | signal regulatory protein alpha | |
| CHST15 | −0.27829 | 0.000133 | 0.003031 | −3.99914 | Down | carbohydrate sulfotransferase 15 | |
| UBN1 | −0.38058 | 0.000134 | 0.003031 | −3.99765 | Down | ubinuclein 1 | |
| NCOA6 | −0.32966 | 0.000148 | 0.003154 | −3.9687 | Down | nuclear receptor coactivator 6 | |
| ARSG | −0.27821 | 0.00017 | 0.003316 | −3.92992 | Down | arylsulfatase G | |
| EIF3CL | −1.35741 | 0.0002 | 0.003608 | −3.88399 | Down | eukaryotic translation initiation factor 3 subunit C like | |
| POLR2A | −0.61547 | 0.000153 | 0.003182 | −3.96085 | Down | RNA polymerase II subunit A | |
| AOC2 | −0.45479 | 0.000182 | 0.003432 | −3.91142 | Down | amine oxidase copper containing 2 | |
| NLRP12 | −0.34542 | 0.00016 | 0.003242 | −3.94814 | Down | NLR family pyrin domain containing 12 | |
| SEC24C | −0.30954 | 0.000158 | 0.003221 | −3.95154 | Down | SEC24 homolog C, COPII coat complex component | |
| KCNMB1 | −0.40521 | 0.000212 | 0.003705 | −3.86745 | Down | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | |
| SLC48A1 | −0.36957 | 0.000185 | 0.003451 | −3.90712 | Down | solute carrier family 48 member 1 | |
| ZNF592 | −0.30397 | 0.00016 | 0.003247 | −3.94689 | Down | zinc finger protein 592 | |
| MEF2D | −0.35897 | 0.000165 | 0.003278 | −3.93885 | Down | myocyte enhancer factor 2D | |
| SLC25A44 | −0.26274 | 0.000166 | 0.003282 | −3.93716 | Down | solute carrier family 25 member 44 | |
| PPCDC | −0.31808 | 0.000179 | 0.003395 | −3.91543 | Down | phosphopantothenoylcysteine decarboxylase | |
| PLEKHO2 | −0.35445 | 0.000175 | 0.003346 | −3.92211 | Down | pleckstrin homology domain containing O2 | |
| PIGO | −0.35859 | 0.000198 | 0.003586 | −3.88709 | Down | phosphatidylinositol glycan anchor biosynthesis class O | |
| ZBTB22 | −0.28471 | 0.000214 | 0.00371 | −3.86516 | Down | zinc finger and BTB domain containing 22 | |
| ZSWIM1 | −0.29063 | 0.000229 | 0.003835 | −3.84574 | Down | zinc finger SWIM-type containing 1 | |
| DUSP18 | −0.46032 | 0.000234 | 0.003882 | −3.83938 | Down | dual specificity phosphatase 18 | |
| BAZ2A | −0.41201 | 0.000191 | 0.003523 | −3.89726 | Down | bromodomain adjacent to zinc finger domain 2A | |
| ARRB1 | −0.2686 | 0.000196 | 0.003567 | −3.89016 | Down | arrestin beta 1 | |
| SMG5 | −0.37995 | 0.0002 | 0.003608 | −3.88407 | Down | SMG5 nonsense mediated mRNA decay factor | |
| DAP | −0.26058 | 0.000204 | 0.003634 | −3.87917 | Down | death associated protein | |
| RIMS3 | −0.50216 | 0.000274 | 0.004209 | −3.79409 | Down | regulating synaptic membrane exocytosis 3 | |
| WIPF2 | −0.31686 | 0.000214 | 0.00371 | −3.86514 | Down | WAS/WASL interacting protein family member 2 | |
| NSD1 | −0.3405 | 0.000219 | 0.003768 | −3.85773 | Down | nuclear receptor binding SET domain protein 1 | |
| VPS53 | −0.37707 | 0.00024 | 0.003926 | −3.83213 | Down | VPS53 subunit of GARP complex | |
| RASGRP4 | −0.33615 | 0.000225 | 0.00382 | −3.85013 | Down | RAS guanyl releasing protein 4 | |
| FAM168A | −0.26973 | 0.000246 | 0.003969 | −3.82519 | Down | family with sequence similarity 168 member A | |
| ZBTB3 | −0.43164 | 0.000328 | 0.004639 | −3.74095 | Down | zinc finger and BTB domain containing 3 | |
| PHC2 | −0.37839 | 0.000246 | 0.003969 | −3.82531 | Down | polyhomeotic homolog 2 | |
| RGL2 | −0.40321 | 0.000252 | 0.004016 | −3.81807 | Down | ral guanine nucleotide dissociation stimulator like 2 | |
| SPINT1 | −0.42854 | 0.00029 | 0.004307 | −3.77766 | Down | serine peptidase inhibitor, Kunitz type 1 | |
| CBX7 | −0.28076 | 0.000267 | 0.004169 | −3.80078 | Down | chromobox 7 | |
| ADAM19 | −0.30366 | 0.000284 | 0.004279 | −3.78351 | Down | ADAM metallopeptidase domain 19 | |
| PRR16 | −0.99695 | 0.000343 | 0.004771 | −3.72824 | Down | proline rich 16 | |
| SP110 | −0.27632 | 0.00029 | 0.004307 | −3.77759 | Down | SP110 nuclear body protein | |
| SIGLEC14 | −0.5177 | 0.000302 | 0.004436 | −3.76517 | Down | sialic acid binding Ig like lectin 14 | |
| RNPEP | −0.35393 | 0.000304 | 0.004441 | −3.76372 | Down | arginylaminopeptidase | |
| ABAT | −0.30955 | 0.000326 | 0.004625 | −3.74264 | Down | 4-aminobutyrate aminotransferase | |
| ITGAX | −0.51435 | 0.000313 | 0.004529 | −3.75521 | Down | integrin subunit alpha X | |
| ARHGEF11 | −0.37753 | 0.000329 | 0.00464 | −3.73998 | Down | Rho guanine nucleotide exchange factor 11 | |
| SLC35F6 | −0.29772 | 0.000368 | 0.004997 | −3.70727 | Down | solute carrier family 35 member F6 | |
| ACP2 | −0.30411 | 0.00039 | 0.005185 | −3.69061 | Down | acid phosphatase 2, lysosomal | |
| SYVN1 | −0.3935 | 0.000362 | 0.004927 | −3.71249 | Down | synoviolin 1 | |
| TMEM229B | −0.33641 | 0.000404 | 0.005292 | −3.68022 | Down | transmembrane protein 229B | |
| C7orf26 | −0.29812 | 0.000413 | 0.005347 | −3.67329 | Down | chromosome 7 open reading frame 26 | |
| ALKBH6 | −0.40327 | 0.000526 | 0.006123 | −3.6017 | Down | alkB homolog 6 | |
| MAST3 | −0.42877 | 0.000386 | 0.005167 | −3.69332 | Down | microtubule associated serine/threonine kinase 3 | |
| ADAR | −0.28407 | 0.000388 | 0.005173 | −3.69224 | Down | adenosine deaminase RNA specific | |
| MAP3K3 | −0.26552 | 0.000395 | 0.005231 | −3.68687 | Down | mitogen-activated protein kinase kinasekinase 3 | |
| MFSD14C | −0.51982 | 0.000578 | 0.006457 | −3.57334 | Down | major facilitator superfamily domain containing 14C | |
| PVR | −0.35231 | 0.000528 | 0.006129 | −3.6006 | Down | PVR cell adhesion molecule | |
| STIM1 | −0.32389 | 0.000409 | 0.005319 | −3.67666 | Down | stromal interaction molecule 1 | |
| STK35 | −0.26227 | 0.000425 | 0.005423 | −3.66486 | Down | serine/threonine kinase 35 | |
| PILRA | −0.29576 | 0.000415 | 0.005359 | −3.67194 | Down | paired immunoglobin like type 2 receptor alpha | |
| PRKCD | −0.27159 | 0.000419 | 0.005389 | −3.66952 | Down | protein kinase C delta | |
| PFKFB4 | −0.29916 | 0.00043 | 0.005461 | −3.6616 | Down | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | |
| RAB3D | −0.28769 | 0.000427 | 0.005423 | −3.6641 | Down | RAB3D, member RAS oncogene family | |
| NAGK | −0.26431 | 0.000445 | 0.005535 | −3.65121 | Down | N-acetylglucosamine kinase | |
| RELL1 | −0.38387 | 0.000562 | 0.006383 | −3.58164 | Down | RELT like 1 | |
| LCNL1 | −1.04762 | 0.000615 | 0.006715 | −3.55463 | Down | lipocalin like 1 | |
| ASPRV1 | −0.51579 | 0.000567 | 0.006394 | −3.57928 | Down | aspartic peptidase retroviral like 1 | |
| TBC1D13 | −0.31201 | 0.000496 | 0.005933 | −3.61904 | Down | TBC1 domain family member 13 | |
| CANT1 | −0.26414 | 0.000469 | 0.005723 | −3.63568 | Down | calcium activated nucleotidase 1 | |
| GPR107 | −0.30509 | 0.000479 | 0.005804 | −3.62991 | Down | G protein-coupled receptor 107 | |
| ATXN1L | −0.28945 | 0.000492 | 0.0059 | −3.62183 | Down | ataxin 1 like | |
| CHST14 | −0.31667 | 0.000614 | 0.00671 | −3.55538 | Down | carbohydrate sulfotransferase 14 | |
| SIGLEC9 | −0.26149 | 0.0005 | 0.005946 | −3.61695 | Down | sialic acid binding Ig like lectin 9 | |
| FLCN | −0.3041 | 0.000527 | 0.006129 | −3.60096 | Down | folliculin | |
| WRAP53 | −0.28624 | 0.000632 | 0.006817 | −3.54662 | Down | WD repeat containing antisense to TP53 | |
| RIPK3 | −0.28326 | 0.000527 | 0.006129 | −3.60102 | Down | receptor interacting serine/threonine kinase 3 | |
| FAM53C | −0.26774 | 0.000505 | 0.005976 | −3.61408 | Down | family with sequence similarity 53 member C | |
| WDFY4 | −0.42866 | 0.000513 | 0.006018 | −3.60918 | Down | WDFY family member 4 | |
| GALNT6 | −0.30319 | 0.000593 | 0.006558 | −3.56589 | Down | polypeptide N-acetylgalactosaminyltransferase 6 | |
| IQCN | −0.59607 | 0.000676 | 0.00706 | −3.52611 | Down | IQ motif containing N | |
| KCNIP2 | −0.4831 | 0.00077 | 0.007639 | −3.48639 | Down | potassium voltage-gated channel interacting protein 2 | |
| USP22 | −0.28086 | 0.000539 | 0.006218 | −3.59461 | Down | ubiquitin specific peptidase 22 | |
| APOM | −0.36363 | 0.0008 | 0.007857 | −3.47507 | Down | apolipoprotein M | |
| MAFF | −0.33734 | 0.000758 | 0.007573 | −3.49137 | Down | MAF bZIP transcription factor F | |
| TNFAIP2 | −0.43598 | 0.000547 | 0.006267 | −3.58999 | Down | TNF alpha induced protein 2 | |
| CRISPLD2 | −0.44839 | 0.000554 | 0.006323 | −3.58616 | Down | cysteine rich secretory protein LCCL domain containing 2 | |
| SMURF1 | −0.28252 | 0.000613 | 0.006707 | −3.55597 | Down | SMAD specific E3 ubiquitin protein ligase 1 | |
| SLC35E2A | −0.65437 | 0.000832 | 0.008038 | −3.46296 | Down | solute carrier family 35 member E2A | |
| ADAMTSL4-AS1 | −0.62083 | 0.00084 | 0.008094 | −3.4601 | Down | ADAMTSL4 antisense RNA 1 | |
| C17orf49 | −0.35504 | 0.000843 | 0.008114 | −3.45892 | Down | chromosome 17 open reading frame 49 | |
| MAPK13 | −0.34929 | 0.00064 | 0.006828 | −3.54262 | Down | mitogen-activated protein kinase 13 | |
| MAPRE3 | −0.41136 | 0.000774 | 0.007663 | −3.48489 | Down | microtubule associated protein RP/EB family member 3 | |
| RIPOR1 | −0.45424 | 0.000623 | 0.00676 | −3.55065 | Down | RHO family interacting cell polarization regulator 1 | |
| EPS15L1 | −0.26529 | 0.000638 | 0.006823 | −3.54359 | Down | epidermal growth factor receptor pathway substrate 15 like 1 | |
| RERE | −0.31584 | 0.000638 | 0.006823 | −3.5437 | Down | arginine-glutamic acid dipeptide repeats | |
| DGLUCY | −0.2802 | 0.000649 | 0.006868 | −3.53869 | Down | D-glutamate cyclase | |
| CSF3R | −0.37028 | 0.000656 | 0.006907 | −3.53531 | Down | colony stimulating factor 3 receptor | |
| HCG27 | −0.41468 | 0.000665 | 0.006981 | −3.53133 | Down | HLA complex group 27 | |
| GNAI2 | −0.31016 | 0.000678 | 0.00706 | −3.52531 | Down | G protein subunit alpha i2 | |
| HSH2D | −0.28176 | 0.000684 | 0.00711 | −3.52276 | Down | hematopoietic SH2 domain containing | |
| KIAA0513 | −0.37074 | 0.000709 | 0.007246 | −3.5118 | Down | KIAA0513 | |
| SEMA4A | −0.32944 | 0.000725 | 0.007356 | −3.50486 | Down | semaphorin 4A | |
| PLBD2 | −0.42359 | 0.000941 | 0.008696 | −3.42516 | Down | phospholipase B domain containing 2 | |
| LRP10 | −0.35142 | 0.000757 | 0.007571 | −3.49174 | Down | LDL receptor related protein 10 | |
| GATAD2B | −0.29403 | 0.000784 | 0.007727 | −3.48124 | Down | GATA zinc finger domain containing 2B | |
| NICN1 | −0.31258 | 0.000918 | 0.008552 | −3.43258 | Down | nicolin 1 | |
| DIAPH1 | −0.31756 | 0.000808 | 0.007898 | −3.47192 | Down | diaphanous related formin 1 | |
| ITGAL | −0.35006 | 0.000857 | 0.008169 | −3.45376 | Down | integrin subunit alpha L | |
| ZNF784 | −0.32453 | 0.001326 | 0.010881 | −3.31793 | Down | zinc finger protein 784 | |
| ARHGAP9 | −0.32141 | 0.000888 | 0.00836 | −3.44285 | Down | Rho GTPase activating protein 9 | |
| WWP2 | −0.3584 | 0.000901 | 0.008438 | −3.43845 | Down | WW domain containing E3 ubiquitin protein ligase 2 | |
| MICALL1 | −0.44326 | 0.001108 | 0.009644 | −3.37439 | Down | MICAL like 1 | |
| TP53 | −0.28135 | 0.000961 | 0.008834 | −3.4185 | Down | tumor protein p53 | |
| WDTC1 | −0.41259 | 0.000934 | 0.008664 | −3.4274 | Down | WD and tetratricopeptide repeats 1 | |
| UBE2C | −0.37342 | 0.001447 | 0.011521 | −3.29045 | Down | ubiquitin conjugating enzyme E2 C | |
| ORAI2 | −0.26578 | 0.000971 | 0.008867 | −3.41533 | Down | ORAI calcium release-activated calcium modulator 2 | |
| TMEM63C | −0.66345 | 0.001471 | 0.011659 | −3.28516 | Down | transmembrane protein 63C | |
| NAPA | −0.30533 | 0.00099 | 0.008953 | −3.40941 | Down | NSF attachment protein alpha | |
| SCAMP2 | −0.27934 | 0.000995 | 0.008979 | −3.40775 | Down | secretory carrier membrane protein 2 | |
| PSAP | −0.26071 | 0.001008 | 0.009037 | −3.40361 | Down | prosaposin | |
| ZNF385A | −0.44893 | 0.001055 | 0.009343 | −3.38947 | Down | zinc finger protein 385A | |
| XPO6 | −0.28059 | 0.001023 | 0.009125 | −3.3991 | Down | exportin 6 | |
| TREML2 | −0.29456 | 0.001038 | 0.009222 | −3.39466 | Down | triggering receptor expressed on myeloid cells like 2 | |
| TMEM106A | −0.35251 | 0.001317 | 0.010844 | −3.32008 | Down | transmembrane protein 106A | |
| CNNM4 | −0.30466 | 0.001368 | 0.011101 | −3.30823 | Down | cyclin and CBS domain divalent metal cation transport mediator 4 | |
| ADA2 | −0.32201 | 0.001086 | 0.009543 | −3.38059 | Down | adenosine deaminase 2 | |
| MPEG1 | −0.26839 | 0.001092 | 0.009571 | −3.37885 | Down | macrophage expressed 1 | |
| SLC9A1 | −0.40045 | 0.001164 | 0.009954 | −3.3589 | Down | solute carrier family 9 member A1 | |
| INTS3 | −0.34455 | 0.001156 | 0.00991 | −3.36104 | Down | integrator complex subunit 3 | |
| APOBEC3D | −0.30439 | 0.001328 | 0.010888 | −3.31758 | Down | apolipoprotein B mRNA editing enzyme catalytic subunit 3D | |
| ZNF324 | −0.29262 | 0.001606 | 0.012416 | −3.2573 | Down | zinc finger protein 324 | |
| SIDT2 | −0.35226 | 0.001217 | 0.010314 | −3.34508 | Down | SID1 transmembrane family member 2 | |
| TMEM214 | −0.29447 | 0.001256 | 0.010538 | −3.33517 | Down | transmembrane protein 214 | |
| ZNF687 | −0.33153 | 0.001277 | 0.010659 | −3.32985 | Down | zinc finger protein 687 | |
| MFN2 | −0.28625 | 0.001236 | 0.01042 | −3.34017 | Down | mitofusin 2 | |
| RAB36 | −0.43526 | 0.001925 | 0.014054 | −3.19916 | Down | RAB36, member RAS oncogene family | |
| PLPPR2 | −0.40458 | 0.001273 | 0.010644 | −3.33082 | Down | phospholipid phosphatase related 2 | |
| DYSF | −0.45611 | 0.00128 | 0.010665 | −3.32913 | Down | dysferlin | |
| FIZ1 | −0.28749 | 0.001808 | 0.013394 | −3.21933 | Down | FLT3 interacting zinc finger 1 | |
| STK10 | −0.26283 | 0.001306 | 0.010781 | −3.3227 | Down | serine/threonine kinase 10 | |
| MAML3 | −0.28886 | 0.001556 | 0.012181 | −3.26737 | Down | mastermind like transcriptional coactivator 3 | |
| KSR1 | −0.37381 | 0.001394 | 0.011257 | −3.30217 | Down | kinase suppressor of ras 1 | |
| TRIM62 | −0.30433 | 0.001646 | 0.012623 | −3.2494 | Down | tripartite motif containing 62 | |
| SESN2 | −0.3122 | 0.00169 | 0.012795 | −3.24092 | Down | sestrin 2 | |
| MARK2 | −0.31865 | 0.00141 | 0.011332 | −3.29873 | Down | microtubule affinity regulating kinase 2 | |
| CDIP1 | −0.31975 | 0.00157 | 0.012243 | −3.26456 | Down | cell death inducing p53 target 1 | |
| PAQR6 | −0.61509 | 0.002215 | 0.015442 | −3.15361 | Down | progestin and adipoQ receptor family member 6 | |
| PISD | −0.27421 | 0.001455 | 0.011557 | −3.28858 | Down | phosphatidylserine decarboxylase | |
| TNFSF12 | −0.28316 | 0.001722 | 0.012942 | −3.2349 | Down | TNF superfamily member 12 | |
| MAP11 | −0.31678 | 0.001495 | 0.011825 | −3.2801 | Down | microtubule associated protein 11 | |
| IQCE | −0.31488 | 0.001787 | 0.013302 | −3.22309 | Down | IQ motif containing E | |
| ADGRE5 | −0.39217 | 0.001542 | 0.012114 | −3.27021 | Down | adhesion G protein-coupled receptor E5 | |
| SCAP | −0.32181 | 0.001592 | 0.012352 | −3.26013 | Down | SREBF chaperone | |
| NECTIN1 | −0.4398 | 0.002047 | 0.014673 | −3.17924 | Down | nectin cell adhesion molecule 1 | |
| CDK5RAP3 | −0.34828 | 0.001582 | 0.01231 | −3.26209 | Down | CDK5 regulatory subunit associated protein 3 | |
| DAPK2 | −0.30512 | 0.001699 | 0.012832 | −3.23936 | Down | death associated protein kinase 2 | |
| PLAGL2 | −0.27659 | 0.001719 | 0.012929 | −3.23551 | Down | PLAG1 like zinc finger 2 | |
| ZDHHC18 | −0.29438 | 0.001667 | 0.012699 | −3.24539 | Down | zinc finger DHHC-type containing 18 | |
| CD4 | −0.29252 | 0.001675 | 0.012725 | −3.24392 | Down | CD4 molecule | |
| ATG16L2 | −0.47049 | 0.001688 | 0.012792 | −3.24146 | Down | autophagy related 16 like 2 | |
| GBGT1 | −0.30319 | 0.002212 | 0.015431 | −3.15412 | Down | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group) | |
| SKIV2L | −0.32579 | 0.001807 | 0.013394 | −3.2196 | Down | Ski2 like RNA helicase | |
| TTC4 | −0.34101 | 0.003031 | 0.019228 | −3.05037 | Down | tetratricopeptide repeat domain 4 | |
| RAD54L2 | −0.37561 | 0.002087 | 0.014855 | −3.17303 | Down | RAD54 like 2 | |
| PI4K2A | −0.26735 | 0.00229 | 0.015792 | −3.14278 | Down | phosphatidylinositol 4-kinase type 2 alpha | |
| JAK3 | −0.30717 | 0.001914 | 0.013982 | −3.20098 | Down | Janus kinase 3 | |
| FLT3 | −0.35297 | 0.002633 | 0.017514 | −3.09708 | Down | fms related tyrosine kinase 3 | |
| RNF31 | −0.33297 | 0.002109 | 0.014969 | −3.16959 | Down | ring finger protein 31 | |
| POMZP3 | −0.4664 | 0.002875 | 0.018477 | −3.06791 | Down | POM121 and ZP3 fusion | |
| LMTK2 | −0.26618 | 0.002202 | 0.015375 | −3.15558 | Down | lemur tyrosine kinase 2 | |
| AOC3 | −0.44883 | 0.002455 | 0.016657 | −3.12003 | Down | amine oxidase copper containing 3 | |
| FANCA | −0.35504 | 0.002422 | 0.016499 | −3.12447 | Down | FA complementation group A | |
| WBP2 | −0.31533 | 0.002039 | 0.014631 | −3.1806 | Down | WW domain binding protein 2 | |
| OGFOD2 | −0.38737 | 0.003433 | 0.020952 | −3.00876 | Down | 2-oxoglutarate and iron dependent oxygenase domain containing 2 | |
| ITIH4 | −0.7173 | 0.003584 | 0.021602 | −2.99422 | Down | inter-alpha-trypsin inhibitor heavy chain 4 | |
| ITGAM | −0.28014 | 0.002099 | 0.01493 | −3.17112 | Down | integrin subunit alpha M | |
| CHD8 | −0.28304 | 0.002143 | 0.015097 | −3.16436 | Down | chromodomain helicase DNA binding protein 8 | |
| DENND1A | −0.31755 | 0.002347 | 0.016118 | −3.13479 | Down | DENN domain containing 1A | |
| TRIM41 | −0.26057 | 0.00236 | 0.016189 | −3.13294 | Down | tripartite motif containing 41 | |
| NLRP1 | −0.3423 | 0.002242 | 0.01557 | −3.14971 | Down | NLR family pyrin domain containing 1 | |
| MMP25 | −0.48039 | 0.002249 | 0.01561 | −3.1487 | Down | matrix metallopeptidase 25 | |
| POPDC2 | −0.32941 | 0.003559 | 0.021496 | −2.99664 | Down | popeye domain containing 2 | |
| CPNE9 | −0.66459 | 0.003856 | 0.022604 | −2.96956 | Down | copine family member 9 | |
| LAG3 | −0.46043 | 0.003252 | 0.020199 | −3.02693 | Down | lymphocyte activating 3 | |
| NDRG2 | −0.27747 | 0.003018 | 0.019177 | −3.05186 | Down | NDRG family member 2 | |
| INPP5B | −0.31274 | 0.002511 | 0.016952 | −3.11262 | Down | inositol polyphosphate-5-phosphatase B | |
| BMF | −0.26451 | 0.002523 | 0.017008 | −3.11107 | Down | Bcl2 modifying factor | |
| INPP5D | −0.26393 | 0.002376 | 0.016265 | −3.13076 | Down | inositol polyphosphate-5-phosphatase D | |
| PAPLN | −0.52955 | 0.004162 | 0.023765 | −2.94356 | Down | papilin, proteoglycan like sulfated glycoprotein | |
| SLC27A3 | −0.31556 | 0.002609 | 0.017417 | −3.10008 | Down | solute carrier family 27 member 3 | |
| XKR8 | −0.26542 | 0.002565 | 0.017192 | −3.10567 | Down | XK related 8 | |
| DOP1B | −0.26995 | 0.002714 | 0.017839 | −3.08698 | Down | DOP1 leucine zipper like protein B | |
| GMIP | −0.3929 | 0.002527 | 0.017026 | −3.11057 | Down | GEM interacting protein | |
| PNKD | −0.29826 | 0.002802 | 0.018154 | −3.07643 | Down | PNKD metallo-beta-lactamase domain containing | |
| ZNF264 | −0.26952 | 0.003525 | 0.021391 | −2.99983 | Down | zinc finger protein 264 | |
| PLXNA2 | −0.4063 | 0.003836 | 0.022539 | −2.97125 | Down | plexin A2 | |
| TAF8 | −0.30568 | 0.00284 | 0.018306 | −3.07201 | Down | TATA-box binding protein associated factor 8 | |
| GYS1 | −0.30134 | 0.002951 | 0.018854 | −3.05932 | Down | glycogen synthase 1 | |
| SLC1A4 | −0.36474 | 0.003534 | 0.021412 | −2.99901 | Down | solute carrier family 1 member 4 | |
| SLC15A3 | −0.28569 | 0.002848 | 0.01835 | −3.07109 | Down | solute carrier family 15 member 3 | |
| TLE3 | −0.32824 | 0.002748 | 0.017961 | −3.08292 | Down | TLE family member 3, transcriptional corepressor | |
| SLC16A5 | −0.31497 | 0.003097 | 0.01951 | −3.04325 | Down | solute carrier family 16 member 5 | |
| OGDH | −0.32269 | 0.002818 | 0.018207 | −3.07457 | Down | oxoglutarate dehydrogenase | |
| RTN1 | −0.33417 | 0.003191 | 0.019886 | −3.03327 | Down | reticulon 1 | |
| THBS3 | −0.34867 | 0.003237 | 0.020126 | −3.0284 | Down | thrombospondin 3 | |
| BCL3 | −0.36376 | 0.003035 | 0.019247 | −3.04991 | Down | BCL3 transcription coactivator | |
| ADCY4 | −0.36448 | 0.003609 | 0.021672 | −2.99194 | Down | adenylatecyclase 4 | |
| ZNF530 | −0.32785 | 0.004519 | 0.025209 | −2.91541 | Down | zinc finger protein 530 | |
| ZMYND15 | −0.48374 | 0.004583 | 0.02545 | −2.9106 | Down | zinc finger MYND-type containing 15 | |
| AMY1B | −0.72088 | 0.005292 | 0.028186 | −2.86091 | Down | amylase alpha 1B | |
| ZNF417 | −0.30434 | 0.003838 | 0.022543 | −2.97107 | Down | zinc finger protein 417 | |
| GTF2IRD2 | −0.3548 | 0.004795 | 0.02631 | −2.89503 | Down | GTF2I repeat domain containing 2 | |
| PRSS21 | −0.78843 | 0.005521 | 0.02903 | −2.84617 | Down | serine protease 21 | |
| CADM4 | −0.3036 | 0.005273 | 0.028121 | −2.86213 | Down | cell adhesion molecule 4 | |
| HIP1 | −0.45352 | 0.003301 | 0.020406 | −3.02192 | Down | huntingtin interacting protein 1 | |
| STIMATE-MUSTN1 | −0.54123 | 0.005515 | 0.029012 | −2.8465 | Down | STIMATE-MUSTN1 readthrough | |
| KCTD11 | −0.2781 | 0.004312 | 0.024369 | −2.93148 | Down | potassium channel tetramerization domain containing 11 | |
| ZNF70 | −0.57012 | 0.005544 | 0.029142 | −2.84472 | Down | zinc finger protein 70 | |
| HIVEP3 | −0.39006 | 0.004369 | 0.024627 | −2.92696 | Down | HIVEP zinc finger 3 | |
| LOC100129697 | −0.60899 | 0.005981 | 0.030664 | −2.81815 | Down | uncharacterized LOC100129697 | |
| CIITA | −0.43886 | 0.003378 | 0.020711 | −3.01412 | Down | class II major histocompatibility complex transactivator | |
| EPOR | −0.27146 | 0.004472 | 0.025006 | −2.91898 | Down | erythropoietin receptor | |
| SHISA4 | −0.64173 | 0.005489 | 0.028917 | −2.84818 | Down | shisa family member 4 | |
| STIMATE | −0.30689 | 0.006148 | 0.031273 | −2.80846 | Down | STIM activating enhancer | |
| ADAT1 | −0.27445 | 0.004127 | 0.023668 | −2.94646 | Down | adenosine deaminasetRNA specific 1 | |
| TTLL11 | −0.30463 | 0.006288 | 0.031761 | −2.80055 | Down | tubulin tyrosine ligase like 11 | |
| H6PD | −0.40411 | 0.00368 | 0.021976 | −2.9853 | Down | hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | |
| RAPGEFL1 | −0.46135 | 0.004927 | 0.02685 | −2.88567 | Down | Rap guanine nucleotide exchange factor like 1 | |
| TMEM63B | −0.31929 | 0.004159 | 0.023761 | −2.94384 | Down | transmembrane protein 63B | |
| PSPN | −0.32479 | 0.006167 | 0.031326 | −2.80738 | Down | persephin | |
| HLA-DQA1 | −1.05471 | 0.004016 | 0.023213 | −2.95571 | Down | major histocompatibility complex, class II, DQ alpha 1 | |
| TRAPPC9 | −0.31907 | 0.004124 | 0.023668 | −2.94672 | Down | trafficking protein particle complex 9 | |
| CCNJL | −0.30896 | 0.00384 | 0.022544 | −2.97093 | Down | cyclin J like | |
| MAP1A | −0.48755 | 0.005854 | 0.030316 | −2.8257 | Down | microtubule associated protein 1A | |
| PPP1R12B | −0.32586 | 0.003774 | 0.022328 | −2.9768 | Down | protein phosphatase 1 regulatory subunit 12B | |
| DNMBP | −0.36414 | 0.004698 | 0.025936 | −2.9021 | Down | dynamin binding protein | |
| CLEC17A | −0.48511 | 0.005274 | 0.028121 | −2.86207 | Down | C-type lectin domain containing 17A | |
| PACS1 | −0.35178 | 0.003745 | 0.022242 | −2.97938 | Down | phosphofurin acidic cluster sorting protein 1 | |
| TRIM25 | −0.26502 | 0.00377 | 0.022316 | −2.97712 | Down | tripartite motif containing 25 | |
| DSP | −1.74666 | 0.007097 | 0.034701 | −2.75765 | Down | desmoplakin | |
| PHF7 | −0.33686 | 0.006229 | 0.031548 | −2.80388 | Down | PHD finger protein 7 | |
| ADGRG3 | −0.36957 | 0.003871 | 0.022639 | −2.96821 | Down | adhesion G protein-coupled receptor G3 | |
| SULT1A2 | −0.76588 | 0.007036 | 0.034482 | −2.76074 | Down | sulfotransferase family 1A member 2 | |
| SPIB | −0.38425 | 0.004951 | 0.026919 | −2.884 | Down | Spi-B transcription factor | |
| DRICH1 | −0.66714 | 0.007466 | 0.036148 | −2.73956 | Down | aspartate rich 1 | |
| ZNF445 | −0.34371 | 0.004446 | 0.024908 | −2.921 | Down | zinc finger protein 445 | |
| USP19 | −0.27666 | 0.004041 | 0.023332 | −2.95362 | Down | ubiquitin specific peptidase 19 | |
| STK36 | −0.29142 | 0.005018 | 0.027206 | −2.87931 | Down | serine/threonine kinase 36 | |
| CDKN2A | −0.69258 | 0.007729 | 0.037039 | −2.72716 | Down | cyclin dependent kinase inhibitor 2A | |
| METTL7A | −0.27873 | 0.004291 | 0.024292 | −2.93314 | Down | methyltransferase like 7A | |
| TTLL3 | −0.40446 | 0.004358 | 0.024578 | −2.92787 | Down | tubulin tyrosine ligase like 3 | |
| C19orf84 | −0.73685 | 0.007933 | 0.037785 | −2.71782 | Down | chromosome 19 open reading frame 84 | |
| ARHGAP31 | −0.30623 | 0.005156 | 0.02773 | −2.86992 | Down | Rho GTPase activating protein 31 | |
| C2CD2L | −0.26804 | 0.004428 | 0.024824 | −2.9224 | Down | C2CD2 like | |
| PLEKHG3 | −0.35043 | 0.00427 | 0.024204 | −2.93484 | Down | pleckstrin homology and RhoGEF domain containing G3 | |
| GBF1 | −0.35336 | 0.004328 | 0.02444 | −2.93017 | Down | golgibrefeldin A resistant guanine nucleotide exchange factor 1 | |
| SLC6A16 | −0.36797 | 0.006412 | 0.032156 | −2.79366 | Down | solute carrier family 6 member 16 | |
| VARS2 | −0.38504 | 0.005076 | 0.027413 | −2.87536 | Down | valyl-tRNAsynthetase 2, mitochondrial | |
| PLEKHM1 | −0.31734 | 0.004414 | 0.024784 | −2.92345 | Down | pleckstrin homology and RUN domain containing M1 | |
| SMIM34A | −0.72037 | 0.008217 | 0.038787 | −2.70514 | Down | small integral membrane protein 34A | |
| MARK4 | −0.3283 | 0.005433 | 0.028678 | −2.85174 | Down | microtubule affinity regulating kinase 4 | |
| SLC38A7 | −0.28303 | 0.005751 | 0.029924 | −2.83191 | Down | solute carrier family 38 member 7 | |
| SLC25A35 | −0.2993 | 0.006192 | 0.031428 | −2.80596 | Down | solute carrier family 25 member 35 | |
| VAT1 | −0.27067 | 0.004901 | 0.026728 | −2.88746 | Down | vesicle amine transport 1 | |
| C15orf39 | −0.40438 | 0.004391 | 0.024697 | −2.92529 | Down | chromosome 15 open reading frame 39 | |
| NF2 | −0.28694 | 0.005349 | 0.028401 | −2.8572 | Down | neurofibromin 2 | |
| BSCL2 | −0.26614 | 0.007512 | 0.036312 | −2.73739 | Down | BSCL2 lipid droplet biogenesis associated, seipin | |
| VDR | −0.2684 | 0.005304 | 0.028225 | −2.86013 | Down | vitamin D receptor | |
| PADI4 | −0.44486 | 0.004656 | 0.025758 | −2.90517 | Down | peptidyl arginine deiminase 4 | |
| ABCG1 | −0.29576 | 0.005169 | 0.027735 | −2.86904 | Down | ATP binding cassette subfamily G member 1 | |
| ABTB2 | −0.44053 | 0.008044 | 0.038142 | −2.71281 | Down | ankyrin repeat and BTB domain containing 2 | |
| SLC16A13 | −0.28493 | 0.007676 | 0.036885 | −2.72966 | Down | solute carrier family 16 member 13 | |
| FHOD1 | −0.31983 | 0.00504 | 0.027298 | −2.87781 | Down | formin homology 2 domain containing 1 | |
| ARID1A | −0.31182 | 0.004979 | 0.027052 | −2.88206 | Down | AT-rich interaction domain 1A | |
| GPR157 | −0.33012 | 0.007318 | 0.03555 | −2.74675 | Down | G protein-coupled receptor 157 | |
| DAAM2 | −1.17025 | 0.008639 | 0.040251 | −2.68706 | Down | dishevelled associated activator of morphogenesis 2 | |
| INCA1 | −0.60309 | 0.009868 | 0.04423 | −2.63853 | Down | inhibitor of CDK, cyclin A1 interacting protein 1 | |
| TIGD3 | −0.368 | 0.006217 | 0.031506 | −2.80456 | Down | tigger transposable element derived 3 | |
| ENTPD2 | −0.85818 | 0.009711 | 0.043759 | −2.64442 | Down | ectonucleoside triphosphate diphosphohydrolase 2 | |
| ARHGEF5 | −0.39012 | 0.009339 | 0.042517 | −2.6587 | Down | Rho guanine nucleotide exchange factor 5 | |
| PLD2 | −0.28888 | 0.005989 | 0.030695 | −2.81768 | Down | phospholipase D2 | |
| POLR1A | −0.3791 | 0.006226 | 0.031544 | −2.80404 | Down | RNA polymerase I subunit A | |
| KIAA0556 | −0.31343 | 0.005811 | 0.030142 | −2.82826 | Down | KIAA0556 | |
| RAP1GAP2 | −0.32685 | 0.005276 | 0.028122 | −2.86195 | Down | RAP1 GTPase activating protein 2 | |
| ADD1 | −0.26923 | 0.005269 | 0.02812 | −2.86242 | Down | adducin 1 | |
| EHBP1L1 | −0.35615 | 0.005468 | 0.028814 | −2.84954 | Down | EH domain binding protein 1 like 1 | |
| FAM160A1 | −0.7446 | 0.010863 | 0.047396 | −2.60316 | Down | family with sequence similarity 160 member A1 | |
| SOGA1 | −0.42952 | 0.007824 | 0.037374 | −2.72278 | Down | suppressor of glucose, autophagy associated 1 | |
| TNFRSF21 | −0.61534 | 0.01054 | 0.046315 | −2.61431 | Down | TNF receptor superfamily member 21 | |
| NFAM1 | −0.29308 | 0.005706 | 0.029771 | −2.83465 | Down | NFAT activating protein with ITAM motif 1 | |
| CNOT3 | −0.30586 | 0.005959 | 0.030608 | −2.81943 | Down | CCR4-NOT transcription complex subunit 3 | |
| RSKR | −0.56514 | 0.010578 | 0.046421 | −2.61296 | Down | ribosomal protein S6 kinase related | |
| PLXNA4 | −0.50001 | 0.010531 | 0.04631 | −2.61461 | Down | plexin A4 | |
| CNTROB | −0.29089 | 0.006896 | 0.033945 | −2.76788 | Down | centrobin, centriole duplication and spindle assembly protein | |
| TBC1D10B | −0.26939 | 0.006094 | 0.031079 | −2.81158 | Down | TBC1 domain family member 10B | |
| NOXRED1 | −0.34558 | 0.011102 | 0.048163 | −2.59509 | Down | NADP dependent oxidoreductase domain containing 1 | |
| HYOU1 | −0.30667 | 0.006028 | 0.030859 | −2.81539 | Down | hypoxia up-regulated 1 | |
| SUPT5H | −0.27837 | 0.005938 | 0.030542 | −2.82067 | Down | SPT5 homolog, DSIF elongation factor subunit | |
| CLPB | −0.26559 | 0.008773 | 0.040714 | −2.68144 | Down | ClpB homolog, mitochondrial AAA ATPase chaperonin | |
| SIGLEC5 | −0.30815 | 0.006387 | 0.032082 | −2.79502 | Down | sialic acid binding Ig like lectin 5 | |
| NCR1 | −0.46793 | 0.008972 | 0.041383 | −2.67332 | Down | natural cytotoxicity triggering receptor 1 | |
| LRRC20 | −0.28981 | 0.010509 | 0.046236 | −2.6154 | Down | leucine rich repeat containing 20 | |
| MAP7D1 | −0.30089 | 0.006066 | 0.030993 | −2.81322 | Down | MAP7 domain containing 1 | |
| GHRL | −0.28653 | 0.008139 | 0.038516 | −2.70858 | Down | ghrelin and obestatinprepropeptide | |
| KDM6B | −0.4334 | 0.006275 | 0.031734 | −2.80128 | Down | lysine demethylase 6B | |
| CCDC17 | −0.32392 | 0.009183 | 0.041985 | −2.66487 | Down | coiled-coil domain containing 17 | |
| U2AF1L4 | −0.26211 | 0.008081 | 0.038264 | −2.71116 | Down | U2 small nuclear RNA auxiliary factor 1 like 4 | |
| CEACAM4 | −0.30283 | 0.006663 | 0.033138 | −2.78007 | Down | CEA cell adhesion molecule 4 | |
| TNS3 | −0.28418 | 0.007707 | 0.036969 | −2.72819 | Down | tensin 3 | |
| ADAP2 | −0.27485 | 0.00825 | 0.038875 | −2.70371 | Down | ArfGAP with dual PH domains 2 | |
| NLRX1 | −0.2759 | 0.007971 | 0.037933 | −2.71612 | Down | NLR family member X1 | |
| RABL2A | −0.30042 | 0.009208 | 0.042068 | −2.66386 | Down | RAB, member of RAS oncogene family like 2A | |
| PROSER3 | −0.47732 | 0.009247 | 0.042198 | −2.66234 | Down | proline and serine rich 3 | |
| MIDN | −0.29956 | 0.006943 | 0.034146 | −2.76547 | Down | midnolin | |
| DENND4B | −0.31441 | 0.006859 | 0.033811 | −2.76981 | Down | DENN domain containing 4B | |
| SORBS3 | −0.40358 | 0.00832 | 0.039149 | −2.70067 | Down | sorbin and SH3 domain containing 3 | |
| PLB1 | −0.36701 | 0.007831 | 0.037384 | −2.72248 | Down | phospholipase B1 | |
| DPEP3 | −0.34095 | 0.009581 | 0.043304 | −2.64937 | Down | dipeptidase 3 | |
| SEMA4B | −0.31138 | 0.007518 | 0.036312 | −2.73711 | Down | semaphorin 4B | |
| WASF2 | −0.28093 | 0.007388 | 0.035832 | −2.74331 | Down | WASP family member 2 | |
| NUCB1 | −0.34217 | 0.007574 | 0.036492 | −2.73442 | Down | nucleobindin 1 | |
| SH3BP2 | −0.28179 | 0.007608 | 0.036623 | −2.73283 | Down | SH3 domain binding protein 2 | |
| P2RX5 | −0.37743 | 0.008788 | 0.040771 | −2.68084 | Down | purinergic receptor P2X 5 | |
| SPN | −0.3575 | 0.007702 | 0.036969 | −2.72842 | Down | sialophorin | |
| KRTCAP2 | −0.27178 | 0.010587 | 0.046448 | −2.61265 | Down | keratinocyte associated protein 2 | |
| MRTFA | −0.32285 | 0.007914 | 0.037715 | −2.7187 | Down | myocardin related transcription factor A | |
| MBOAT7 | −0.29593 | 0.007972 | 0.037933 | −2.71605 | Down | membrane bound O-acyltransferase domain containing 7 | |
| PREX1 | −0.30088 | 0.008158 | 0.038573 | −2.70775 | Down | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 | |
| YLPM1 | −0.28757 | 0.008714 | 0.040515 | −2.68392 | Down | YLP motif containing 1 | |
| STK40 | −0.26465 | 0.008277 | 0.038982 | −2.70252 | Down | serine/threonine kinase 40 | |
| ARHGAP17 | −0.33169 | 0.009266 | 0.04223 | −2.66157 | Down | Rho GTPase activating protein 17 | |
| VNN3 | −0.30084 | 0.008574 | 0.040052 | −2.68977 | Down | vanin 3 | |
| SLC9A8 | −0.26299 | 0.008652 | 0.040285 | −2.68649 | Down | solute carrier family 9 member A8 | |
| RPGRIP1 | −0.27294 | 0.010455 | 0.046081 | −2.6173 | Down | RPGR interacting protein 1 | |
| LRRC4 | −0.27126 | 0.009351 | 0.042557 | −2.65825 | Down | leucine rich repeat containing 4 | |
| MAVS | −0.37027 | 0.009896 | 0.04429 | −2.63751 | Down | mitochondrial antiviral signaling protein | |
| DENND3 | −0.29167 | 0.008663 | 0.040323 | −2.68605 | Down | DENN domain containing 3 | |
| BAG6 | −0.29939 | 0.008921 | 0.041228 | −2.67539 | Down | BCL2 associated athanogene 6 | |
| STAT2 | −0.3148 | 0.008975 | 0.041387 | −2.67319 | Down | signal transducer and activator of transcription 2 | |
| TAGLN | −0.47191 | 0.01024 | 0.045397 | −2.62496 | Down | transgelin | |
| ARHGEF40 | −0.30666 | 0.009153 | 0.041943 | −2.66604 | Down | Rho guanine nucleotide exchange factor 40 | |
| HEATR6 | −0.28169 | 0.011601 | 0.049803 | −2.57873 | Down | HEAT repeat containing 6 | |
| DGAT2 | −0.26818 | 0.009139 | 0.041901 | −2.6666 | Down | diacylglycerol O-acyltransferase 2 | |
| PRKD2 | −0.30467 | 0.009203 | 0.042065 | −2.66408 | Down | protein kinase D2 | |
| AGER | −0.3384 | 0.009421 | 0.042727 | −2.65554 | Down | advanced glycosylation end-product specific receptor | |
| UBA7 | −0.26693 | 0.009299 | 0.042344 | −2.66029 | Down | ubiquitin like modifier activating enzyme 7 | |
| CAMKK1 | −0.29228 | 0.011032 | 0.047934 | −2.59743 | Down | calcium/calmodulin dependent protein kinase kinase 1 | |
| DLGAP4 | −0.29263 | 0.009963 | 0.044477 | −2.63502 | Down | DLG associated protein 4 | |
| REC8 | −0.3437 | 0.010365 | 0.04582 | −2.62047 | Down | REC8 meiotic recombination protein | |
| TLN1 | −0.4416 | 0.009401 | 0.042661 | −2.65628 | Down | talin 1 | |
| QSOX1 | −0.28813 | 0.009808 | 0.044044 | −2.64077 | Down | quiescin sulfhydryl oxidase 1 | |
| ZNF692 | −0.27196 | 0.010424 | 0.045995 | −2.6184 | Down | zinc finger protein 692 | |
| CSF1R | −0.29204 | 0.00998 | 0.044538 | −2.63442 | Down | colony stimulating factor 1 receptor | |
| ABCC10 | −0.3171 | 0.01149 | 0.04946 | −2.58231 | Down | ATP binding cassette subfamily C member 10 | |
| ABTB1 | −0.33918 | 0.010031 | 0.044708 | −2.63253 | Down | ankyrin repeat and BTB domain containing 1 | |
| GALNS | −0.2628 | 0.011209 | 0.048514 | −2.59152 | Down | galactosamine (N-acetyl)-6-sulfatase | |
| PRRC2A | −0.42124 | 0.010301 | 0.045643 | −2.62278 | Down | proline rich coiled-coil 2A | |
| SLC11A1 | −0.32785 | 0.010591 | 0.046449 | −2.61254 | Down | solute carrier family 11 member 1 | |
| TEP1 | −0.27091 | 0.011336 | 0.048899 | −2.58735 | Down | telomerase associated protein 1 | |
| P2RX1 | −0.33856 | 0.011621 | 0.049837 | −2.57809 | Down | purinergic receptor P2X 1 | |
Fig. 1.
Volcano plot of differentially expressed genes. Genes with a significant change of more than two-fold were selected. Green dot represented up regulated significant genes and red dot represented down regulated significant genes
Fig. 2.
Heat map of differentially expressed genes. Legend on the top left indicate log fold change of genes. (A1 – A43 = healthy donors’ samples; B1 – B14 = T1D samples)
Gene Ontology (GO) and pathway enrichment analyses of DEGs
To identify the pathways which had the most significant involvement with the genes identified, up regulated and down regulated genes are listed in Table 3 and Table 4. DEGs were submitted into ToppGene for GO and REACTOME pathway enrichment analysis. GO enrichment analysis revealed that in BP terms, the up regulated genes were mainly enriched in cell-cell signaling and reproductive process, whereas down regulated genes were mainly enriched in vesicle fusion and biological adhesion. In CC terms, up regulated genes were mainly enriched in integral component of plasma membrane and supramolecularfiber, whereas down regulated genes were mainly enriched in whole membrane and cell junction. In MF terms, up regulated genes were mainly enriched in signaling receptor activity and structural molecule activity, whereas down regulated genes were mainly enriched in lipid binding and GTPase binding. REACTOME pathway analysis demonstrated that up regulated genes were significantly enriched in signaling by GPCR and muscle contraction, whereas down regulated genes were mainly enriched in innate immune system and cytokine signaling in immune system.
Table 3.
The enriched pathway terms of the up and down regulated differentially expressed genes
| Pathway ID | Pathway Name | P-value | FDR B&H | FDR B&Y | Bonferroni | Gene Count | Gene |
|---|---|---|---|---|---|---|---|
| Up regulated genes | |||||||
| 1,269,543 | Signaling by GPCR | 3.16E-03 | 1.94E-01 | 1.00E+00 | 7.89E-01 | 16 |
OR2T29,NPBWR1,TRHR,AVP,GPR37,OR10J3,GRIN2B, RGS4,PTHLH,CRHR2, OR51E2,OR51E1,EGFR,OR6C70, CCL13,CCL19 |
| 1,269,868 | Muscle contraction | 5.98E-03 | 1.94E-01 | 1.00E+00 | 1.00E+00 | 5 | MYH6,NPPC,KCNK4,ATP1A4,PLN |
| 1,269,958 | Digestion of dietary carbohydrate | 5.00E-02 | 2.98E-01 | 1.00E+00 | 1.00E+00 | 1 | AMY1A |
| 1,457,790 | Keratinization | 1.22E-01 | 1.00E+00 | 3.53E-01 | 1.00E+00 | 3 | KRT39,KRT20,KRT38 |
| 1,270,189 | Biological oxidations | 1.41E-01 | 3.67E-01 | 1.00E+00 | 1.00E+00 | 3 | CYP2F1,AS3MT,UGT2A3 |
| 1,269,907 | SLC-mediated transmembrane transport | 4.87E-01 | 6.38E-01 | 1.00E+00 | 1.00E+00 | 2 | AVP,G6PC |
| Down regulated genes | |||||||
| 1,269,203 | Innate Immune System | 1.03E-02 | 3.35E-01 | 1.00E+00 | 1.00E+00 | 16 |
CRISPLD2,DSP,OSCAR,C5AR2,SIGLEC14,ITGAX,MEFV,GAB2,MMP25,IGF2R,ATP6V0D1, DTX4,TLN1,PRKACA,ADGRE5,CLEC4C |
| 1,269,310 | Cytokine Signaling in Immune system | 1.26E-01 | 5.91E-01 | 1.00E+00 | 1.00E+00 | 8 | HLA-DQA1,ITGAX,GAB2,LGALS9,CIITA,TLN1,PRKACA,IL17RA |
| 1,269,957 | Metabolism of carbohydrates | 1.31E-01 | 5.91E-01 | 1.00E+00 | 1.00E+00 | 4 | NDST1,AMY1B,SLC9A1,PRKACA |
| 1,269,876 | Vesicle-mediated transport | 1.41E-01 | 5.91E-01 | 1.00E+00 | 1.00E+00 | 7 | VPS37C,HIP1,GABARAP,APOL1,ARF3,RAB36,IGF2R |
| 1,269,507 | Signaling by Rho GTPases | 3.11E-01 | 6.03E-01 | 1.00E+00 | 1.00E+00 | 4 | ARHGEF5,GMIP,ARHGAP1,ARAP3 |
| 1,269,649 | Gene Expression | 9.87E-01 | 9.89E-01 | 1.00E+00 | 1.00E+00 | 6 | CDKN2A,POLR2A,ZNF385A,EIF3CL,BAZ2A,ZNF70 |
Table 4.
The enriched GO terms of the up and down regulated differentially expressed genes
| GO ID | CATEGORY | GO Name | P Value | FDR B&H | FDR B&Y | Bonferroni | Gene Count | Gene |
|---|---|---|---|---|---|---|---|---|
| Up regulated genes | ||||||||
| GO:0007267 | BP | cell-cell signaling | 6.48E-03 | 1.84E-01 | 1.00E+00 | 1.00E+00 | 22 | TRHDE,NPBWR1,MYH6,AVP,PPFIA2,IL17B,PCDHB10,PCDHB2,GRIA4,GRIN2B,DCC,RGS4,PTHLH,CRHR2,GJA1,CSNK1A1L,DKK1,EGFR,SNAP91,RIMS4,LRP2,CCL13 |
| GO:0022414 | BP | reproductive process | 1.22E-02 | 1.99E-01 | 1.00E+00 | 1.00E+00 | 19 | NPPC,AVP,BTBD18,MEIOB,RAD21L1,TEX15,PTHLH,GJA1,EGFR,SPATA16,MIF,OSR1,LRP2,HFM1,ACSBG2,SPATA22,ATP1A4,PRL,UTF1 |
| GO:0005887 | CC | integral component of plasma membrane | 1.14E-03 | 1.17E-01 | 7.35E-01 | 3.43E-01 | 22 | TRHDE,SEMA6B,RDH8,NPBWR1,TMC2,TRHR,GPR37,PCDHB10,PCDHB2,TM4SF5,GRIA4,GRIN2B,DCC,KCNK4,PTPRT,CRHR2,ADGRL4,GJA1,EGFR,LRFN5,UPK1B,ATP1A4 |
| GO:0099512 | CC | supramolecularfiber | 1.65E-02 | 1.84E-01 | 1.00E+00 | 1.00E+00 | 17 | ABRA,DNAH3,MYH6,MYOT,NRAP,TMC2,MYH13,KIF1A,GRIN2B,GJA1,KRT39,MFAP2,TRIM55,LRP2,KRT20,KRT38,PTPN20 |
| GO:0038023 | MF | signaling receptor activity | 1.59E-03 | 1.30E-01 | 8.79E-01 | 7.75E-01 | 22 | OR2T29,NPBWR1,MYOT,TRHR,GPR37,OR10J3,GRIA4,GRIN2B,DCC,PTPRT,CRHR2,ADGRL4,MTRNR2L1,OR51E2,MTRNR2L6,OR51E1,DKK1,EGFR,OR6C70,LRP2,ADGRF4,FCAMR |
| GO:0005198 | MF | structural molecule activity | 3.67E-02 | 2.51E-01 | 1.00E+00 | 1.00E+00 | 10 | MYOT,EPB41L4B,MRPL12,PPFIA2,EMILIN3,KRT39,MFAP2,UPK1B,KRT20,KRT38 |
| Down regulated genes | ||||||||
| GO:0006906 | BP | vesicle fusion | 1.55E-04 | 7.94E-02 | 6.71E-01 | 4.06E-01 | 17 | CRISPLD2,DSP,RIMS3,OSCAR,SIGLEC14,DYSF,ITGAX,ITIH4,GAB2,LGALS9,MMP25,IGF2R,SCAMP5,TLN1,ADGRE5,TNFAIP2,CLEC4C |
| GO:0022610 | BP | biological adhesion | 2.52E-03 | 2.18E-01 | 1.00E+00 | 1.00E+00 | 19 | CDKN2A,MYADM,DSP,HLA-DQA1,LAG3,SIGLEC14,DYSF,ITGAX,TNFRSF21,LGALS9,SLC9A1,TLN1,NECTIN1,SORBS3,AOC3,PLXNA4,PXN,ADGRE5,PLXNA2 |
| GO:0098805 | CC | whole membrane | 4.42E-03 | 1.66E-01 | 1.00E+00 | 1.00E+00 | 21 | VPS37C,MYADM,HIP1,TPCN2,DSP,HLA-DQA1,SIGLEC14,GABARAP,DYSF,ITGAX,MICALL1,MMP25,ARHGAP1,SLC9A1,IGF2R,ATP6V0D1,SCAMP5,PRKACA,ADGRE5,CLEC4C,ATG16L2 |
| GO:0030054 | CC | cell junction | 2.83E-02 | 3.05E-01 | 1.00E+00 | 1.00E+00 | 15 | MYADM,DSP,ARHGEF5,RIMS3,LASP1,SLC9A1,IGF2R,SCAMP5,TLN1,NECTIN1,SORBS3,PXN,ADGRE5,ALKBH6,PDZD3 |
| GO:0008289 | MF | lipid binding | 2.91E-03 | 1.08E-01 | 7.31E-01 | 1.00E+00 | 13 | HIP1,CPNE9,ARHGEF5,PAQR6,APOL1,DYSF,GAB2,MICALL1,SLC9A1,IGF2R,ARAP3,TLN1,APOL2 |
| GO:0051020 | MF | GTPase binding | 5.51E-03 | 1.08E-01 | 7.31E-01 | 1.00E+00 | 10 | ARHGEF5,RGL3,RIMS3,MICALL1,ARHGAP1,PRKACA,DAAM2,RIPOR1,RGL2,RAPGEFL1 |
BP Biological Process, CC Cellular Component and MF Molecular Functions
PPI network construction and module analysis
Interactions between the identified up and down regulated genes were reported by constructing a PPI network. In total, there were 5017 nodes and 8133 edges in the network (Fig.3a). According to node degree, betweenness centrality, stress centrality and closeness centrality levels, the top four hub nodes were: EGFR (degree, 1343; betweenness, 0.514227; stress, 4.35E+08; closeness, 0.441893), GRIN2B (degree, 195; betweenness, 0.008701; stress, 14,535,992; closeness, GJA1 (degree,170 0.03151; betweenness, 64,939,702; stress, 0.31364; closeness, 0.282164), CAP2 (degree, 108; betweenness, 0.004218; stress, 888,128; closeness, 0.325945), MIF (degree, 99; betweenness, 0.025028; stress, 7,627,912; closeness, 0.362124), POLR2A (degree, 512; betweenness, 0.095104; stress, 2E+08; closeness, 0.3738), PRKACA (degree, 350; betweenness, 0.104658; stress, 44,280,174; closeness, 0.378052), GABARAP (degree, 322; betweenness, 0.144708; stress, 36,234,824; closeness, 0.358401), TLN1 (degree, 223; betweenness, 0.027406; stress, 67,578,124; closeness, 0.35998), and PXN (degree, 173; betweenness, 0.029203; stress, 29,047,866; closeness,0.360318) and are listed in Table 5. Significant modules were subsequently constructed with 12 nodes and 23 edges for up regulated genes (Fig.3b) and 5 nodes and 10 edges for down regulated genes, which gained the highest PEWCC1 score (Fig.3c). Subsequent functional enrichment analysis revealed that the genes in these modules were mainly enriched in cell-cell signaling and cytokine signaling in immune system.
Fig. 3.
PPI network and the most significant modules of DEGs. a The PPI network of DEGs was constructed using Cytoscape. b The most significant module was obtained from PPI network with 12 nodes and 23 edges for up regulated genes. c The most significant module was obtained from PPI network with 5 nodes and 10 edges for down regulated genes. Up regulated genes are marked in green; Down regulated genes are marked in red
Table 5.
Topology table for up and down regulated genes
| Regulation | Node | Degree | Betweenness | Stress | Closeness |
|---|---|---|---|---|---|
| Up | EGFR | 1343 | 0.514227 | 4.35E+08 | 0.441893 |
| Up | GRIN2B | 195 | 0.008701 | 14,535,992 | 0.282164 |
| Up | GJA1 | 170 | 0.03151 | 64,939,702 | 0.31364 |
| Up | CAP2 | 108 | 0.004218 | 888,128 | 0.325945 |
| Up | MIF | 99 | 0.025028 | 7,627,912 | 0.362124 |
| Up | DCC | 98 | 0.009465 | 15,166,420 | 0.286956 |
| Up | PRL | 89 | 0.001208 | 656,482 | 0.239894 |
| Up | EYA1 | 72 | 0.003864 | 4,335,792 | 0.271944 |
| Up | RGS4 | 63 | 0.003414 | 1,243,420 | 0.31129 |
| Up | GRIA4 | 55 | 0.001352 | 431,502 | 0.292547 |
| Up | CCL19 | 50 | 0.001236 | 1,457,894 | 0.1951 |
| Up | DKK1 | 50 | 0.003569 | 4,044,234 | 0.25252 |
| Up | PLN | 43 | 0.003324 | 524,170 | 0.286083 |
| Up | GPR37 | 41 | 0.021208 | 9,337,328 | 0.303261 |
| Up | LRP2 | 39 | 0.023544 | 9,018,868 | 0.307583 |
| Up | PTHLH | 38 | 0.001269 | 1,103,574 | 0.257729 |
| Up | PPFIA2 | 33 | 0.002618 | 3,942,042 | 0.269956 |
| Up | KIF1A | 31 | 0.011317 | 2,986,868 | 0.345485 |
| Up | HOXB7 | 31 | 0.002165 | 2,106,446 | 0.268893 |
| Up | MYOT | 28 | 0.003103 | 475,758 | 0.275841 |
| Up | OTX2 | 28 | 0.003016 | 868,076 | 0.271263 |
| Up | NPPC | 27 | 0.003211 | 986,326 | 0.247419 |
| Up | KRT20 | 26 | 0.005296 | 5,544,830 | 0.279444 |
| Up | MRPL12 | 25 | 0.050618 | 70,486,194 | 0.310399 |
| Up | NPBWR1 | 23 | 4.01E-04 | 207,170 | 0.174777 |
| Up | TRHR | 22 | 4.10E-04 | 210,106 | 0.238152 |
| Up | CCL13 | 20 | 0.003552 | 1,650,164 | 0.263645 |
| Up | MFAP2 | 19 | 0.002005 | 451,990 | 0.228053 |
| Up | TRIM55 | 18 | 0.021705 | 17,474,648 | 0.300609 |
| Up | NEUROG3 | 18 | 0.011467 | 9,544,416 | 0.269256 |
| Up | NRAP | 18 | 0.001974 | 406,892 | 0.285085 |
| Up | PTPRT | 18 | 0.00104 | 208,946 | 0.324523 |
| Up | OSR1 | 17 | 4.56E-04 | 195,068 | 0.226447 |
| Up | EFS | 17 | 0.003557 | 2,975,070 | 0.285232 |
| Up | HBZ | 17 | 0.006623 | 4,433,868 | 0.287818 |
| Up | KCNK4 | 16 | 4.01E-04 | 117,736 | 0.247125 |
| Up | AVP | 16 | 0.006488 | 3,769,102 | 0.26391 |
| Up | SOX18 | 16 | 8.04E-04 | 761,526 | 0.244028 |
| Up | NACA2 | 15 | 0.002639 | 3,304,692 | 0.274822 |
| Up | SRXN1 | 15 | 0.005715 | 9,265,020 | 0.276852 |
| Up | UTF1 | 13 | 1 | 12 | 1 |
| Up | RNF180 | 13 | 4.01E-04 | 186,722 | 0.235697 |
| Up | KRT38 | 12 | 0.011531 | 15,515,646 | 0.273676 |
| Up | FAP | 12 | 0.005985 | 10,442,836 | 0.259379 |
| Up | GULP1 | 12 | 0.001542 | 1,584,446 | 0.281416 |
| Up | IL17B | 12 | 4.02E-04 | 151,558 | 0.24843 |
| Up | CRHR2 | 11 | 0.002005 | 1,044,220 | 0.245978 |
| Up | RFPL4A | 10 | 9.09E-06 | 2638 | 0.1894 |
| Up | SNAP91 | 10 | 0.001514 | 2,227,728 | 0.265994 |
| Up | ADGRL4 | 10 | 0 | 0 | 0 |
| Up | FBXO10 | 10 | 0.002727 | 598,280 | 0.287801 |
| Up | CST6 | 9 | 0.009382 | 6,670,420 | 0.28234 |
| Up | PADI3 | 9 | 0.003682 | 1,684,994 | 0.267321 |
| Up | LIPF | 9 | 0.002462 | 1,222,458 | 0.239008 |
| Up | CA10 | 8 | 0.00882 | 3,036,648 | 0.251628 |
| Up | EPB41L4B | 8 | 0.00328 | 3,044,266 | 0.280229 |
| Up | OR51E2 | 8 | 0.002481 | 1,735,460 | 0.249674 |
| Up | RIMS4 | 8 | 4.46E-04 | 187,102 | 0.255497 |
| Up | MYT1L | 8 | 1.71E-04 | 156,968 | 0.255523 |
| Up | C4orf48 | 7 | 4.02E-04 | 410,864 | 0.238654 |
| Up | EMILIN3 | 7 | 0.002789 | 890,368 | 0.2335 |
| Up | CSNK1A1L | 6 | 0.002373 | 3,707,900 | 0.264526 |
| Up | ATP1A4 | 6 | 0.001778 | 1,343,858 | 0.269795 |
| Up | OR6C70 | 6 | 0 | 0 | 1 |
| Up | MEIOB | 6 | 1.19E-04 | 55,294 | 0.237857 |
| Up | UPK1B | 5 | 0.001266 | 639,316 | 0.238883 |
| Up | TEX15 | 5 | 8.47E-04 | 384,696 | 0.261104 |
| Up | CAMK1G | 5 | 0.001061 | 955,066 | 0.263353 |
| Up | FOXQ1 | 5 | 0.02441 | 34,422,300 | 0.29497 |
| Up | MYH13 | 4 | 0.007248 | 6,307,480 | 0.276193 |
| Up | MYH6 | 4 | 0.006387 | 8,432,142 | 0.276223 |
| Up | SPATA22 | 4 | 0.001497 | 616,922 | 0.255628 |
| Up | TRHDE | 4 | 0.004478 | 568,880 | 0.325562 |
| Up | CCDC144A | 4 | 0.001246 | 906,138 | 0.212789 |
| Up | PCDHB10 | 4 | 8.03E-04 | 313,938 | 0.212698 |
| Up | CNMD | 4 | 0.001108 | 411,030 | 0.251134 |
| Up | ABRA | 4 | 0.001639 | 940,076 | 0.263019 |
| Up | MS4A5 | 4 | 0 | 0 | 0.246088 |
| Up | DNAH3 | 3 | 5.51E-04 | 333,004 | 0.269839 |
| Up | MTRNR2L1 | 3 | 9.66E-04 | 646,606 | 0.269168 |
| Up | KPNA7 | 3 | 4.63E-04 | 356,676 | 0.259541 |
| Up | CBLN2 | 3 | 0 | 0 | 1 |
| Up | FSIP2 | 3 | 4.14E-04 | 158,112 | 0.250276 |
| Up | SPATA16 | 3 | 0 | 0 | 0.237426 |
| Up | ZNF214 | 2 | 0.004409 | 2,022,086 | 0.235753 |
| Up | CCDC140 | 2 | 4.01E-04 | 96,422 | 0.215353 |
| Up | UGT2A3 | 2 | 8.95E-04 | 518,942 | 0.239952 |
| Up | FAM71D | 2 | 4.04E-04 | 236,600 | 0.24016 |
| Up | GOLGA6B | 2 | 0 | 0 | 0.221585 |
| Up | C2orf73 | 2 | 8.02E-04 | 393,150 | 0.236301 |
| Up | GOLGA8G | 2 | 0 | 0 | 1 |
| Up | SMCO1 | 1 | 4.28E-04 | 175,370 | 0.225341 |
| Up | ANKRD30B | 1 | 0 | 0 | 1 |
| Up | FCAMR | 1 | 0 | 0 | 0.225719 |
| Up | HFM1 | 1 | 8.96E-05 | 46,366 | 0.226673 |
| Up | BTBD18 | 1 | 0 | 0 | 0.306486 |
| Up | ACSBG2 | 1 | 4.02E-04 | 116,692 | 0.247358 |
| Up | KRT39 | 1 | 0 | 0 | 0.251806 |
| Up | G6PC | 1 | 0.001203 | 289,260 | 0.215428 |
| Up | RBM46 | 1 | 1.99E-06 | 1374 | 0.252879 |
| Up | PCDHB2 | 1 | 0 | 0 | 1 |
| Up | AS3MT | 1 | 0 | 0 | 0.210364 |
| Up | RAD21L1 | 1 | 0 | 0 | 1 |
| Up | CAPN9 | 1 | 2.61E-06 | 2714 | 0.211893 |
| Up | FABP6 | 1 | 0 | 0 | 1 |
| Down | POLR2A | 512 | 0.095104 | 2E+08 | 0.3738 |
| Down | PRKACA | 350 | 0.104658 | 44,280,174 | 0.378052 |
| Down | GABARAP | 322 | 0.144708 | 36,234,824 | 0.358401 |
| Down | TLN1 | 223 | 0.027406 | 67,578,124 | 0.35998 |
| Down | PXN | 173 | 0.029203 | 29,047,866 | 0.360318 |
| Down | HIP1 | 146 | 0.007469 | 12,022,620 | 0.347944 |
| Down | GAB2 | 118 | 0.014217 | 38,718,180 | 0.340041 |
| Down | SYVN1 | 114 | 0.025941 | 12,050,404 | 0.307887 |
| Down | KCNIP2 | 110 | 0.002849 | 14,186,360 | 0.253084 |
| Down | ARHGAP1 | 106 | 0.011263 | 27,047,958 | 0.348406 |
| Down | NECTIN1 | 102 | 0.003189 | 17,978,038 | 0.252469 |
| Down | RGL2 | 88 | 0.003069 | 3,605,218 | 0.263534 |
| Down | ASF1B | 85 | 0.00926 | 21,237,598 | 0.2861 |
| Down | IGF2R | 78 | 0.010589 | 26,691,414 | 0.303021 |
| Down | SLC9A1 | 75 | 0.009561 | 24,396,634 | 0.292461 |
| Down | VPS37C | 75 | 0.006908 | 5,646,832 | 0.29327 |
| Down | MEFV | 72 | 0.001361 | 31,003,730 | 0.301081 |
| Down | CDKN2A | 72 | 0.051693 | 14,128,370 | 0.321613 |
| Down | MAP1A | 63 | 0.008662 | 3,403,950 | 0.291879 |
| Down | ARF3 | 60 | 0.004127 | 11,523,596 | 0.287784 |
| Down | CIITA | 59 | 0.006319 | 10,301,788 | 0.302892 |
| Down | WDTC1 | 57 | 0.005909 | 19,161,622 | 0.278569 |
| Down | MICALL1 | 53 | 0.005986 | 7,902,576 | 0.285919 |
| Down | ITGAX | 53 | 0.001212 | 13,088,030 | 0.238757 |
| Down | SORBS3 | 51 | 0.016308 | 10,468,808 | 0.314749 |
| Down | DSP | 47 | 0.039735 | 2,314,856 | 0.347581 |
| Down | BAZ2A | 45 | 0.004013 | 13,101,300 | 0.289472 |
| Down | MAPRE3 | 44 | 0.006813 | 4,554,084 | 0.28533 |
| Down | CRTC2 | 44 | 0.004812 | 11,994,716 | 0.296709 |
| Down | PADI4 | 43 | 0.002174 | 7,728,076 | 0.275765 |
| Down | SPINT1 | 42 | 0.001717 | 6,257,478 | 0.263492 |
| Down | ARHGEF5 | 40 | 0.003561 | 7,025,544 | 0.336483 |
| Down | LASP1 | 40 | 0.021943 | 9,410,452 | 0.31303 |
| Down | PDZD3 | 39 | 0.005273 | 6,150,510 | 0.249549 |
| Down | HIVEP3 | 39 | 0.001859 | 4,355,942 | 0.26672 |
| Down | TNFRSF21 | 36 | 0.001781 | 3,131,524 | 0.274883 |
| Down | SOGA1 | 36 | 0.005248 | 10,217,032 | 0.291623 |
| Down | MBD6 | 34 | 0.002017 | 1,737,436 | 0.231979 |
| Down | ATP6V0D1 | 33 | 0.026324 | 1,957,202 | 0.303649 |
| Down | IQCN | 32 | 0.015047 | 5,650,026 | 0.283239 |
| Down | IL17RA | 30 | 0.020601 | 4,651,714 | 0.286807 |
| Down | ABTB2 | 29 | 0.001793 | 4,772,698 | 0.279695 |
| Down | INCA1 | 29 | 0.011463 | 2,924,018 | 0.276668 |
| Down | MAST3 | 28 | 0.019115 | 4,567,048 | 0.308592 |
| Down | BEST1 | 28 | 4.42E-04 | 3,684,990 | 0.260082 |
| Down | PRSS21 | 28 | 0.001117 | 5,817,460 | 0.25749 |
| Down | TPCN2 | 27 | 0.014228 | 4,144,602 | 0.284792 |
| Down | LAG3 | 26 | 4.41E-06 | 6,746,636 | 0.238038 |
| Down | GMIP | 24 | 8.12E-04 | 3,636,310 | 0.263896 |
| Down | CLEC4C | 24 | 4.01E-04 | 725,910 | 0.175956 |
| Down | TAGLN | 23 | 0.016019 | 4,532,938 | 0.283771 |
| Down | FAM219A | 20 | 0.008105 | 916,962 | 0.287867 |
| Down | NCR1 | 20 | 0.002234 | 349,872 | 0.271381 |
| Down | PRRC2A | 18 | 0.015874 | 2,767,592 | 0.307261 |
| Down | KCNMB1 | 18 | 8.42E-04 | 2,984,594 | 0.257118 |
| Down | EIF3CL | 17 | 0.003808 | 1,129,844 | 0.284272 |
| Down | H6PD | 17 | 5.55E-04 | 3,133,402 | 0.259123 |
| Down | MMP25 | 17 | 4.01E-04 | 2,598,252 | 0.238837 |
| Down | ENTPD2 | 16 | 1 | 2,170,770 | 1 |
| Down | DYSF | 16 | 0.009592 | 704,606 | 0.292839 |
| Down | LGALS9 | 16 | 0.01981 | 1,417,206 | 0.288134 |
| Down | DPEP2 | 16 | 0.007617 | 1,500,838 | 0.260885 |
| Down | POMZP3 | 14 | 8.35E-05 | 836,800 | 0.254857 |
| Down | EXTL3 | 13 | 0.004948 | 611,924 | 0.27899 |
| Down | EPHX1 | 13 | 0.006221 | 2,003,020 | 0.279491 |
| Down | C15orf39 | 12 | 0.00794 | 610,110 | 0.291793 |
| Down | PLXNA2 | 12 | 0.009415 | 1,162,970 | 0.277268 |
| Down | PLPPR2 | 12 | 0.006567 | 1,448,934 | 0.253961 |
| Down | MYADM | 11 | 0.007222 | 952,256 | 0.283771 |
| Down | GTPBP1 | 11 | 0.005922 | 1,877,862 | 0.299976 |
| Down | ADGRE5 | 10 | 0.014659 | 888,184 | 0.289203 |
| Down | SULT1A2 | 10 | 0.00172 | 1,783,464 | 0.247973 |
| Down | INKA2 | 10 | 0.00214 | 1,184,052 | 0.279616 |
| Down | NDST1 | 10 | 0.001942 | 1,716,840 | 0.257383 |
| Down | TTLL3 | 9 | 0.002348 | 134,132 | 0.261694 |
| Down | DRICH1 | 9 | 0.002408 | 1,799,342 | 0.237302 |
| Down | APOL2 | 9 | 0.007736 | 489,254 | 0.289489 |
| Down | ZNF70 | 9 | 0.001286 | 3,985,632 | 0.223763 |
| Down | ASPRV1 | 9 | 0.00395 | 1,038,668 | 0.290552 |
| Down | PLXNA4 | 8 | 0.001243 | 473,354 | 0.262534 |
| Down | FAM160A1 | 8 | 4.10E-04 | 882,848 | 0.241043 |
| Down | PLBD2 | 8 | 0.002764 | 1,265,098 | 0.278057 |
| Down | RNF122 | 8 | 0.001044 | 1,049,362 | 0.265329 |
| Down | PAQR6 | 8 | 4.10E-04 | 868,456 | 0.23693 |
| Down | CHKB | 7 | 0 | 602,254 | 0.217363 |
| Down | CRISPLD2 | 7 | 3.80E-06 | 943,864 | 0.256153 |
| Down | DUSP18 | 7 | 0.002971 | 325,170 | 0.315506 |
| Down | TRANK1 | 7 | 4.02E-04 | 801,248 | 0.245821 |
| Down | TP53INP2 | 6 | 1.70E-07 | 703,508 | 0.247198 |
| Down | ARAP3 | 6 | 4.92E-04 | 286,916 | 0.268169 |
| Down | TNFAIP2 | 6 | 0.001439 | 633,692 | 0.254324 |
| Down | APOL1 | 5 | 6.25E-04 | 48,364 | 0.233895 |
| Down | PRR16 | 5 | 0.001298 | 158,878 | 0.26692 |
| Down | ITIH4 | 5 | 4.46E-04 | 356,728 | 0.266806 |
| Down | SIGLEC14 | 5 | 0 | 273,222 | 1 |
| Down | C5AR2 | 5 | 0.019084 | 54,700 | 0.270983 |
| Down | DTX4 | 5 | 8.06E-04 | 445,430 | 0.256483 |
| Down | SCAMP5 | 5 | 0.002526 | 469,900 | 0.229016 |
| Down | SH3D21 | 5 | 1.03E-04 | 675,458 | 0.314928 |
| Down | LY6G5B | 4 | 6.87E-04 | 43,440 | 0.259947 |
| Down | TMEM121B | 4 | 0 | 217,638 | 0.1804 |
| Down | AOC3 | 4 | 0.002207 | 251,106 | 0.268748 |
| Down | DAAM2 | 3 | 0.00264 | 78,488 | 0.259838 |
| Down | ZBTB3 | 3 | 0.006264 | 225,562 | 0.267838 |
| Down | LCNL1 | 3 | 9.23E-05 | 198,214 | 0.235286 |
| Down | RIMS3 | 2 | 4.16E-04 | 11,332 | 0.223944 |
| Down | ZNF385A | 2 | 6.60E-04 | 3498 | 0.264948 |
| Down | RIPOR1 | 2 | 6.43E-04 | 1512 | 0.277964 |
| Down | KDM6B | 2 | 0.003441 | 321,702 | 0.271411 |
| Down | PAPLN | 2 | 0.001857 | 53,928 | 0.244759 |
| Down | RAB36 | 2 | 4.01E-04 | 4276 | 0.188797 |
| Down | NOMO2 | 2 | 5.94E-04 | 78 | 0.280182 |
| Down | AOC2 | 2 | 5.51E-04 | 3886 | 0.250113 |
| Down | PROSER3 | 2 | 4.60E-05 | 2 | 0.23941 |
| Down | WDFY4 | 2 | 2.38E-06 | 184,474 | 0.236975 |
| Down | ATG16L2 | 2 | 0.001016 | 322,434 | 0.299651 |
| Down | RAPGEFL1 | 2 | 7.68E-05 | 9928 | 0.260599 |
| Down | CPNE9 | 1 | 9.19E-05 | 0 | 0.23639 |
| Down | RSKR | 1 | 4.69E-06 | 0 | 0.247739 |
| Down | RGL3 | 1 | 0 | 0 | 0.234621 |
| Down | SHISA4 | 1 | 0 | 0 | 1 |
| Down | TMEM63C | 1 | 0 | 0 | 0.24945 |
| Down | NPIPB3 | 1 | 8.84E-06 | 0 | 0.229639 |
| Down | CLEC17A | 1 | 0 | 0 | 0.209331 |
| Down | TIFAB | 1 | 0 | 0 | 1 |
| Down | OSCAR | 1 | 0 | 0 | 1 |
| Down | AGAP9 | 1 | 0 | 0 | 0.236256 |
Prediction of key miRNAs
The regulatory relationships between the target genes and their miRNAs were established using Cytoscape, which showed that the single gene was regulated by multiple miRNAs is shown in Fig.4a. Subsequently, 106 miRNAs (ex, hsa-mir-4257) targeting GRIN2B, 83 miRNAs (ex, hsa-mir-564) targeting EGFR, 66 miRNAs (ex, hsa-mir-587) targeting DKK1, 64 miRNAs (ex, hsa-mir-941) targeting GJA1, 54 miRNAs (ex, hsa-mir-561-3p) targeting RGS4, 190 miRNAs (ex, hsa-mir-4300) targeting TLN1, 139 miRNAs (ex, hsa-mir-5694) targeting IGF2R, 117 miRNAs (ex, hsa-mir-378b) targeting POLR2A, 113 miRNAs (ex, hsa-mir-3918) targeting ARHGAP1 and 102 miRNAs (ex, hsa-mir-6719-3p) targeting HIP1, and were verified in miRNet database are listed in Table 6. Integrating with the result of REACTOME pathway analysis, it was indicated that these key target genes - miRNA network was mainly involved in the signaling by GPCR and innate immune system.
Fig. 4.
a Target gene - miRNA regulatory network between target genes and miRNAs. b Target gene - TF regulatory network between target genes and TFs. Up regulated genes are marked in green; down regulated genes are marked in red; The chocolate color triangle nodes represent the key miRNAs; the blue color triangle nodes represent the key miRNAs
Table 6.
miRNA - target gene and TF - target gene interaction
| Regulation | Target Genes | Degree | MicroRNA | Regulation | Target Genes | Degree | TF |
|---|---|---|---|---|---|---|---|
| UP | COL12A1 | 110 | hsa-mir-526b-5p | UP | SUZ12 | 164 | PAX3 |
| UP | COL1A2 | 81 | hsa-mir-1254 | UP | AR | 162 | ANKRD18B |
| UP | SIX4 | 73 | hsa-mir-1909-5p | UP | STAT3 | 147 | WT1 |
| UP | GNG12 | 69 | hsa-mir-3194-3p | UP | TP53 | 138 | ADCYAP1R1 |
| UP | HAS2 | 63 | hsa-mir-30e-5p | UP | EGR1 | 137 | KIF1A |
| UP | COL3A1 | 58 | hsa-mir-4691-3p | UP | SMAD4 | 130 | WFDC1 |
| UP | PRKAA2 | 57 | hsa-mir-3619-5p | UP | NANOG | 129 | MAGI1 |
| UP | DKK1 | 56 | hsa-mir-579-3p | UP | REST | 123 | LHX2 |
| UP | EGFR | 56 | hsa-mir-494-3p | UP | TP63 | 121 | CYR61 |
| UP | RGS4 | 50 | hsa-mir-526a | UP | POU5F1 | 121 | PDE10A |
| UP | CSRNP3 | 50 | hsa-mir-338-3p | UP | MTF2 | 120 | ESRP2 |
| UP | SPRY4 | 50 | hsa-mir-21-5p | UP | TCF4 | 115 | EBF3 |
| UP | GJA1 | 50 | hsa-mir-185-5p | UP | MYC | 114 | DDC |
| UP | PRRX1 | 49 | hsa-mir-888-3p | UP | HNF4A | 114 | EGFR |
| UP | GRIN2B | 48 | hsa-let-7a-5p | UP | RUNX2 | 92 | CELF4 |
| UP | GDA | 44 | hsa-mir-548d-5p | UP | RUNX1 | 87 | BCAR1 |
| UP | BDKRB2 | 40 | hsa-let-7f-5p | UP | SETDB1 | 87 | LMO1 |
| UP | HOXB8 | 38 | hsa-mir-30d-3p | UP | RNF2 | 85 | SIX1 |
| UP | EFEMP1 | 37 | hsa-let-7a-2-3p | UP | SPI1 | 84 | PTHLH |
| UP | PGR | 35 | hsa-mir-320b | UP | EZH2 | 81 | BARX2 |
| UP | KIF1A | 33 | hsa-mir-125a-5p | UP | PPARD | 79 | EXOC3L4 |
| UP | CAP2 | 33 | hsa-let-7c-5p | UP | SIN3B | 79 | SPRY4 |
| UP | EYA1 | 30 | hsa-mir-133a-3p | UP | SMARCA4 | 78 | FOXQ1 |
| UP | NPNT | 30 | hsa-mir-1304-3p | UP | MITF | 76 | GNG12 |
| UP | MAGI1 | 29 | hsa-let-7f-1-3p | UP | BMI1 | 76 | LRFN5 |
| UP | MICU3 | 28 | hsa-mir-182-5p | UP | GATA2 | 75 | ZSCAN10 |
| UP | PDE10A | 28 | hsa-mir-1288-3p | UP | TCF3 | 74 | IGSF21 |
| UP | SYT4 | 27 | hsa-mir-320a | UP | SALL4 | 74 | SULF1 |
| UP | GULP1 | 26 | hsa-mir-532-5p | UP | PPARG | 73 | PRRX1 |
| UP | HOXB7 | 26 | hsa-mir-2277-3p | UP | JARID2 | 72 | DMRTA2 |
| UP | AMER2 | 25 | hsa-mir-369-3p | UP | SOX9 | 72 | PTPRT |
| UP | MTRNR2L1 | 25 | hsa-mir-4793-3p | UP | TRIM28 | 71 | RGS20 |
| UP | SLC9A2 | 25 | hsa-mir-15b-5p | UP | FLI1 | 69 | MRO |
| UP | EEF1G | 25 | hsa-mir-106b-5p | UP | ESR1 | 67 | RERG |
| UP | FBXO10 | 24 | hsa-mir-23c | UP | KLF4 | 67 | RFX4 |
| UP | FAXC | 24 | hsa-mir-135a-5p | UP | SRY | 67 | SRXN1 |
| UP | ADAMTS9 | 24 | hsa-mir-181a-2-3p | UP | RCOR3 | 64 | C8orf4 |
| UP | FOXQ1 | 24 | hsa-mir-503-5p | UP | GATA1 | 64 | COL12A1 |
| UP | EPB41L4B | 23 | hsa-mir-141-5p | UP | E2F1 | 64 | GJA1 |
| UP | SH3GL2 | 23 | hsa-mir-548 am-5p | UP | YAP1 | 63 | HAS2 |
| UP | CLVS2 | 23 | hsa-mir-32-3p | UP | POU3F2 | 63 | HOXD8 |
| UP | GPR158 | 22 | hsa-mir-302d-3p | UP | CREM | 62 | OSR1 |
| UP | SOX2 | 22 | hsa-mir-361-5p | UP | PBX1 | 62 | OTX2 |
| UP | FSTL5 | 21 | hsa-mir-5100 | UP | RAD21 | 62 | PKNOX2 |
| UP | LRRTM2 | 21 | hsa-mir-125b-5p | UP | FOXP1 | 62 | TRAPPC5 |
| UP | FAP | 21 | hsa-mir-30a-5p | UP | EP300 | 61 | EN1 |
| UP | MIF | 21 | hsa-mir-139-3p | UP | TET1 | 58 | HES5 |
| UP | GABRA4 | 21 | hsa-mir-23a-3p | UP | SMAD3 | 56 | OVOL1 |
| UP | TMEM121 | 21 | hsa-mir-3065-3p | UP | NR3C1 | 55 | DKK1 |
| UP | GPR37 | 21 | hsa-mir-192-5p | UP | EED | 55 | TBX20 |
| UP | SNAP91 | 21 | hsa-mir-29a-3p | UP | OLIG2 | 53 | DPP10 |
| UP | BCAR1 | 21 | hsa-mir-1296-5p | UP | ERG | 50 | MYRIP |
| UP | PPFIA2 | 20 | hsa-mir-140-3p | UP | FOXA2 | 48 | MNX1 |
| UP | LAMA4 | 20 | hsa-mir-30e-3p | UP | PHC1 | 48 | ZFPM2 |
| UP | AREG | 20 | hsa-mir-449b-5p | UP | KDM5B | 46 | EEF1G |
| UP | PAX3 | 20 | hsa-mir-5690 | UP | TFAP2A | 46 | NOS1 |
| UP | PRSS12 | 19 | hsa-mir-1260a | UP | TFAP2C | 44 | EYA1 |
| UP | HHIP | 19 | hsa-mir-488-3p | UP | PRDM14 | 43 | TAC4 |
| UP | SULF1 | 19 | hsa-mir-130a-3p | UP | JUN | 42 | PRSS12 |
| UP | PTPRT | 19 | hsa-mir-518c-5p | UP | ZNF281 | 41 | PDLIM4 |
| UP | PTHLH | 18 | hsa-mir-376a-5p | UP | CREB1 | 40 | ASCL1 |
| UP | TEAD4 | 18 | hsa-mir-520c-3p | UP | RBPJ | 39 | CAMK1G |
| UP | URGCP-MRPS24 | 16 | hsa-mir-933 | UP | CUX1 | 39 | TRIM55 |
| UP | CBLN2 | 16 | hsa-mir-3065-3p | UP | NFE2L2 | 38 | LRP2 |
| UP | TRHDE | 16 | hsa-let-7i-5p | UP | ASH2L | 37 | RPE65 |
| UP | SLC30A3 | 16 | hsa-let-7 g-5p | UP | SCLY | 36 | KCNIP1 |
| UP | NPPC | 16 | hsa-mir-497-5p | UP | BACH1 | 35 | EFEMP1 |
| UP | PPP2R2C | 16 | hsa-mir-219a-5p | UP | RCOR1 | 34 | OR51E2 |
| UP | ZFPM2 | 16 | hsa-mir-4705 | UP | CTNNB1 | 33 | KRT39 |
| UP | SIX1 | 16 | hsa-mir-139-5p | UP | EWSR1 | 32 | BDKRB2 |
| UP | GABRB3 | 16 | hsa-mir-582-3p | UP | SMAD2 | 32 | CAP2 |
| UP | SEMA6B | 15 | hsa-mir-221-5p | UP | ZNF217 | 31 | THSD4 |
| UP | EBF3 | 15 | hsa-mir-629-5p | UP | SOX17 | 31 | UTF1 |
| UP | THSD4 | 15 | hsa-mir-612 | UP | DMRT1 | 30 | DCC |
| UP | MFAP2 | 15 | hsa-mir-503-5p | UP | DNAJC2 | 30 | MEGF10 |
| UP | ESRP2 | 15 | hsa-mir-98-5p | UP | RELA | 30 | SIX4 |
| UP | RASSF9 | 15 | hsa-mir-588 | UP | FOXP2 | 28 | CBLN2 |
| UP | TIMP4 | 14 | hsa-mir-1343-3p | UP | ATF3 | 28 | PDPN |
| UP | PDE1A | 14 | hsa-mir-369-3p | UP | NR0B1 | 28 | SLC30A3 |
| UP | RERG | 14 | hsa-mir-671-5p | UP | EOMES | 28 | WIF1 |
| UP | MNX1 | 14 | hsa-mir-548z | UP | TAL1 | 27 | AS3MT |
| UP | MYT1L | 14 | hsa-mir-199a-3p | UP | TFCP2L1 | 27 | CACNA1G |
| UP | RFX6 | 14 | hsa-mir-33a-3p | UP | KLF1 | 27 | CCL17 |
| UP | TRAPPC5 | 13 | hsa-mir-1269b | UP | TBX3 | 27 | HHIP |
| UP | TMEM151A | 13 | hsa-let-7e-5p | UP | ARNT | 26 | PADI3 |
| UP | LRP2 | 13 | hsa-mir-1305 | UP | ELF5 | 24 | HFM1 |
| UP | GRM5 | 13 | hsa-mir-22-3p | UP | CEBPB | 24 | NPY |
| UP | ITGBL1 | 13 | hsa-mir-16-2-3p | UP | MYCN | 21 | EPB41L4B |
| UP | LHX2 | 13 | hsa-mir-3661 | UP | YY1 | 21 | RIMS4 |
| UP | RGS20 | 13 | hsa-mir-4659a-3p | UP | ESRRB | 21 | SMTNL2 |
| UP | CDH18 | 13 | hsa-mir-550a-3p | UP | ELF1 | 20 | SPDEF |
| UP | C4orf48 | 12 | hsa-mir-497-5p | UP | NR1I2 | 19 | CBLC |
| UP | LARP6 | 12 | hsa-mir-126-3p | UP | HSF1 | 19 | HOXB7 |
| UP | GRIA4 | 12 | hsa-mir-377-3p | UP | ELK1 | 19 | NEUROG3 |
| UP | TEX15 | 12 | hsa-mir-1304-5p | UP | NACC1 | 19 | REN |
| UP | SCG3 | 12 | hsa-mir-448 | UP | MYBL2 | 19 | SP9 |
| UP | LRRC8E | 12 | hsa-mir-500a-5p | UP | ZFX | 19 | TMEM121 |
| UP | SPDEF | 12 | hsa-mir-939-5p | UP | E2F4 | 18 | AMER2 |
| UP | KCNT2 | 11 | hsa-mir-548o-3p | UP | AHR | 18 | CNTNAP4 |
| UP | OTOGL | 11 | hsa-mir-548n | UP | CTCF | 18 | GRIN2B |
| UP | TMEM145 | 11 | hsa-mir-1913 | UP | FOXO3 | 17 | BTC |
| UP | RIMS4 | 11 | hsa-mir-326 | UP | SIN3A | 17 | GPR158 |
| UP | SRXN1 | 11 | hsa-mir-195-5p | UP | CDX2 | 17 | HOXB8 |
| UP | TRPA1 | 11 | hsa-mir-320d | UP | MEF2A | 17 | HSD11B2 |
| UP | SELE | 11 | hsa-mir-17-5p | UP | CNOT3 | 17 | SCN3B |
| UP | HES5 | 11 | hsa-mir-4511 | UP | SOX11 | 16 | LRRC74A |
| UP | C3orf80 | 10 | hsa-mir-369-3p | UP | CEBPD | 16 | PDE1A |
| UP | PKNOX2 | 10 | hsa-mir-490-3p | UP | TCF7 | 16 | PPP2R2C |
| UP | EPN3 | 10 | hsa-mir-1825 | UP | LYL1 | 16 | SLC9A2 |
| UP | HRCT1 | 10 | hsa-mir-374a-5p | UP | STAT5A | 15 | CYP39A1 |
| UP | SERPIND1 | 10 | hsa-mir-452-5p | UP | HTT | 15 | PGR |
| UP | CRHR2 | 10 | hsa-mir-31-5p | UP | LMO2 | 15 | RNF180 |
| UP | MIPOL1 | 10 | hsa-mir-651-5p | UP | SREBF2 | 15 | TMEM151A |
| UP | MYH6 | 9 | hsa-mir-301a-3p | UP | PAX6 | 14 | ACSBG2 |
| UP | PMCH | 9 | hsa-mir-30a-5p | UP | DROSHA | 14 | ANO4 |
| UP | C8orf34 | 9 | hsa-mir-302c-3p | UP | GFI1B | 14 | FFAR1 |
| UP | ANO4 | 9 | hsa-mir-29b-3p | UP | TTF2 | 14 | NR0B2 |
| UP | SCEL | 9 | hsa-mir-671-5p | UP | STAT4 | 14 | PRLHR |
| UP | RHOJ | 9 | hsa-mir-103a-3p | UP | GATA3 | 13 | BCO1 |
| UP | PDLIM4 | 9 | hsa-mir-1270 | UP | CCND1 | 13 | COL1A2 |
| UP | CYP39A1 | 9 | hsa-mir-1179 | UP | ZFP42 | 13 | EFS |
| UP | SLC26A3 | 9 | hsa-mir-494-3p | UP | GATA4 | 13 | MMP27 |
| UP | OVOL1 | 9 | hsa-mir-15a-5p | UP | MEIS1 | 11 | DNAI1 |
| UP | BTC | 9 | hsa-mir-194-5p | UP | TCF7L2 | 11 | ELAVL3 |
| UP | CNTFR | 9 | hsa-mir-708-5p | UP | STAT1 | 11 | FOLH1 |
| UP | MRPL12 | 9 | hsa-mir-98-5p | UP | IRF8 | 11 | GDA |
| UP | SP9 | 8 | hsa-mir-1343-3p | UP | SMAD1 | 11 | LEMD1 |
| UP | GPC6 | 8 | hsa-mir-1306-5p | UP | ZIC3 | 11 | TIMP4 |
| UP | IRX5 | 8 | hsa-mir-522-5p | UP | FOXO1 | 10 | DAND5 |
| UP | KRT20 | 8 | hsa-mir-429 | UP | IRF1 | 10 | RHOJ |
| UP | LRFN5 | 8 | hsa-mir-369-3p | UP | TBX5 | 9 | FBXO10 |
| UP | TM4SF5 | 8 | hsa-mir-203a-3p | UP | DACH1 | 9 | NKAIN4 |
| UP | ANP32D | 8 | hsa-mir-375 | UP | RCOR2 | 9 | SOX18 |
| UP | BCO1 | 8 | hsa-mir-137 | UP | MYB | 8 | CCDC158 |
| UP | SPINK4 | 8 | hsa-mir-374a-5p | UP | HOXC9 | 8 | RGS4 |
| UP | SCN3B | 8 | hsa-mir-10b-5p | UP | PDX1 | 8 | SYT4 |
| UP | SOX18 | 8 | hsa-mir-373-3p | UP | SRF | 7 | ABRA |
| UP | MTRNR2L6 | 8 | hsa-mir-30b-5p | UP | BCL3 | 7 | ADAM7 |
| UP | EMILIN3 | 8 | hsa-mir-1301-3p | UP | HOXB4 | 7 | BPIFC |
| UP | ECM2 | 8 | hsa-mir-548e-3p | UP | SREBF1 | 7 | C8ORF34 |
| UP | DKK2 | 8 | hsa-mir-1260b | UP | ZNF274 | 7 | CWH43 |
| UP | CAPN9 | 8 | hsa-mir-20b-5p | UP | VDR | 7 | ELTD1 |
| UP | CRYAA | 8 | hsa-mir-185-3p | UP | KLF5 | 7 | GSX2 |
| UP | OSR1 | 8 | hsa-mir-185-3p | UP | PADI4 | 7 | KCNT2 |
| UP | SHISA8 | 7 | hsa-mir-376a-5p | UP | GBX2 | 7 | NELL1 |
| UP | SPINK13 | 7 | hsa-mir-16-5p | UP | KLF2 | 7 | SOX2 |
| UP | LEMD1 | 7 | hsa-mir-147a | UP | NFIB | 6 | BTBD16 |
| UP | NPBWR1 | 7 | hsa-mir-373-3p | UP | NOTCH1 | 6 | CAPSL |
| UP | OR51E2 | 7 | hsa-mir-616-5p | UP | PRDM5 | 6 | CYP2W1 |
| UP | PDPN | 7 | hsa-mir-520c-3p | UP | IKZF1 | 6 | EMILIN3 |
| UP | GPR6 | 7 | hsa-mir-93-5p | UP | MECOM | 6 | MICU3 |
| UP | ASCL1 | 7 | hsa-mir-302a-3p | UP | ESR2 | 6 | NPNT |
| UP | BTBD16 | 7 | hsa-mir-671-5p | UP | RARG | 6 | THRSP |
| UP | PCDHB2 | 7 | hsa-mir-1343-3p | UP | XRN2 | 5 | C2ORF73 |
| UP | CELF4 | 7 | hsa-mir-4511 | UP | ASXL1 | 5 | FNDC8 |
| UP | BARX2 | 7 | hsa-mir-638 | UP | TBP | 5 | FSD2 |
| UP | CA10 | 7 | hsa-mir-219a-2-3p | UP | THRA | 5 | GNAT1 |
| UP | PLA2G5 | 7 | hsa-mir-122-5p | UP | CHD1 | 5 | MIF |
| UP | HOXD8 | 7 | hsa-mir-340-5p | UP | CEBPA | 5 | SERPIND1 |
| UP | INHA | 7 | hsa-mir-346 | UP | HIF1A | 5 | UPK1B |
| UP | ALPI | 7 | hsa-mir-148b-3p | UP | HOXD13 | 4 | ANGPT4 |
| UP | PLN | 6 | hsa-mir-205-5p | UP | NUCKS1 | 4 | CRP |
| UP | SLC51B | 6 | hsa-mir-194-5p | UP | PHF8 | 4 | TEAD4 |
| UP | WT1 | 6 | hsa-mir-766-5p | UP | ZNF652 | 3 | CNTN2 |
| UP | DAND5 | 6 | hsa-mir-122-5p | UP | DCP1A | 3 | GULP1 |
| UP | REG1B | 6 | hsa-mir-224-5p | UP | TAF7L | 3 | IRX5 |
| UP | RNF180 | 6 | hsa-mir-103a-2-5p | UP | KDM5A | 3 | MRPL12 |
| UP | MEGF10 | 6 | hsa-mir-369-3p | UP | TFEB | 3 | SPINK4 |
| UP | DMRTA2 | 6 | hsa-mir-588 | UP | SALL1 | 2 | GRIA4 |
| UP | KCNH5 | 6 | hsa-mir-4786-3p | UP | ETS1 | 2 | IZUMO1 |
| UP | ACSBG2 | 6 | hsa-mir-940 | UP | BP1 | 2 | SELE |
| UP | IL17B | 6 | hsa-mir-23b-3p | UP | ZNF322 | 2 | TRHDE |
| UP | AMBP | 6 | hsa-mir-224-3p | UP | GLI1 | 2 | ZSWIM2 |
| UP | HECW1 | 6 | hsa-mir-4701-3p | UP | MYBL1 | 1 | CSHL1 |
| UP | AS3MT | 6 | hsa-mir-2277-3p | UP | KDM6A | 1 | DRD2 |
| UP | EFS | 6 | hsa-mir-210-3p | UP | ETS2 | 1 | GPC6 |
| UP | COL6A5 | 6 | hsa-mir-590-3p | UP | CHD7 | 1 | INHA |
| UP | DNAH3 | 6 | hsa-mir-605-5p | UP | AP1S2 | 1 | IZUMO1 |
| UP | ADCYAP1R1 | 6 | hsa-mir-365b-3p | UP | NR1H3 | 1 | MRPL12 |
| UP | NACA2 | 6 | hsa-mir-500a-3p | UP | NR4A2 | 1 | MYT1L |
| UP | CCDC144A | 6 | hsa-mir-4789-5p | UP | STAT6 | 1 | PLN |
| UP | SI | 6 | hsa-mir-203a-3p | UP | HCFC1 | 1 | SCG3 |
| UP | ELAVL3 | 6 | hsa-mir-151a-5p | UP | PRDM16 | 1 | TRHDE |
| UP | 6 | hsa-mir-20a-5p | Down | SPI1 | 316 | STAT3 | |
| UP | ZNF728 | 5 | hsa-mir-550a-3p | Down | RUNX1 | 235 | SETDB1 |
| UP | MYH4 | 5 | hsa-mir-99b-5p | Down | MYC | 235 | TP53 |
| UP | CCDC169 | 5 | hsa-mir-125b-2-3p | Down | EGR1 | 227 | TLE3 |
| UP | SLCO6A1 | 5 | hsa-mir-1180-3p | Down | FLI1 | 222 | IRF1 |
| UP | TUBA3C | 5 | hsa-mir-3619-5p | Down | SOX2 | 216 | VDR |
| UP | SLC22A25 | 5 | hsa-mir-200b-3p | Down | HNF4A | 210 | BCL3 |
| UP | HSD11B2 | 5 | hsa-mir-769-3p | Down | NANOG | 194 | KIAA0247 |
| UP | MRGPRF | 5 | hsa-mir-2467-5p | Down | MITF | 180 | ABTB2 |
| UP | HSPB2 | 5 | hsa-mir-100-5p | Down | POU5F1 | 179 | CNOT3 |
| UP | MYRIP | 5 | hsa-mir-4708-3p | Down | TP63 | 175 | MEF2D |
| UP | LMO1 | 5 | hsa-mir-1224-3p | Down | CREM | 173 | SEC14L1 |
| UP | GPR15 | 5 | hsa-mir-138-5p | Down | E2F1 | 167 | STAT6 |
| UP | CAPSL | 5 | hsa-mir-155-5p | Down | GATA2 | 161 | ARID1A |
| UP | HBZ | 5 | hsa-mir-146a-5p | Down | CREB1 | 160 | EHBP1L1 |
| UP | IGSF21 | 5 | hsa-mir-182-5p | Down | GATA1 | 156 | TNS3 |
| UP | NT5C1A | 5 | hsa-mir-373-3p | Down | TAL1 | 139 | TRAPPC9 |
| UP | PLA2G10 | 5 | hsa-mir-34a-5p | Down | KLF4 | 138 | PRCC |
| UP | CST6 | 5 | hsa-mir-522-5p | Down | AR | 138 | SLC9A8 |
| UP | AVP | 5 | hsa-mir-302a-3p | Down | REST | 134 | PADI4 |
| UP | CCL19 | 5 | hsa-mir-148b-3p | Down | FOXP1 | 132 | BMF |
| UP | PHF21B | 5 | hsa-mir-4482-5p | Down | TFAP2C | 124 | PLEKHG3 |
| UP | RHBDL2 | 5 | hsa-mir-210-3p | Down | TET1 | 124 | STK40 |
| UP | DCC | 5 | hsa-mir-542-3p | Down | PPARG | 124 | TRIM25 |
| UP | CBLC | 5 | hsa-mir-195-5p | Down | SOX9 | 120 | DLGAP4 |
| UP | CDKL2 | 5 | hsa-mir-135a-5p | Down | SIN3B | 119 | LASP1 |
| UP | ISY1-RAB43 | 4 | hsa-mir-378 g | Down | SRY | 107 | MIDN |
| UP | BTBD18 | 4 | hsa-mir-941 | Down | MECOM | 102 | CD97 |
| UP | ANKRD18B | 4 | hsa-mir-374a-5p | Down | SUZ12 | 102 | PLXNA2 |
| UP | C17orf102 | 4 | hsa-mir-376c-3p | Down | FOXA2 | 101 | CLPB |
| UP | FSIP2 | 4 | hsa-mir-22-5p | Down | E2F4 | 101 | POLR2A |
| UP | PERM1 | 4 | hsa-mir-345-5p | Down | TCF3 | 101 | SLC1A4 |
| UP | CYP4X1 | 4 | hsa-mir-210-3p | Down | TCF4 | 97 | STK10 |
| UP | KPNA7 | 4 | hsa-mir-191-5p | Down | ERG | 96 | ARRB1 |
| UP | OR51E1 | 4 | hsa-mir-145-5p | Down | PPARD | 96 | PVRL1 |
| UP | ANKRD30B | 4 | hsa-mir-27b-3p | Down | TRIM28 | 92 | ADAR |
| UP | LRRC3B | 4 | hsa-let-7 g-3p | Down | SMAD4 | 91 | DAP |
| UP | C2orf73 | 4 | hsa-mir-605-5p | Down | MYCN | 91 | ZNFX1 |
| UP | MAP3K19 | 4 | hsa-mir-520f-3p | Down | ZFX | 89 | TAF8 |
| UP | GLYATL1 | 4 | hsa-mir-1343-3p | Down | CCND1 | 88 | KDM6B |
| UP | NELL1 | 4 | hsa-mir-20a-5p | Down | KDM5B | 84 | WASF2 |
| UP | SLCO1C1 | 4 | hsa-mir-128-3p | Down | ASH2L | 82 | ATP6V0A1 |
| UP | IL21 | 4 | hsa-mir-372-3p | Down | YY1 | 82 | HIVEP3 |
| UP | ZSCAN10 | 4 | hsa-mir-302a-3p | Down | EOMES | 81 | RERE |
| UP | NEUROG3 | 4 | hsa-mir-373-3p | Down | ZNF281 | 80 | TBC1D13 |
| UP | ASPA | 4 | hsa-mir-1271-5p | Down | ATF3 | 79 | WBP2 |
| UP | WFDC1 | 4 | hsa-mir-941 | Down | TBX5 | 79 | WRAP53 |
| UP | SLC10A1 | 4 | hsa-mir-449a | Down | DMRT1 | 75 | F11R |
| UP | SLC16A8 | 4 | hsa-mir-550a-3-5p | Down | SCLY | 74 | PISD |
| UP | PDE6C | 4 | hsa-mir-18a-3p | Down | FOXO3 | 73 | ADAM19 |
| UP | ABCC12 | 4 | hsa-mir-3611 | Down | LMO2 | 73 | SEC24C |
| UP | G6PC | 4 | hsa-mir-33b-5p | Down | TFCP2L1 | 72 | FAM168A |
| UP | FAM131C | 4 | hsa-mir-1343-3p | Down | HOXB4 | 72 | GBF1 |
| UP | SMTNL2 | 4 | hsa-mir-373-3p | Down | MYBL2 | 71 | SEMA4B |
| UP | NLRP14 | 4 | hsa-mir-941 | Down | SALL4 | 70 | BAG6 |
| UP | PCDHB10 | 4 | hsa-mir-374a-5p | Down | TCF7 | 69 | DOPEY2 |
| UP | ANGPT4 | 4 | hsa-mir-107 | Down | TFAP2A | 69 | WWP2 |
| UP | REN | 4 | hsa-mir-200c-3p | Down | RCOR3 | 68 | KSR1 |
| UP | APOH | 4 | hsa-mir-136-5p | Down | SMAD3 | 67 | SIPA1L1 |
| UP | EN1 | 4 | hsa-mir-381-3p | Down | ESR1 | 66 | PPCDC |
| UP | CCL17 | 4 | hsa-mir-148b-3p | Down | RUNX2 | 66 | PREX1 |
| UP | C14orf39 | 4 | hsa-mir-330-5p | Down | SMARCA4 | 65 | GATAD2B |
| UP | HFM1 | 4 | hsa-mir-490-5p | Down | RAD21 | 64 | MKL1 |
| UP | OTX2 | 4 | hsa-mir-181a-5p | Down | GATA4 | 63 | GABARAP |
| UP | PDE11A | 4 | hsa-mir-1343-3p | Down | GFI1B | 63 | NDE1 |
| UP | B3GALT1 | 4 | hsa-mir-4496 | Down | EP300 | 62 | MAP7D1 |
| UP | NR0B2 | 4 | hsa-mir-24-3p | Down | PRDM14 | 62 | TNFRSF21 |
| UP | CTAGE6 | 3 | hsa-mir-99b-5p | Down | MEIS1 | 61 | CSNK2B |
| UP | PMF1-BGLAP | 3 | hsa-let-7b-5p | Down | NR0B1 | 61 | IP6K1 |
| UP | C19orf81 | 3 | hsa-mir-130b-5p | Down | PBX1 | 61 | LY6G5B |
| UP | C1orf141 | 3 | hsa-mir-3685 | Down | CUX1 | 60 | ATP6V0D1 |
| UP | LHFPL3 | 3 | hsa-mir-30d-5p | Down | YAP1 | 59 | CBX7 |
| UP | OR51B4 | 3 | hsa-mir-214-3p | Down | KLF1 | 58 | GAB2 |
| UP | KCNIP1 | 3 | hsa-mir-10b-5p | Down | TEAD4 | 58 | STIM1 |
| UP | DPP10 | 3 | hsa-mir-1301-3p | Down | CEBPB | 57 | AGER |
| UP | FAM71D | 3 | hsa-mir-301a-5p | Down | KDM5A | 57 | SYVN1 |
| UP | GYPA | 3 | hsa-mir-31-5p | Down | CTCF | 57 | YLPM1 |
| UP | SERPINA9 | 3 | hsa-mir-212-3p | Down | SRF | 56 | ADD1 |
| UP | KLK4 | 3 | hsa-mir-429 | Down | WT1 | 56 | PNKD |
| UP | SERPINB12 | 3 | hsa-mir-598-3p | Down | STAT4 | 55 | GNAI2 |
| UP | TBX20 | 3 | hsa-mir-34c-5p | Down | MTF2 | 54 | MAPKAPK2 |
| UP | TCHH | 3 | hsa-mir-147a | Down | XRN2 | 52 | SLC9A1 |
| UP | ZSCAN1 | 3 | hsa-mir-155-5p | Down | HOXC9 | 50 | TRIM41 |
| UP | DUSP15 | 3 | hsa-mir-146a-5p | Down | RBPJ | 49 | ARHGAP17 |
| UP | ZNF214 | 3 | hsa-mir-224-5p | Down | FOXP2 | 49 | DGAT2 |
| UP | TRIM55 | 3 | hsa-mir-429 | Down | EZH2 | 49 | SIRPA |
| UP | PADI3 | 3 | hsa-mir-129-2-3p | Down | IRF8 | 49 | XPO6 |
| UP | DDC | 3 | hsa-mir-517a-3p | Down | CTNNB1 | 48 | TLN1 |
| UP | MAS1 | 3 | hsa-mir-182-5p | Down | TTF2 | 45 | FAM53C |
| UP | KIF25 | 3 | hsa-mir-101-3p | Down | SMAD2 | 45 | MFN2 |
| UP | CTCFL | 3 | hsa-mir-100-5p | Down | DACH1 | 45 | POLR1A |
| UP | KCNJ13 | 3 | hsa-mir-9-5p | Down | SOX17 | 45 | SESN2 |
| UP | REG1A | 3 | hsa-mir-1270 | Down | FOXP3 | 44 | ACP2 |
| UP | UPK1B | 3 | hsa-mir-29c-3p | Down | RELA | 43 | DTX4 |
| UP | RFX4 | 3 | hsa-mir-532-3p | Down | ESRRB | 41 | BAZ2A |
| UP | NKAIN4 | 3 | hsa-mir-1343-3p | Down | ZNF217 | 41 | NF2 |
| UP | CLUL1 | 3 | hsa-mir-941 | Down | MYB | 41 | RAB37 |
| UP | ADAM7 | 3 | hsa-mir-302a-3p | Down | ELK1 | 41 | SNX11 |
| UP | C8B | 3 | hsa-mir-373-3p | Down | TBP | 40 | AGPAT1 |
| UP | CACNA1G | 3 | hsa-mir-1343-3p | Down | ELF1 | 40 | ITGA5 |
| UP | TSPYL6 | 3 | hsa-mir-423-5p | Down | NR3C1 | 39 | DYSF |
| UP | KCNK4 | 3 | hsa-mir-27a-3p | Down | ETS1 | 39 | KRTCAP2 |
| UP | WIF1 | 3 | hsa-mir-200b-3p | Down | THAP11 | 38 | DENND1A |
| UP | RPE65 | 3 | hsa-mir-103a-3p | Down | EWSR1 | 37 | KIAA0556 |
| UP | FABP6 | 3 | hsa-mir-214-3p | Down | BMI1 | 37 | MAML3 |
| UP | ZPLD1 | 3 | hsa-mir-148b-3p | Down | SIN3A | 37 | NDST1 |
| UP | COX8C | 3 | hsa-mir-132-3p | Down | RNF2 | 36 | RTN1 |
| UP | ALDOB | 3 | hsa-mir-4690-5p | Down | SOX11 | 35 | C14ORF159 |
| UP | MAS1L | 3 | hsa-mir-7-5p | Down | ASXL1 | 35 | PACS1 |
| UP | FOLH1 | 3 | hsa-mir-100-5p | Down | CRX | 34 | SCAP |
| UP | CYP2F1 | 3 | hsa-mir-34b-5p | Down | JUN | 33 | CTDSP2 |
| UP | RAD21L1 | 2 | hsa-mir-103a-3p | Down | ZFP42 | 33 | MARK2 |
| UP | CFHR1 | 2 | hsa-mir-671-5p | Down | MEF2A | 33 | TOP3A |
| UP | EXOC3L4 | 2 | hsa-mir-133a-3p | Down | PHF8 | 32 | GSK3A |
| UP | C10orf113 | 2 | hsa-mir-941 | Down | TFEB | 32 | OGDH |
| UP | DPPA5 | 2 | hsa-mir-182-5p | Down | JARID2 | 32 | RAP1GAP2 |
| UP | LPA | 2 | hsa-mir-147a | Down | SREBF2 | 31 | SIK3 |
| UP | RD3 | 2 | hsa-mir-744-5p | Down | STAT5A | 29 | MAFF |
| UP | NRAP | 2 | hsa-mir-129-2-3p | Down | DNAJC2 | 28 | C15ORF39 |
| UP | PRELP | 2 | hsa-mir-382-5p | Down | NFE2L2 | 28 | CHST15 |
| UP | C2orf80 | 2 | hsa-mir-124-3p | Down | TBX3 | 27 | CIITA |
| UP | TMEM72 | 2 | hsa-mir-103a-3p | Down | PDX1 | 27 | FAM214B |
| UP | NPAP1 | 2 | hsa-mir-26a-5p | Down | CHD1 | 27 | INTS3 |
| UP | FREM3 | 2 | hsa-mir-3928-3p | Down | NR1I2 | 27 | SETDB1 |
| UP | LIPF | 2 | hsa-mir-27a-3p | Down | HSF1 | 26 | DNMBP |
| UP | HEPHL1 | 2 | hsa-mir-15a-3p | Down | OLIG2 | 26 | RNF24 |
| UP | OR52N5 | 2 | hsa-mir-34b-5p | Down | LYL1 | 26 | ZNF592 |
| UP | GSX2 | 2 | hsa-mir-155-5p | Down | CDX2 | 25 | CDK5RAP3 |
| UP | WFDC5 | 2 | hsa-mir-191-5p | Down | NR1H3 | 25 | SMG5 |
| UP | TRHR | 2 | hsa-mir-182-5p | Down | BACH1 | 23 | JAK3 |
| UP | OR1L3 | 2 | hsa-mir-200a-3p | Down | GATA3 | 23 | RNPEP |
| UP | OR2K2 | 2 | hsa-mir-146a-5p | Down | PRDM5 | 23 | SMURF1 |
| UP | KRT78 | 2 | hsa-mir-126-3p | Down | ELF5 | 22 | CRTC2 |
| UP | A2ML1 | 2 | hsa-mir-449a | Down | TAF7L | 22 | PRKACA |
| UP | CCDC158 | 2 | hsa-mir-375 | Down | NACC1 | 22 | SLC44A2 |
| UP | CCDC140 | 2 | hsa-mir-520f-3p | Down | NUCKS1 | 22 | VAMP2 |
| UP | CCDC27 | 2 | hsa-mir-942-5p | Down | ESR2 | 21 | EPS15L1 |
| UP | LRRC71 | 2 | hsa-mir-23b-3p | Down | DCP1A | 21 | MICALL1 |
| UP | FUT6 | 2 | hsa-mir-330-3p | Down | AP1S2 | 21 | TRPC4AP |
| UP | CNTNAP4 | 2 | hsa-mir-15a-5p | Down | TCF7L2 | 20 | HIP1 |
| UP | UGT2A3 | 2 | hsa-mir-210-3p | Down | PAX3 | 20 | SPN |
| UP | CRP | 2 | hsa-mir-378 g | Down | ARNT | 20 | TMEM229B |
| UP | CDH15 | 2 | hsa-mir-1343-3p | Down | RCOR1 | 20 | ZNF692 |
| UP | CST8 | 2 | hsa-mir-27a-3p | Down | NFIB | 19 | RELL1 |
| UP | MYH7 | 2 | hsa-mir-155-5p | Down | STAT1 | 19 | TK2 |
| UP | CYP2W1 | 2 | hsa-mir-124-3p | Down | PAX6 | 18 | CRISPLD2 |
| UP | CAMK1G | 2 | hsa-mir-3661 | Down | CEBPA | 18 | VPS37C |
| UP | TMPRSS12 | 2 | hsa-mir-26a-5p | Down | DROSHA | 14 | ABCG1 |
| UP | RBM46 | 2 | hsa-mir-27a-3p | Down | EED | 14 | CAMKK1 |
| UP | MYOT | 2 | hsa-mir-26a-5p | Down | CLOCK | 14 | FLCN |
| UP | LRAT | 2 | hsa-mir-375 | Down | PHC1 | 14 | KIAA0319L |
| UP | KRT38 | 2 | hsa-mir-16-5p | Down | SREBF1 | 14 | QSOX1 |
| UP | FFAR1 | 2 | hsa-mir-146a-5p | Down | AHR | 14 | SYK |
| UP | LHCGR | 2 | hsa-mir-7-5p | Down | SMAD1 | 13 | PIK3R5 |
| UP | CSNK1A1L | 2 | hsa-mir-374a-5p | Down | HCFC1 | 13 | PPP1R12 |
| UP | ZSCAN4 | 2 | hsa-mir-122-5p | Down | THRA | 13 | RNF31 |
| UP | ABCB5 | 2 | hsa-mir-1-3p | Down | ZIC3 | 13 | SMARCD1 |
| UP | BOLA2B | 2 | hsa-mir-603 | Down | IKZF1 | 12 | PHC2 |
| UP | S100A7A | 2 | hsa-mir-26b-5p | Down | FOXO1 | 11 | TNFRSF1B |
| UP | IRGC | 2 | hsa-mir-205-5p | Down | NOTCH1 | 10 | ZNF324 |
| UP | P2RX2 | 2 | hsa-mir-146a-5p | Down | HIF1A | 9 | DAPK2 |
| UP | MYOG | 2 | hsa-mir-200b-3p | Down | RARG | 9 | MBD6 |
| UP | GHSR | 2 | hsa-mir-212-3p | Down | RCOR2 | 9 | NSD1 |
| UP | CNTN2 | 2 | hsa-mir-1908-5p | Down | KDM6A | 8 | GALNS |
| UP | RBAK-RBAKDN | 1 | hsa-mir-378a-5p | Down | FOXM1 | 8 | PI4K2A |
| UP | HSPE1-MOB4 | 1 | hsa-mir-1-3p | Down | ETS2 | 8 | ZSWIM1 |
| UP | KRTAP10–5 | 1 | hsa-mir-20a-5p | Down | HTT | 7 | SCAMP5 |
| UP | AMY1A | 1 | hsa-mir-335-5p | Down | POU3F2 | 6 | GPSM3 |
| UP | MKRN2OS | 1 | hsa-mir-766-3p | Down | TCF21 | 5 | GYS1 |
| UP | RFPL4A | 1 | hsa-mir-101-3p | Down | CEBPD | 5 | POPDC2 |
| UP | TDRD15 | 1 | hsa-mir-455-5p | Down | ZNF274 | 5 | SUPT5H |
| UP | GCGR | 1 | hsa-mir-101-3p | Down | MYBL1 | 4 | CNTROB |
| UP | CSHL1 | 1 | hsa-mir-146a-5p | Down | CDKN2AIP | 4 | MAP3K3 |
| UP | KRT39 | 1 | hsa-mir-1-3p | Down | CHD7 | 4 | SNX27 |
| UP | FSD2 | 1 | hsa-mir-5682 | Down | SALL1 | 3 | DIAPH1 |
| UP | TMPRSS11B | 1 | hsa-mir-27a-3p | Down | PRDM16 | 3 | GALNT6 |
| UP | SPATA8 | 1 | hsa-mir-182-5p | Down | ZNF322 | 3 | KDELR1 |
| UP | BPIFC | 1 | hsa-mir-27a-3p | Down | GBX2 | 3 | PLXNA4 |
| UP | MRGPRE | 1 | hsa-mir-31-5p | Down | NR4A2 | 3 | PPP1R10 |
| UP | TMIGD1 | 1 | hsa-mir-124-3p | Down | HOXD13 | 3 | RAF1 |
| UP | IZUMO1 | 1 | hsa-mir-146a-5p | Down | ZNF652 | 3 | U2AF1L4 |
| UP | CCL13 | 1 | hsa-mir-27a-3p | Down | ZNF263 | 1 | PRSS21 |
| UP | GPR62 | 1 | hsa-mir-520f-3p | Down | KLF2 | 1 | PXN |
| UP | RPRML | 1 | hsa-mir-146a-5p | Down | KLF5 | 1 | PXN |
| UP | ABRA | 1 | hsa-mir-520f-3p | Down | E2F7 | 1 | ZNF687 |
| UP | LIPM | 1 | hsa-mir-188-3p | Down | BCL11B | 1 | SP110 |
| UP | EFCAB3 | 1 | hsa-mir-135b-5p | ||||
| UP | PRL | 1 | hsa-mir-27a-3p | ||||
| UP | UTF1 | 1 | hsa-mir-302a-3p | ||||
| UP | LKAAEAR1 | 1 | hsa-mir-146a-5p | ||||
| UP | FRMPD2 | 1 | hsa-mir-3929 | ||||
| UP | TM4SF20 | 1 | hsa-mir-128-3p | ||||
| UP | TBX10 | 1 | hsa-mir-429 | ||||
| UP | MS4A5 | 1 | hsa-mir-146a-5p | ||||
| UP | MOGAT2 | 1 | hsa-mir-210-3p | ||||
| UP | ZSWIM2 | 1 | hsa-mir-27a-3p | ||||
| UP | MEIOB | 1 | hsa-mir-302a-3p | ||||
| UP | TMPRSS15 | 1 | hsa-mir-34b-5p | ||||
| UP | THRSP | 1 | hsa-mir-27a-3p | ||||
| UP | TMC2 | 1 | hsa-mir-27a-3p | ||||
| UP | DRD2 | 1 | hsa-mir-101-3p | ||||
| UP | SPATA16 | 1 | hsa-mir-27a-3p | ||||
| UP | THSD7B | 1 | hsa-mir-129-2-3p | ||||
| UP | CELA2A | 1 | hsa-mir-450b-5p | ||||
| UP | EGR4 | 1 | hsa-mir-129-2-3p | ||||
| UP | MRO | 1 | hsa-mir-27a-3p | ||||
| UP | NPBWR2 | 1 | hsa-mir-146a-5 | ||||
| UP | PRLHR | 1 | hsa-mir-26a-5p | ||||
| UP | OPRM1 | 1 | hsa-mir-590-3p | ||||
| UP | CRX | 1 | hsa-mir-766-3p | ||||
| UP | GGTLC2 | 1 | hsa-mir-107 | ||||
| UP | PLA2G3 | 1 | hsa-mir-27a-3p | ||||
| UP | NXPE1 | 1 | hsa-mir-34a-5p | ||||
| UP | RDH8 | 1 | hsa-mir-27a-3p | ||||
| UP | NPFFR2 | 1 | hsa-mir-26a-5p | ||||
| UP | MYH13 | 1 | hsa-mir-26a-5p | ||||
| UP | RASA4B | 1 | hsa-mir-335-5p | ||||
| UP | GOLGA6L9 | 1 | hsa-mir-335-5p | ||||
| UP | KRTAP10–6 | 1 | hsa-mir-335-5p | ||||
| UP | TAC4 | 1 | hsa-mir-335-5p | ||||
| UP | OR3A1 | 1 | hsa-mir-335-5p | ||||
| UP | NPY | 1 | hsa-mir-335-5p | ||||
| UP | HSD3B2 | 1 | hsa-mir-335-5p | ||||
| UP | UGT2A1 | 1 | hsa-mir-26b-5p | ||||
| Down | MIDN | 182 | hsa-mir-4705 | ||||
| Down | NSD1 | 163 | hsa-mir-1271-3p | ||||
| Down | ZNF264 | 153 | hsa-mir-4517 | ||||
| Down | BAZ2A | 153 | hsa-mir-137 | ||||
| Down | ZNFX1 | 141 | hsa-mir-150-3p | ||||
| Down | ARID1A | 138 | hsa-mir-3929 | ||||
| Down | GATAD2B | 126 | hsa-mir-4803 | ||||
| Down | SOGA1 | 123 | hsa-mir-1304-3p | ||||
| Down | PLAGL2 | 116 | hsa-mir-196a-5p | ||||
| Down | PRR14L | 113 | hsa-mir-3691-5p | ||||
| Down | POLR2A | 111 | hsa-mir-3187-3p | ||||
| Down | SESN2 | 110 | hsa-mir-1825 | ||||
| Down | ARF3 | 109 | hsa-mir-2278 | ||||
| Down | PSAP | 108 | hsa-mir-7-1-3p | ||||
| Down | ATXN1L | 107 | hsa-mir-1915-5p | ||||
| Down | PRRC2A | 105 | hsa-mir-760 | ||||
| Down | ADAR | 105 | hsa-mir-3157-3p | ||||
| Down | MEF2D | 104 | hsa-mir-642b-3p | ||||
| Down | TLN1 | 102 | hsa-mir-148b-3p | ||||
| Down | USP22 | 100 | hsa-mir-4511 | ||||
| Down | WASF2 | 94 | hsa-mir-34c-3p | ||||
| Down | KDM6B | 90 | hsa-mir-519b-3p | ||||
| Down | MTF1 | 90 | hsa-mir-516b-5p | ||||
| Down | STAT3 | 85 | hsa-mir-544a | ||||
| Down | DIAPH1 | 85 | hsa-mir-518c-5p | ||||
| Down | STK35 | 82 | hsa-mir-3177-5p | ||||
| Down | DENND4B | 81 | hsa-mir-1304-5p | ||||
| Down | TMEM127 | 80 | hsa-mir-1277-5p | ||||
| Down | GLYR1 | 80 | hsa-mir-188-5p | ||||
| Down | PPP1R10 | 80 | hsa-mir-296-5p | ||||
| Down | MAVS | 79 | hsa-mir-490-3p | ||||
| Down | RAB11FIP1 | 79 | hsa-mir-199a-3p | ||||
| Down | MBD6 | 78 | hsa-mir-1913 | ||||
| Down | DSP | 77 | hsa-mir-217 | ||||
| Down | IGF2R | 77 | hsa-mir-519d-3p | ||||
| Down | CHD8 | 77 | hsa-mir-520a-3p | ||||
| Down | ASF1B | 75 | hsa-mir-196b-3p | ||||
| Down | HYOU1 | 74 | hsa-mir-18b-3p | ||||
| Down | SCAMP2 | 74 | hsa-mir-1287-5p | ||||
| Down | LASP1 | 73 | hsa-mir-106b-3p | ||||
| Down | RAD54L2 | 73 | hsa-mir-141-5p | ||||
| Down | IRF1 | 73 | hsa-mir-1296-5p | ||||
| Down | SEC24C | 73 | hsa-mir-181c-5p | ||||
| Down | CPSF7 | 69 | hsa-mir-3115 | ||||
| Down | TNFRSF21 | 68 | hsa-mir-129-1-3p | ||||
| Down | XPO6 | 66 | hsa-mir-139-5p | ||||
| Down | SMARCD1 | 65 | hsa-mir-10a-5p | ||||
| Down | TRIM25 | 65 | hsa-mir-19a-5p | ||||
| Down | GBF1 | 63 | hsa-mir-148a-3p | ||||
| Down | TBC1D13 | 63 | hsa-mir-301b-3p | ||||
| Down | MAP1A | 62 | hsa-let-7f-2-3p | ||||
| Down | NCOA6 | 61 | hsa-mir-23a-3p | ||||
| Down | CTDSP2 | 60 | hsa-mir-21-5p | ||||
| Down | FAM168A | 59 | hsa-mir-331-3p | ||||
| Down | LMBR1L | 59 | hsa-mir-30e-3p | ||||
| Down | TP53 | 58 | hsa-mir-1246 | ||||
| Down | GNAI2 | 58 | hsa-mir-5009-5p | ||||
| Down | TAPBP | 57 | hsa-mir-566 | ||||
| Down | SORT1 | 57 | hsa-mir-1301-3p | ||||
| Down | MYADM | 56 | hsa-mir-506-3p | ||||
| Down | STK40 | 55 | hsa-mir-4458 | ||||
| Down | NF2 | 54 | hsa-mir-188-3p | ||||
| Down | KDELR1 | 54 | hsa-mir-196a-5p | ||||
| Down | MAPKAPK2 | 54 | hsa-mir-1976 | ||||
| Down | MFN2 | 54 | hsa-mir-1288-3p | ||||
| Down | RAF1 | 53 | hsa-mir-744-3p | ||||
| Down | WBP2 | 53 | hsa-mir-7-1-3p | ||||
| Down | RNF24 | 53 | hsa-mir-512-3p | ||||
| Down | TLE3 | 53 | hsa-mir-744-5p | ||||
| Down | TRIM41 | 53 | hsa-mir-939-5p | ||||
| Down | YLPM1 | 52 | hsa-mir-99b-3p | ||||
| Down | SMURF1 | 52 | hsa-mir-548d-3p | ||||
| Down | SLC25A44 | 52 | hsa-mir-5582-3p | ||||
| Down | F11R | 52 | hsa-mir-1299 | ||||
| Down | C15orf39 | 51 | hsa-mir-649 | ||||
| Down | SIPA1L1 | 51 | hsa-mir-922 | ||||
| Down | CRTC2 | 51 | hsa-mir-4690-5p | ||||
| Down | PI4KB | 50 | hsa-mir-4487 | ||||
| Down | ARHGAP1 | 49 | hsa-mir-3188 | ||||
| Down | NDST1 | 49 | hsa-mir-551a | ||||
| Down | LMTK2 | 49 | hsa-mir-548d-5p | ||||
| Down | SNX27 | 49 | hsa-mir-624-3p | ||||
| Down | MAP7D1 | 48 | hsa-mir-5094 | ||||
| Down | IP6K1 | 48 | hsa-mir-107 | ||||
| Down | ZDHHC18 | 48 | hsa-mir-708-5p | ||||
| Down | VAT1 | 48 | hsa-mir-573 | ||||
| Down | CANT1 | 48 | hsa-mir-615-3p | ||||
| Down | RERE | 48 | hsa-mir-1914-3p | ||||
| Down | MTMR3 | 47 | hsa-mir-378d | ||||
| Down | PIGS | 47 | hsa-mir-628-5p | ||||
| Down | PHC2 | 47 | hsa-mir-765 | ||||
| Down | SEC14L1 | 47 | hsa-mir-769-5p | ||||
| Down | POLR1A | 46 | hsa-mir-1281 | ||||
| Down | MAPRE3 | 46 | hsa-mir-3180-3p | ||||
| Down | ITGA5 | 46 | hsa-mir-876-3p | ||||
| Down | PACS1 | 46 | hsa-mir-30c-1-3p | ||||
| Down | ZNF445 | 46 | hsa-mir-548j-5p | ||||
| Down | GPR107 | 45 | hsa-mir-708-5p | ||||
| Down | PREX1 | 45 | hsa-mir-608 | ||||
| Down | ZNF592 | 45 | hsa-mir-760 | ||||
| Down | PBX2 | 44 | hsa-mir-548ar-3p | ||||
| Down | SYVN1 | 44 | hsa-let-7f-1-3p | ||||
| Down | SCAMP5 | 43 | hsa-mir-618 | ||||
| Down | H6PD | 43 | hsa-mir-1285-5p | ||||
| Down | TP53INP2 | 43 | hsa-mir-365a-3p | ||||
| Down | PISD | 42 | hsa-mir-664a-5p | ||||
| Down | BAG6 | 42 | hsa-mir-450a-1-3p | ||||
| Down | ADD1 | 42 | hsa-mir-18b-5p | ||||
| Down | MAP3K3 | 42 | hsa-mir-4802-3p | ||||
| Down | TBC1D10B | 41 | hsa-mir-301a-3p | ||||
| Down | RNF122 | 40 | hsa-mir-455-5p | ||||
| Down | SLC9A1 | 39 | hsa-let-7 g-3p | ||||
| Down | UBE2C | 39 | hsa-mir-4664-5p | ||||
| Down | BMF | 39 | hsa-mir-1910–5p | ||||
| Down | PLEKHG3 | 39 | hsa-mir-3689f | ||||
| Down | TMEM214 | 39 | hsa-mir-1468-5p | ||||
| Down | PLBD2 | 39 | hsa-mir-377-3p | ||||
| Down | FAM160A1 | 39 | hsa-mir-616-5p | ||||
| Down | EGLN2 | 38 | hsa-mir-3687 | ||||
| Down | ZNF385A | 38 | hsa-mir-2114-5p | ||||
| Down | WIPF2 | 38 | hsa-mir-181d-5p | ||||
| Down | EXTL3 | 38 | hsa-mir-30d-3p | ||||
| Down | VAMP2 | 38 | hsa-mir-135a-5p | ||||
| Down | PVR | 37 | hsa-mir-200c-3p | ||||
| Down | SLC1A4 | 37 | hsa-mir-3065-3p | ||||
| Down | GPR157 | 37 | hsa-mir-520a-3p | ||||
| Down | TNS3 | 37 | hsa-mir-543 | ||||
| Down | AGPAT1 | 37 | hsa-mir-873-5p | ||||
| Down | ARHGAP17 | 36 | hsa-mir-199b-5p | ||||
| Down | SLC48A1 | 36 | hsa-mir-320d | ||||
| Down | CPT2 | 36 | hsa-mir-634 | ||||
| Down | FLCN | 36 | hsa-mir-33b-5p | ||||
| Down | PXN | 36 | hsa-mir-421 | ||||
| Down | SLC44A2 | 36 | hsa-mir-320a | ||||
| Down | SMG5 | 36 | hsa-mir-501-3p | ||||
| Down | SLC35F6 | 35 | hsa-mir-29a-3p | ||||
| Down | NDE1 | 35 | hsa-mir-629-5p | ||||
| Down | CYTH2 | 35 | hsa-mir-342-5p | ||||
| Down | KCTD2 | 35 | hsa-mir-204-3p | ||||
| Down | MBOAT7 | 34 | hsa-mir-522-5p | ||||
| Down | DLGAP4 | 34 | hsa-mir-379-5p | ||||
| Down | TMBIM1 | 34 | hsa-mir-3689e | ||||
| Down | MARK2 | 34 | hsa-mir-548q | ||||
| Down | STAT2 | 33 | hsa-mir-509-3-5p | ||||
| Down | SEMA4B | 33 | hsa-mir-766-5p | ||||
| Down | OGDH | 33 | hsa-mir-494-3p | ||||
| Down | CNNM4 | 33 | hsa-mir-520c-3p | ||||
| Down | UBN1 | 33 | hsa-mir-30b-3p | ||||
| Down | KIAA0319L | 33 | hsa-mir-4999-5p | ||||
| Down | HIP1 | 33 | hsa-mir-302d-3p | ||||
| Down | TRPC4AP | 33 | hsa-mir-4487 | ||||
| Down | PPP1R12B | 32 | hsa-mir-3127-5p | ||||
| Down | PNKD | 32 | hsa-mir-638 | ||||
| Down | ABAT | 32 | hsa-mir-378a-3p | ||||
| Down | CNOT3 | 32 | hsa-mir-548n | ||||
| Down | MOB3A | 31 | hsa-mir-4443 | ||||
| Down | LRP10 | 31 | hsa-mir-922 | ||||
| Down | C6orf89 | 31 | hsa-mir-181c-5p | ||||
| Down | CYB561D1 | 31 | hsa-mir-2114-5p | ||||
| Down | CBX7 | 30 | hsa-mir-519a-3p | ||||
| Down | GBA2 | 30 | hsa-mir-4518 | ||||
| Down | PLXNA2 | 30 | hsa-mir-3619-5p | ||||
| Down | TAGLN | 30 | hsa-mir-3200-3p | ||||
| Down | RGL2 | 30 | hsa-mir-3943 | ||||
| Down | METTL7A | 30 | hsa-mir-3613-3p | ||||
| Down | PIGO | 30 | hsa-mir-29c-3p | ||||
| Down | PROSER3 | 30 | hsa-mir-328-3p | ||||
| Down | C6orf136 | 30 | hsa-mir-532-3p | ||||
| Down | TRANK1 | 29 | hsa-mir-671-5p | ||||
| Down | PRKACA | 29 | hsa-mir-3179 | ||||
| Down | INTS3 | 29 | hsa-mir-5699-3p | ||||
| Down | ARHGEF40 | 29 | hsa-mir-548ax | ||||
| Down | GYS1 | 28 | hsa-mir-4437 | ||||
| Down | ACP2 | 28 | hsa-mir-4521 | ||||
| Down | QSOX1 | 28 | hsa-mir-3180-3p | ||||
| Down | VPS37C | 28 | hsa-mir-15b-3p | ||||
| Down | SIK3 | 28 | hsa-mir-137 | ||||
| Down | MAFF | 28 | hsa-mir-423-5p | ||||
| Down | PRCC | 28 | hsa-mir-590-5p | ||||
| Down | GSK3A | 27 | hsa-mir-378d | ||||
| Down | DNMBP | 27 | hsa-mir-4733-5p | ||||
| Down | BCL3 | 27 | hsa-mir-548y | ||||
| Down | LY6G5B | 27 | hsa-mir-497-5p | ||||
| Down | SLC38A7 | 26 | hsa-mir-522-5p | ||||
| Down | FANCA | 26 | hsa-mir-2355-3p | ||||
| Down | ATP6V0D1 | 26 | hsa-mir-582-3p | ||||
| Down | GABARAP | 26 | hsa-mir-888-3p | ||||
| Down | FAM53C | 26 | hsa-mir-548b-3p | ||||
| Down | PFKFB4 | 26 | hsa-mir-550a-3-5p | ||||
| Down | SCAP | 26 | hsa-mir-365b-3p | ||||
| Down | ZNF692 | 26 | hsa-mir-3127-3p | ||||
| Down | SIRPA | 25 | hsa-mir-3685 | ||||
| Down | WDTC1 | 25 | hsa-mir-361-3p | ||||
| Down | RAB3D | 25 | hsa-mir-744-3p | ||||
| Down | STIM1 | 24 | hsa-mir-939-5p | ||||
| Down | PRKCD | 24 | hsa-mir-383-5p | ||||
| Down | STAT6 | 24 | hsa-mir-520c-3p | ||||
| Down | SUPT5H | 24 | hsa-mir-188-3p | ||||
| Down | ZNF687 | 24 | hsa-mir-579-3p | ||||
| Down | SH3BP2 | 24 | hsa-mir-5008-5p | ||||
| Down | CASC3 | 24 | hsa-mir-3934-5p | ||||
| Down | SF3A1 | 24 | hsa-mir-583 | ||||
| Down | RAPGEFL1 | 24 | hsa-mir-320c | ||||
| Down | ABCC10 | 24 | hsa-mir-31-5p | ||||
| Down | ADAM19 | 24 | hsa-mir-29c-3p | ||||
| Down | EPHX1 | 23 | hsa-mir-376a-5p | ||||
| Down | PAQR6 | 23 | hsa-mir-424-5p | ||||
| Down | RAP1GAP2 | 23 | hsa-mir-362-5p | ||||
| Down | KSR1 | 23 | hsa-mir-150-3p | ||||
| Down | VPS53 | 23 | hsa-mir-3662 | ||||
| Down | HEATR6 | 23 | hsa-mir-4803 | ||||
| Down | BET1L | 23 | hsa-mir-500a-5p | ||||
| Down | PLEKHO2 | 22 | hsa-mir-484 | ||||
| Down | NUCB1 | 22 | hsa-mir-335-5p | ||||
| Down | RIMS3 | 22 | hsa-mir-455-3p | ||||
| Down | SNX11 | 22 | hsa-mir-624-5p | ||||
| Down | SORBS3 | 22 | hsa-mir-3619-5p | ||||
| Down | ZNF324 | 22 | hsa-mir-361-3p | ||||
| Down | PRKD2 | 22 | hsa-mir-22-3p | ||||
| Down | FAM219A | 22 | hsa-mir-4726-3p | ||||
| Down | CHST15 | 21 | hsa-mir-29b-1-5p | ||||
| Down | MAML3 | 21 | hsa-mir-221-5p | ||||
| Down | ARRB2 | 21 | hsa-mir-181c-5p | ||||
| Down | CD4 | 21 | hsa-mir-140-3p | ||||
| Down | HLA-DQA1 | 21 | hsa-mir-330-3p | ||||
| Down | FAM214B | 21 | hsa-mir-3176 | ||||
| Down | ADAT1 | 21 | hsa-mir-191-5p | ||||
| Down | ARHGEF11 | 21 | hsa-mir-744-5p | ||||
| Down | TTLL11 | 21 | hsa-mir-302c-3p | ||||
| Down | CDKN2A | 20 | hsa-mir-24-1-5p | ||||
| Down | DUSP18 | 20 | hsa-mir-106b-5p | ||||
| Down | SP110 | 20 | hsa-mir-148a-5p | ||||
| Down | SPINT1 | 20 | hsa-mir-452-5p | ||||
| Down | ATP6V0A1 | 19 | hsa-mir-377-3p | ||||
| Down | SIDT2 | 19 | hsa-mir-301a-5p | ||||
| Down | RXRB | 19 | hsa-mir-32-5p | ||||
| Down | APOL2 | 19 | hsa-mir-103a-3p | ||||
| Down | USP19 | 19 | hsa-mir-3200-3p | ||||
| Down | IQCE | 19 | hsa-mir-146b-5p | ||||
| Down | CHST14 | 19 | hsa-mir-671-5p | ||||
| Down | TMEM179B | 19 | hsa-mir-631 | ||||
| Down | CXCL16 | 19 | hsa-mir-200c-3p | ||||
| Down | RNF19B | 19 | hsa-mir-99b-5p | ||||
| Down | NAPA | 19 | hsa-mir-103a-3p | ||||
| Down | ARRB1 | 18 | hsa-mir-16-2-3p | ||||
| Down | CASP9 | 18 | hsa-mir-1291 | ||||
| Down | SMAP2 | 18 | hsa-mir-629-3p | ||||
| Down | DENND1A | 18 | hsa-mir-361-5p | ||||
| Down | LRRC4 | 18 | hsa-let-7c-5p | ||||
| Down | NLRX1 | 18 | hsa-mir-1255a | ||||
| Down | TNFRSF1B | 18 | hsa-mir-125b-5p | ||||
| Down | CDK5RAP3 | 18 | hsa-mir-342-3p | ||||
| Down | TK2 | 18 | hsa-mir-302c-3p | ||||
| Down | NLRP1 | 18 | hsa-mir-15b-5p | ||||
| Down | TAF8 | 18 | hsa-mir-548 h-3p | ||||
| Down | GALNT6 | 18 | hsa-mir-331-5p | ||||
| Down | RNPEP | 18 | hsa-mir-4664-5p | ||||
| Down | ORAI2 | 17 | hsa-mir-5699-3p | ||||
| Down | PLEKHM1 | 17 | hsa-mir-589-5p | ||||
| Down | PLXNA4 | 17 | hsa-mir-17-3p | ||||
| Down | KIAA0513 | 17 | hsa-mir-3065-3p | ||||
| Down | P2RX5 | 17 | hsa-let-7f-5p | ||||
| Down | ZSWIM1 | 17 | hsa-mir-196b-5p | ||||
| Down | MICALL1 | 17 | hsa-mir-650 | ||||
| Down | DENND3 | 17 | hsa-mir-450b-5p | ||||
| Down | WWP2 | 17 | hsa-mir-1202 | ||||
| Down | LRRC20 | 16 | hsa-let-7 g-5p | ||||
| Down | TEP1 | 16 | hsa-mir-1281 | ||||
| Down | TNFAIP2 | 16 | hsa-mir-522-5p | ||||
| Down | HIVEP3 | 16 | hsa-mir-29b-3p | ||||
| Down | DAP | 16 | hsa-mir-339-5p | ||||
| Down | HSH2D | 16 | hsa-mir-449a | ||||
| Down | CDIP1 | 16 | hsa-let-7i-5p | ||||
| Down | MAPK13 | 16 | hsa-mir-520 h | ||||
| Down | KCTD21 | 15 | hsa-mir-1910–5p | ||||
| Down | NAGK | 15 | hsa-mir-92a-1-5p | ||||
| Down | DTX4 | 15 | hsa-mir-561-5p | ||||
| Down | GAB2 | 15 | hsa-mir-378 g | ||||
| Down | ABCG1 | 15 | hsa-mir-588 | ||||
| Down | CCNJL | 15 | hsa-let-7a-5p | ||||
| Down | DYSF | 15 | hsa-mir-520c-3p | ||||
| Down | RTN1 | 15 | hsa-mir-9-5p | ||||
| Down | RELL1 | 15 | hsa-mir-320b | ||||
| Down | ARHGAP30 | 15 | hsa-mir-30e-5p | ||||
| Down | SETDB1 | 14 | hsa-mir-3928-3p | ||||
| Down | BSCL2 | 14 | hsa-mir-106a-5p | ||||
| Down | EPS15L1 | 14 | hsa-mir-4448 | ||||
| Down | MAST3 | 14 | hsa-mir-518a-3p | ||||
| Down | APOL1 | 14 | hsa-mir-133a-3p | ||||
| Down | FHOD1 | 14 | hsa-mir-199a-5p | ||||
| Down | VARS2 | 14 | hsa-mir-1260a | ||||
| Down | SLC9A8 | 14 | hsa-mir-1468-5p | ||||
| Down | SKIV2L | 14 | hsa-mir-939-5p | ||||
| Down | C17orf49 | 13 | hsa-mir-4804-5p | ||||
| Down | INPP5B | 13 | hsa-mir-301a-5p | ||||
| Down | CLN3 | 13 | hsa-mir-29b-2-5p | ||||
| Down | TPCN2 | 13 | hsa-mir-532-3p | ||||
| Down | NDRG2 | 13 | hsa-mir-2355-5p | ||||
| Down | IL17RA | 13 | hsa-mir-769-3p | ||||
| Down | ABTB2 | 13 | hsa-mir-3685 | ||||
| Down | TMEM63B | 13 | hsa-mir-2110 | ||||
| Down | ARHGAP31 | 13 | hsa-mir-5690 | ||||
| Down | STK10 | 13 | hsa-mir-138-5p | ||||
| Down | RNF31 | 13 | hsa-mir-103a-2-5p | ||||
| Down | GTPBP1 | 13 | hsa-mir-548an | ||||
| Down | SLC15A3 | 13 | hsa-mir-373-3p | ||||
| Down | VDR | 13 | hsa-mir-449c-5p | ||||
| Down | DAAM2 | 13 | hsa-mir-940 | ||||
| Down | FIZ1 | 12 | hsa-mir-5100 | ||||
| Down | TMEM106A | 12 | hsa-mir-933 | ||||
| Down | POMZP3 | 12 | hsa-mir-203a-3p | ||||
| Down | CADM4 | 12 | hsa-mir-4726-3p | ||||
| Down | TRAPPC9 | 12 | hsa-mir-330-3p | ||||
| Down | ZNF530 | 12 | hsa-mir-181b-5p | ||||
| Down | RAB36 | 11 | hsa-mir-374a-5p | ||||
| Down | LGALS9 | 11 | hsa-mir-133a-3p | ||||
| Down | PI4K2A | 11 | hsa-mir-346 | ||||
| Down | ST6GALNAC2 | 11 | hsa-mir-212-3p | ||||
| Down | AOC2 | 11 | hsa-mir-3199 | ||||
| Down | ARSG | 11 | hsa-mir-183-5p | ||||
| Down | SLC27A3 | 11 | hsa-mir-503-5p | ||||
| Down | C7orf26 | 11 | hsa-mir-320e | ||||
| Down | SLC16A5 | 11 | hsa-mir-885-5p | ||||
| Down | RNF135 | 11 | hsa-mir-217 | ||||
| Down | TMEM229B | 11 | hsa-mir-2467-5p | ||||
| Down | XKR8 | 10 | hsa-mir-125a-5p | ||||
| Down | CRISPLD2 | 10 | hsa-mir-365b-5p | ||||
| Down | ARHGEF5 | 10 | hsa-mir-302d-3p | ||||
| Down | PRSS21 | 10 | hsa-let-7d-5p | ||||
| Down | JAK3 | 10 | hsa-mir-221-3p | ||||
| Down | MARK4 | 10 | hsa-mir-2277-3p | ||||
| Down | PRR16 | 10 | hsa-let-7b-5p | ||||
| Down | ZNF70 | 10 | hsa-mir-589-3p | ||||
| Down | TTLL3 | 10 | hsa-mir-1179 | ||||
| Down | ZBTB3 | 9 | hsa-mir-29c-3p | ||||
| Down | EHBP1L1 | 9 | hsa-mir-548a-3p | ||||
| Down | ZBTB22 | 9 | hsa-mir-642a-5p | ||||
| Down | CHKB | 9 | hsa-mir-1229-3p | ||||
| Down | STK36 | 9 | hsa-mir-5581-3p | ||||
| Down | ABTB1 | 9 | hsa-mir-21-3p | ||||
| Down | PTPN18 | 9 | hsa-mir-647 | ||||
| Down | ARAP3 | 9 | hsa-mir-616-5p | ||||
| Down | PPCDC | 9 | hsa-mir-500a-5p | ||||
| Down | PIK3R5 | 9 | hsa-mir-3064-5p | ||||
| Down | ZNF417 | 9 | hsa-mir-1271-5p | ||||
| Down | SLC16A13 | 9 | hsa-mir-873-3p | ||||
| Down | TOP3A | 9 | hsa-mir-181a-2-3p | ||||
| Down | CSNK2B | 9 | hsa-mir-3619-5p | ||||
| Down | INPP5D | 8 | hsa-mir-589-3p | ||||
| Down | THBS3 | 8 | hsa-mir-933 | ||||
| Down | ZNF784 | 8 | hsa-mir-432-3p | ||||
| Down | SYK | 8 | hsa-mir-3158-3p | ||||
| Down | TRIM62 | 8 | hsa-mir-522-5p | ||||
| Down | CLPB | 8 | hsa-mir-1180-3p | ||||
| Down | TMEM63C | 8 | hsa-mir-4999-5p | ||||
| Down | SEMA4A | 8 | hsa-mir-628-5p | ||||
| Down | GPSM3 | 8 | hsa-mir-664b-5p | ||||
| Down | ALKBH6 | 8 | hsa-mir-766-3p | ||||
| Down | SPN | 7 | hsa-let-7e-5p | ||||
| Down | CSF1R | 7 | hsa-mir-3065-3p | ||||
| Down | NICN1 | 7 | hsa-mir-24-3p | ||||
| Down | SLC6A16 | 7 | hsa-mir-4254 | ||||
| Down | C2CD2L | 7 | hsa-mir-125a-5p | ||||
| Down | EPOR | 7 | hsa-mir-3611 | ||||
| Down | CIITA | 7 | hsa-mir-142-3p | ||||
| Down | DGKG | 7 | hsa-mir-574-5p | ||||
| Down | PAPLN | 7 | hsa-mir-133a-3p | ||||
| Down | KCNIP2 | 7 | hsa-mir-548e-3p | ||||
| Down | DPEP3 | 7 | hsa-mir-30a-5p | ||||
| Down | CCDC17 | 7 | hsa-mir-1908-5p | ||||
| Down | TTC4 | 7 | hsa-mir-23b-3p | ||||
| Down | ADAP2 | 6 | hsa-mir-26b-5p | ||||
| Down | RPGRIP1 | 6 | hsa-mir-374a-5p | ||||
| Down | DGAT2 | 6 | hsa-mir-218-5p | ||||
| Down | ASPRV1 | 6 | hsa-mir-520c-3p | ||||
| Down | FLT3 | 6 | hsa-mir-212-3p | ||||
| Down | SHISA4 | 6 | hsa-mir-22-5p | ||||
| Down | RAB37 | 6 | hsa-mir-214-3p | ||||
| Down | CAMKK1 | 6 | hsa-mir-5008-5p | ||||
| Down | GMIP | 6 | hsa-mir-1303 | ||||
| Down | REC8 | 6 | hsa-mir-5680 | ||||
| Down | PLD2 | 6 | hsa-mir-200b-3p | ||||
| Down | GALNS | 6 | hsa-mir-874-3p | ||||
| Down | CNTROB | 6 | hsa-mir-1254 | ||||
| Down | APOM | 6 | hsa-mir-10b-5p | ||||
| Down | KCTD11 | 6 | hsa-mir-140-3p | ||||
| Down | ITGAX | 5 | hsa-mir-126-3p | ||||
| Down | OSCAR | 5 | hsa-mir-7-5p | ||||
| Down | PTAFR | 5 | hsa-mir-497-5p | ||||
| Down | DAPK2 | 5 | hsa-mir-520c-3p | ||||
| Down | WDFY4 | 5 | hsa-mir-338-3p | ||||
| Down | ATG16L2 | 5 | hsa-mir-362-3p | ||||
| Down | C19orf54 | 5 | hsa-mir-296-3p | ||||
| Down | SIGLEC9 | 5 | hsa-mir-147a | ||||
| Down | AOC3 | 5 | hsa-mir-103a-3p | ||||
| Down | U2AF1L4 | 5 | hsa-mir-660-5p | ||||
| Down | RGL3 | 5 | hsa-mir-676-3p | ||||
| Down | PHF7 | 4 | hsa-mir-147a | ||||
| Down | WRAP53 | 4 | hsa-mir-205-5p | ||||
| Down | P2RX1 | 4 | hsa-mir-191-5p | ||||
| Down | PSPN | 4 | hsa-mir-335-5p | ||||
| Down | SIGLEC5 | 4 | hsa-mir-941 | ||||
| Down | POPDC2 | 4 | hsa-mir-10b-5p | ||||
| Down | SH3D21 | 4 | hsa-mir-615-5p | ||||
| Down | TIGD3 | 4 | hsa-mir-548o-3p | ||||
| Down | KIAA0556 | 4 | hsa-mir-101-3p | ||||
| Down | LAG3 | 4 | hsa-mir-146a-5p | ||||
| Down | ARHGAP9 | 4 | hsa-mir-372-3p | ||||
| Down | SMPD2 | 4 | hsa-mir-27b-5p | ||||
| Down | ZMYND15 | 4 | hsa-mir-194-5p | ||||
| Down | PLB1 | 4 | hsa-mir-205-5p | ||||
| Down | NOMO2 | 4 | hsa-mir-15a-3p | ||||
| Down | SULT1A2 | 4 | hsa-mir-210-3p | ||||
| Down | MPEG1 | 4 | hsa-mir-28-5p | ||||
| Down | SPIB | 4 | hsa-mir-200b-5p | ||||
| Down | EIF3CL | 3 | hsa-mir-194-5p | ||||
| Down | TNFSF12 | 3 | hsa-mir-29c-3p | ||||
| Down | GTF2IRD2 | 3 | hsa-mir-522-5p | ||||
| Down | OGFOD2 | 3 | hsa-mir-3613-5p | ||||
| Down | C16orf54 | 3 | hsa-mir-27a-3p | ||||
| Down | CLEC17A | 3 | hsa-mir-30c-1-3p | ||||
| Down | ITGAL | 3 | hsa-mir-4651 | ||||
| Down | VNN3 | 3 | hsa-mir-671-5p | ||||
| Down | TREML2 | 3 | hsa-mir-214-3p | ||||
| Down | RIPK3 | 3 | hsa-mir-212-3p | ||||
| Down | ADCY4 | 3 | hsa-mir-1290 | ||||
| Down | CPNE9 | 3 | hsa-mir-301a-5p | ||||
| Down | KRTCAP2 | 3 | hsa-mir-603 | ||||
| Down | BEST1 | 3 | hsa-mir-144-3p | ||||
| Down | ITGAM | 3 | hsa-mir-372-3p | ||||
| Down | RASGRP4 | 3 | hsa-mir-34c-5p | ||||
| Down | HCG27 | 3 | hsa-mir-941 | ||||
| Down | APOBEC3D | 3 | hsa-mir-449b-5p | ||||
| Down | RABL2A | 2 | hsa-mir-1-3p | ||||
| Down | ITIH4 | 2 | hsa-mir-101-3p | ||||
| Down | MMP25 | 2 | hsa-mir-212-3p | ||||
| Down | PILRA | 2 | hsa-mir-16-5p | ||||
| Down | CSF3R | 2 | hsa-mir-941 | ||||
| Down | SLC25A35 | 2 | hsa-mir-1343-3p | ||||
| Down | C5AR2 | 2 | hsa-mir-34a-5p | ||||
| Down | KCNMB1 | 2 | hsa-mir-195-5p | ||||
| Down | NOXRED1 | 2 | hsa-mir-520f-3p | ||||
| Down | NPIPB3 | 2 | hsa-mir-154-5p | ||||
| Down | PDZD3 | 2 | hsa-mir-210-3p | ||||
| Down | UBA7 | 2 | hsa-mir-130a-3p | ||||
| Down | BLOC1S3 | 2 | hsa-mir-34c-5p | ||||
| Down | NFAM1 | 2 | hsa-mir-1293 | ||||
| Down | C19orf84 | 2 | hsa-mir-182-5p | ||||
| Down | AMY1B | 1 | hsa-mir-335-5p | ||||
| Down | PADI4 | 1 | hsa-mir-335-5p | ||||
| Down | DRICH1 | 1 | hsa-mir-335-5p | ||||
| Down | LCNL1 | 1 | hsa-mir-335-5p | ||||
| Down | CEACAM4 | 1 | hsa-mir-31-5p | ||||
| Down | GBGT1 | 1 | hsa-mir-429 | ||||
| Down | GHRL | 1 | hsa-mir-941 | ||||
| Down | TMEM234 | 1 | hsa-mir-1-3p | ||||
| Down | DPEP2 | 1 | hsa-mir-129-2-3p | ||||
| Down | SIRPB2 | 1 | hsa-mir-302a-3p | ||||
| Down | CLEC4C | 1 | hsa-mir-27a-3p | ||||
| Down | AGER | 1 | hsa-mir-191-5p | ||||
| Down | TIFAB | 1 | hsa-mir-146a-5p |
Prediction of key TFs
The regulatory relationships between the target genes and their TFs were established using Cytoscape, which showed that the single gene was regulated by multiple TFs is shown in Fig.4b. Subsequently, 19 TFs (ex, FOXD1) targeting RGS4, 16 TFs (ex, GATA2) targeting EYA1, 12 TFs (ex, FOXL1) targeting GRIA4, 11 TFs (ex, TP53) targeting CCL19, 11 TFs (ex, JUND) targeting PRL, 15 TFs (ex, STAT3) targeting PRKACA, 14 TFs (ex, TFAP2A) targeting GAB2 , 12 TFs (ex, KLF5) targeting HIP1, 10 TFs (ex, PPARG) targeting PXN and 9 TFs (ex, HINFP) targeting RGL2 were verified in NetworkAnalyst database are listed in Table 6. Integrating with the result of REACTOME pathway analysis, it was indicated that these key target genes - TF network was mainly involved in the signaling by GPCR and innate immune system.
Validation of hub genes
As these 4 genes are remarkably expressed in T1D, we executed a ROC curve analysis to calculate their sensitivity and specificity for the diagnosis of T1D. As shown in Fig. 5 EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN achieved an AUC value of >0.982, demonstrating that these genes have high sensitivity and specificity for T1D diagnosis. We further used RT-PCR to detect the mRNA expression of the hub gene. The 10 hub genes contain two up regulated genes (EGFR, GRIN2B, GJA1, CAP2 and MIF) and two down regulated gene (POLR2A, PRKACA, GABARAP, TLN1 and PXN). The RT-PCR data showed that although the trend of expression patterns of these 10 hub genes were consistent, among these up regulated genes, only EGFR, GRIN2B, GJA1, CAP2 and MIF were significantly up regulated in T1D. In addition, the expression of POLR2A, PRKACA, GABARAP, TLN1 and PXN were reduced in T1D (Fig. 6).
Fig. 5.
ROC curve analyses of hub genes. a EGFR. b GRIN2B. c GJA1. d CAP2. e MIF. f POLR2A. g PRKACA. h GABARAP. i TLN1. j PXN
Fig. 6.
RT-PCR analyses of hub genes. a EGFR. b GRIN2B. c GJA1. d CAP2. e MIF. f POLR2A. g PRKACA. h GABARAP. i TLN1. j PXN
Molecular Docking studies
The docking simulations are conducted in the present study is to identify the active site conformation and major interactions responsible for complex stability with the receptor binding sites. In T1D over expression of genes are identified and their proteins of x-ray crystallographic structure are selected from PDB for docking studies. The drugs containing thiazolidindione ring pioglitazone are most commonly used either alone or in combination with other antidibetic drugs. The docking studies of pioglitazone (as standard) and designed molecules containing the heterocyclic ring of thiazolidinedione have been carried out using Sybyl X 2.1 drug design software. The docking studies were performed to know the biding interaction of pioglitazone standard and designed molecules on identified over expressed genes of protein. The X- RAY crystallographic structure of two proteins from each over expressedgenes of epidermal growth factor receptor (EGFR), cyclase associated actin aytoskeleton aegulatory arotein 2 (CAP2), glutamate inotropic receptor NMDA type subunit 2B (GRIN2B), gap junction protein plpha 1 (GJA1) and macrophage migration inhibitory factor (MIF) and one protein from each of their co-crystallised PDB code 2XYJ, 4 K41, 5EWL, 2ZW3 and 4WR8 respectively were selected for the docking studies to identify and predict the potential molecule based on the binding score with the protein and effective against type 1 diabetes mellitus. A total of 54 molecules were designed and the binding score greater than six are believed to be good, few molecules obtained excellent binding score (C-score) with particular protein greater than 10The designed molecules obtained binding or score c- score less than 5 are TSPZP19, TBPZ38, TBPZ41 and TSIO4, TSPZ12, TBIO32, TBPZ40 TBPZ41 TBPZ42 TBPZ43 TBPZ44 TBPZ45 TBPZP46 and TSIO2, TSIO3, TSIO5, TSPZP20, TSPZP23, TBIO32, TBPZP48, TBPZP53 and TSIO1, TSIO9, TSPZ11, TSPZ12, TSPZ13, TSPZ14, TSPZ18, TSPZP19, TSPZP20, TSPZP23, TSPZP26, TSPZP27, TBIO28, TBIO30, TBIO31 TBIO32, TBIO35, TBIO36, TBPZ37, TBPZ39, TBPZ40, TBPZ41, TBPZ44, TBPZ45, TBPZP47, TBPZP49, TBPZP50 with PDB code of protein 2XYJ and 5EWL and 2ZW3 and 4WR8 respectively. The molecules obtained binding score 5 to 7 are TSIO1, TSIO2, TSIO3, TSIO4, TSIO5, TSIO7, TSIO8, TSIO9, TSPZ10, TSPZ11, TSPZ12, TSPZ13, TSPZ14, TSPZ16, TSPZ17, TSPZ18, TSPZP20, TSPZP21, TSPZP24, TSPZP25, TSPZP26, TBIO28, TBIO29, TBIO31, TBIO32, TBIO33, TBIO35, TBIO36, TBPZ39, TBPZ40, TBPZ42, TBPZ43, TBPZ40, TBPZ42, TBPZ43, TBPZ44, TBPZ45, TBPZP47, TBPZP48, TBPZP49, TBPZP50, TBPZP52, TBPZP53, TBPZP54 and TSIO1, TSIO2, TSIO3, TSIO5, TSIO6, TSIO7 TSIO8, TSIO9, TSPZ10, TSPZ11, TSPZ13, TSPZ14, TSPZ15, TSPZ16, TSPZ17, TSPZ18, TSPZP19, TSPZP20, TSPZP21 TSPZP22, TSPZP23, TSPZP24, TSPZP25, TSPZP26, TSPZP27, TBIO28, TBIO29, TBIO30, TBIO31, TBIO33, TBIO34, TBIO35, TBIO36, TBPZ37, TBPZ38, TBPZ39, TBPZ40, TBPZ42, TBPZ43, TBPZ44, TBPZ45, TBPZP46, TBPZP47, TBPZP49, TBPZP50, TBPZP51, TBPZP52, TBPZP53 and TSIO1, TSIO4, TSIO7, TSIO8, TSIO9, TSPZ10, TSPZ11, TSPZ12, TSPZ13, TSPZ14, TSPZ15, TSPZ16, TSPZ17, TSPZ18, TSPZP19, TSPZP21, TSPZP22, TSPZP24, TSPZP25, TSPZP26, TSPZP27, TBIO28, TBIO29, TBIO30, TBIO31, TBIO34, TBIO35, TBIO36, TBPZ37, TBPZ38, TBPZ39, TBPZ40, TBPZ41, TBPZ42, TBPZ43, TBPZ44, TBPZ45, TBPZP46 TBPZP47, TBPZP49, TBPZP50, TBPZP52 and TSIO2, TSIO3, TSIO4, TSIO5, TSIO6, TSIO7, TSIO8, TSPZ10, TSPZ15, TSPZ16, TSPZ17, TSPZP21, TSPZP22, TSPZP25, TBIO29, TBIO33, TBIO34, TBPZ38 TBPZ42, TBPZ43, TBPZP46, TBPZP48 with PDB protein 2XYJ and 5EWL and 2ZW3 and 4WR8 respectively. The molecules obtained c-score greater than 7 and less than 10 are TSIO6, TSPZ15, TSPZP22, TSPZP23, TSPZP27, TBIO30, TBIO34, TBPZ37, TBPZP46, TBPZP51, PIO (STD) and the molecules TSIO1, TSIO2, TSIO3, TSIO4, TSIO5, TSIO6, TSIO7, TSIO9, TSPZ10, TSPZ11, TSPZ12, TSPZ13, TSPZ14,TSPZ16, TSPZ17, TSPZ18, TSPZP19, TSPZP20, TSPZP21, TSPZP22, TSPZP23, TSPZP25, TSPZP26, TSPZP27, TBIO28, TBIO29, TBIO31, TBIO32, TBIO33, TBIO34, TBIO36, TBPZ37, TBPZ38, TBPZ39, TBPZ40, TBPZ41, TBPZ42, TBPZ43, TBPZ44, TBPZ45, TBPZP46 TBPZP47, TBPZP48, TBPZP49, TBPZP50, TBPZP51, TBPZP52, TBPZP53, TBPZP54, PIO (STD) and the molecules TSIO6, TBIO33, TBPZP51 and the molecule TBPZP51 with PDB code of 2XYJ and 4 K41 and 2ZW3 and 4WR8 respectively. Pioglitazone was used as a standard; it obtained good binding score of 8.396 and 7.648with two PDB proteins 2XYJ and 4WR8 respectively.
Discussion
Pathological complications of T1D remains undetermined, hyperglycemia develops to play a key role [47]. Although T1D is rare compared to type 2 diabetics, it might affect in any part of the body, such as the eyes, kidneys, heart, peripheral and autonomic nervous systems [48]. Considering the poor prognosis of T1D, understanding the specific molecular biomarkers of the disease is important for initial diagnosis and therapy to increase survival rates. In this investigation, we examined the expression profiling by high throughput sequencing dataset GSE123658 including T1D group and healthy donors group to identify the molecular mechanism of T1D and seek some molecular biomarkers. Bioinformatics analysis of these biological factors is applied to explore genes that are favorable to treatment.
In total 284 DEGs, 142 up regulated and 142 down regulated genes were identified. Polymorphic gene ARMS2 has an important role in the advancement of T1D [49]. Polymorphic gene AS3MT was reported to be associated with progression of T1D [50]. Wang et al [51] also reported that CRHR2 are abnormally expressed in hypertension patients, but this gene might be induces hypertension in T1D patients. Investigation has indicated that RNF122 decrease expression is associated with hyperactivity disorder [52]; this finding is consistent with our results and indicates that RNF122 might be involved in the development of T1D. A previous investigation found that autophagy regulating TP53INP2 gene expression was associated with development of T1D [53]. Polymorphic gene CRTC2 is well known for its critical role in type 2 diabetes [54], but this polymorphic gene might be responsible for advancement of T1D.
GO and REACTOME pathway enrichment analyses were performed to explore interactions among the DEGs. These DEGs were mainly enriched in cell-cell signaling, integral component of plasma membrane, signaling receptor activity, signaling by GPCR, vesicle fusion, whole membrane, lipid binding and innate immune system. Altered MYH6 gene was known to play a role in congenital heart defects [55], but this gene might be induces T1D in patients with congenital heart defects. McKenna et al [56] found that AVP (arginine vasopressin) play essential roles in the T1D. Yue et al [57] concluded that high GRIA4 expression was correlated with abdominal aortic aneurysm progression, but this gene might be answerable for advancement of T1D in patients with abdominal aortic aneurysm. Kochetova el at [58] found that GRIN2B is a significant biomarker for type 2 diabetes compared to healthy controls, but it was confirmed for the first time in our study that GRIN2B expression in T1D indicates a good prognosis. Recent investigations demonstrated that DCC (DCC netrin 1 receptor) gene can mediate angiogenesis and plays an important role in diabetic kidney disease [59]. Ruiz de Azua et al [60] indicated that RGS4 was associated progression of type 2 diabetes, but this gene might be essential for T1D progression. A previous investigation demonstrated that GJA1 was associated with the progression of atrial fibrillation [61], but might be important gene signatures of T1D in patients with atrial fibrillation. Faienza et al [62] and Galán et al [63] demonstrated that, GREM1 and EGFR (epidermal growth factor receptor) might be important for predicting treatment response in T1D. TRHR (thyrotropin releasing hormone receptor) is considered a potential biomarker of hypertension [64], but this gene might be associated with development of T1D in patients with hypertension. PTPRT (protein tyrosine phosphatase receptor type T) has been reported to serve a role in obesity associated insulin resistance [65], but this gene might be involved in progression of T1D. Research has demonstrated that FCAMR (Fc fragment of IgA and IgM receptor) gene could contribute to progression of atherosclerosis [66], but this gene might be crucial for progression of T1D in patients with atherosclerosis. Sun et al. [67] revealed that CCL19 was associated with diabetic nephropathy in patients with T1D. DSP (desmoplakin) has been reported to be expressed in cardiomyopathy [68], but this gene might be linked with progression of T1D in patients with cardiomyopathy. Xu et al. [69] have demonstrated that ITIH4 are related with coronary heart disease, but this gene might be responsible for advancement of T1D in patients with coronary heart disease. Miyashita et al [70] demonstrate that GAB2 plays a role in Alzheimer disease progression, but this gene might be crucial for T1D in patients with Alzheimer disease. McCann et al. [71] showed that IGF2R played an important role in T1D. Previous studies reported that the expression of MYADM (myeloid associated differentiation marker) induced hypertension [72], but this gene might be liable for advancement of T1D in patients with hypertension. Fan et al. [73] and Chan et al. [74] revealed that TPCN2 and APOL1 were associated with type 2 diabetes, but these genes might be responsible for development of T1D. Previous investigation had confirmed that MEFV (MEFV innate immuity regulator, pyrin) play critical roles in ischemic heart disease [75], but this gene might be essential for progression of T1D in patients with ischemic heart disease. Wang et al [76] state that the expression of DTX4 is important event in obesity, but this gene might be linked with progression of T1D in patients with obesity.
We analyzed the protein–protein interactions (PPI) and modules of the DEGs involved in T1D. Table 5 summarizes the PPI network hub genes (five up regulated and five down regulated) that were identified in the T1D, which included EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN. A recent study showed that protein expression levels of CAP2 were up regulated in cardiomyopathy patients [77], but this gene might be responsible for T1D in patients with cardiomyopathy. MIF (macrophage migration inhibitory factor) [78] and KIF1A [79] were reported to be associated with T1D. Recent research suggested that PXN (paxillin) is involved in hypertension [80], but this gene might be associated with progression of T1D in patients with obesity. POLR2A, PRKACA, GABARAP, TLN1 and CIITA (class II major histocompatibility complex transactivator) might be considered as a novel biomarkers associated with the development of T1D.
Target gene - miRNA regulatory network and target gene - TF regulatory network analysis demonstrated that DEGs interacted directly or indirectly. The more edges associated with genes, miRNAs and TFs indicated the more potential selection for the targets. Table 6 summarizes the target gene - miRNA regulatory network and target gene - TF regulatory network (target genes, miRNAs and TFs) that were identified in the T1D, which included GRIN2B, EGFR, DKK1, GJA1, RGS4, TLN1, IGF2R, POLR2A, ARHGAP1, HIP1, RGS4, EYA1, CCL19, PRL, PRKACA, GAB2, HIP1, PXN , RGL2, hsa-mir-4257, hsa-mir-564, hsa-mir-587, hsa-mir-941, hsa-mir-561-3p, hsa-mir-4300, hsa-mir-5694, hsa-mir-378b, hsa-mir-3918, hsa-mir-6719-3p, FOXD1, GATA2, FOXL1, TP53, JUND, STAT3, TFAP2A, KLF5, PPARG and HINFP. STAT3 had been reported to be involved in the pathogenesis of T1D [81]. Polymorphic gene GATA2 has been reported to be crucial for the progression of coronary artery disease [82], but this gene might be responsible for advancement of T1D in patients with coronary artery disease. PRKACA (protein kinase cAMP-activated catalytic subunit alpha), DSP (desmoplakin), hsa-mir-4257, hsa-mir-564, hsa-mir-4300, hsa-mir-5694, RGS4, FOXD1, EYA1, TFAP2A and GAB2 might be considered as a novel biomarkers associated with the development of T1D.
In addition, we also performed validation of hub genes by ROC analysis and RT-PCR. Results showed that these hub genes differentiated T1D group from healthy donors group, and may be candidates for diagnostic biomarkers and new therapeutic target. Moreover, EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN are involved in progression of T1D.
Among all few molecules of TSIO8, TSPZ15, TSPZP24, TBIO30, TBIO35 (Fig.7) obtained excellent binding score of 11.084 with PDB code 4 K41, the values are depicted in Table 7. The molecule TSIO8 (Fig. 8) has highest binding score its interaction with protein 4 K41, and formed hydrogen bond interaction of 4″’ –NH2 group with CYS-217, the hetero atom 1 oxygen and 3″ aromatic hydroxyl group (−OH) formed hydrogen bonding interactions with same amino acid LYS-213. The 3″ hydroxyl group also farmed hydrogen bond interaction with ASP-157 respectively. The sulphur of thiazolidinone ring 1′-S formed two hydrogen bond interactions with different amino acids LEU-16 & GLY-15 and 4′-C ring carbonyl formed interaction with GLY-302 respectively. The molecule also formed pi-pi interactions of electrons of aromatic ring with TYR-306, and pi-sigma interaction with GLU-214 and 2′ C=O of thiazolidine ring formed unfavourable interaction with calcium 401 (Ca) following 2′ C=O formed carbon-hydrogen interaction with GLY-13, All interactions with amino acids and metal are depicted by 3D (Fig.9) and 2D (Fig.10) figures.
Fig. 7.
Structures of Designed Molecules
Table 7.
Docking results of Designed Molecules on Over Expressed Proteins
| Sl. No/Code | Over expressed gene: EGFR | Over expressed gene: CAP2 | Over expressed gene: GRIN2B | Over expressed gene: GJA1 | Over expressed gene: MIF | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PDB: 2XYJ | PDB:4 K41 | PDB:5EWL | PDB: 2ZW3 | PDB: 4WR8 | |||||||||||
| Total Score | Crash (−Ve) |
Polar | Total Score | Crash (−Ve) |
Polar | Total Score | Crash (−Ve) |
Polar | Total Score | Crash (−Ve) |
Polar | Total Score | Crash (−Ve) |
Polar | |
| TSIO1 | 5.708 | −1.859 | 2.223 | 9.497 | −0.989 | 5.432 | 5.265 | −1.280 | 4.250 | 5.286 | −1.003 | 0.800 | 4.725 | −1.368 | 1.708 |
| TSIO2 | 5.105 | −1.784 | 2.893 | 9.728 | −1.388 | 5.353 | 5.521 | −1.228 | 3.688 | 4.881 | −0.951 | 2.131 | 5.419 | −2.125 | 0.841 |
| TSIO3 | 5.729 | −1.113 | 1.112 | 9.456 | −2.449 | 4.970 | 5.195 | −2.525 | 3.514 | 4.584 | −1.042 | 0.965 | 5.331 | −4.193 | 3.443 |
| TSIO4 | 5.842 | −0.864 | 0.598 | 10.152 | −1.938 | 6.319 | 4.315 | −1.041 | 3.793 | 5.266 | −2.776 | 1.233 | 5.417 | −1.767 | 1.069 |
| TSIO5 | 5.500 | −1.562 | 1.525 | 9.432 | −1.132 | 5.363 | 5.577 | −1.238 | 3.432 | 4.921 | −0.988 | 2.079 | 5.590 | −1.579 | 3.093 |
| TSIO6 | 7.204 | −1.628 | 3.166 | 10.018 | −0.815 | 5.325 | 6.381 | −2.325 | 2.695 | 7.272 | −1.458 | 0 | 5.970 | −1.865 | 1.184 |
| TSIO7 | 5.602 | −2.721 | 1.729 | 9.631 | −1.052 | 5.231 | 5.244 | −2.231 | 2.943 | 5.489 | −1.284 | 1.538 | 5.760 | −3.956 | 3.505 |
| TSIO8 | 6.934 | −1.501 | 2.102 | 11.084 | −2.034 | 7.653 | 5.869 | −1.008 | 3.605 | 5.258 | −3.205 | 1.973 | 5.406 | −2.204 | 0.608 |
| TSIO9 | 6.729 | −0.869 | 1.107 | 9.449 | −1.024 | 5.437 | 6.182 | −1.013 | 3.745 | 6.191 | −2.129 | 1.364 | 4.990 | −1.732 | 1.135 |
| TSPZ10 | 5.806 | −1.608 | 2.698 | 9.531 | −1.000 | 5.404 | 5.049 | −1.424 | 4.118 | 5.824 | −0.884 | 2.163 | 5.158 | −0.943 | 1.423 |
| TSPZ11 | 5.062 | −1.899 | 1.706 | 9.691 | −1.139 | 6.313 | 5.810 | −1.269 | 4.181 | 6.165 | −1.190 | 0.465 | 4.706 | −1.751 | 1.18 |
| TSPZ12 | 6.254 | −1.409 | 2.367 | 9.527 | −2.615 | 5.096 | 4.213 | −1.174 | 3.821 | 5.348 | −1.272 | 2.181 | 4.378 | −2.139 | 0.396 |
| TSPZ13 | 6.562 | −1.307 | 5.202 | 9.499 | −1.016 | 5.274 | 5.150 | −0.841 | 3.722 | 5.735 | −0.931 | 2.155 | 4.606 | −2.490 | 1.565 |
| TSPZ14 | 5.129 | −1.943 | 1.634 | 9.654 | −0.964 | 5.326 | 5.671 | −1.154 | 4.189 | 5.812 | −1.097 | 0.269 | 4.928 | −2.712 | 1.038 |
| TSPZ15 | 7.059 | −2.752 | 2.284 | 10.263 | −1.023 | 5.207 | 5.431 | −1.739 | 2.642 | 6.811 | −1.633 | 1.323 | 6.368 | −2.305 | 0.113 |
| TSPZ16 | 6.160 | −2.286 | 0.006 | 8.689 | −2.540 | 4.568 | 5.913 | −0.710 | 3.105 | 6.013 | −1.135 | 2.082 | 6.021 | −2.462 | 0.222 |
| TSPZ17 | 6.407 | −1.750 | 0.937 | 9.812 | −2.408 | 5.061 | 5.800 | −1.002 | 3.600 | 6.514 | −1.207 | 0.506 | 5.130 | −2.065 | 0.440 |
| TSPZ18 | 6.568 | −1.612 | 1.112 | 8.767 | −2.126 | 5.501 | 5.188 | −1.351 | 4.072 | 5.871 | −1.577 | 2.158 | 4.798 | −1.301 | 1.228 |
| TSPZP19 | 4.784 | −2.116 | 0.003 | 8.602 | −1.654 | 6.396 | 5.398 | −1.745 | 3.543 | 5.147 | −1.504 | 1.124 | 4.275 | −2.790 | 0 |
| TSPZP20 | 5.781 | −2.549 | 1.063 | 8.219 | −3.381 | 3.885 | 5.780 | −1.815 | 3.600 | 4.684 | −1.714 | 2.044 | 4.805 | −1.447 | 0.001 |
| TSPZP21 | 5.031 | −5.142 | 1.128 | 9.111 | −3.271 | 5.677 | 5.659 | −1.312 | 2.571 | 5.204 | −1.613 | 0.919 | 5.660 | −1.490 | 0.020 |
| TSPZP22 | 7.624 | −1.675 | 1.109 | 8.814 | −2.974 | 4.716 | 5.367 | −1.149 | 3.704 | 5.641 | −0.878 | 1.196 | 5.631 | −1.579 | 1.198 |
| TSPZP23 | 7.198 | −1.682 | 0.115 | 8.854 | −1.658 | 6.596 | 5.582 | −1.513 | 2.814 | 4.523 | −0.907 | 0.033 | 4.134 | −3.073 | 1.121 |
| TSPZP24 | 6.026 | −2.349 | 0.116 | 10.430 | 10.430 | 4.262 | 6.320 | −1.665 | 2.335 | 5.267 | −1.261 | 1.159 | 7.992 | −1.273 | 1.256 |
| TSPZP25 | 5.006 | −5.129 | 1.127 | 8.972 | −3.033 | 3.770 | 5.772 | −1.268 | 3.687 | 5.658 | −1.419 | 1.289 | 5.515 | −1.345 | 0 |
| TSPZP26 | 5.267 | −5.637 | 0.954 | 8.539 | −1.481 | 6.14 | 6.208 | −1.424 | 2.718 | 5.394 | −2.135 | 0.914 | 4.436 | −1.363 | 0 |
| TSPZP27 | 7.221 | −2.321 | 0.498 | 8.648 | −1.512 | 6.329 | 5.863 | −1.335 | 2.652 | 5.038 | −1.501 | 0.936 | 4.689 | −3.173 | 1.167 |
| TBIO28 | 5.387 | −2.438 | 2.608 | 8.796 | −1.210 | 4.261 | 5.251 | −0.834 | 1.829 | 5.187 | −0.854 | 0.744 | 4.877 | −1.324 | 2.044 |
| TBIO29 | 5.132 | −1.505 | 1.865 | 9.195 | −1.258 | 4.255 | 5.170 | −0.793 | 1.803 | 5.125 | −1.417 | 1.155 | 5.035 | −1.222 | 1.403 |
| TBIO30 | 7.079 | −1.923 | 0.858 | 10.531 | −1.372 | 4.924 | 5.586 | −1.159 | 3.148 | 5.276 | −1.395 | 0.930 | 4.453 | −0.929 | 0 |
| TBIO31 | 6.090 | −1.967 | 1.929 | 8.801 | −0.773 | 4.174 | 5.224 | −0.770 | 1.840 | 5.232 | −1.215 | 1.152 | 4.573 | −1.631 | 1.900 |
| TBIO32 | 5.157 | −2.015 | 0.004 | 8.867 | −0.924 | 4.276 | 4.924 | −1.049 | 2.634 | 4.916 | −1.432 | 1.125 | 4.759 | −1.525 | 1.991 |
| TBIO33 | 5.796 | −2.689 | 0.709 | 9.892 | −0.980 | 4.358 | 5.024 | −1.110 | 1.764 | 7.055 | −2.062 | 0.020 | 5.620 | −1.766 | 1.242 |
| TBIO34 | 7.079 | −1.923 | 0.858 | 9.161 | −0.875 | 4.317 | 5.143 | −0.657 | 2.822 | 5.051 | −0.845 | 2.321 | 5.584 | −1.952 | 1.290 |
| TBIO35 | 6.542 | −2.270 | 1.959 | 10.372 | −1.124 | 5.275 | 5.860 | −1.513 | 2.938 | 5.191 | −1.312 | 0.875 | 4.650 | −0.957 | 0 |
| TBIO36 | 6.164 | −1.506 | 0.996 | 8.912 | −1.847 | 4.162 | 5.036 | −0.853 | 1.831 | 5.431 | −1.234 | 0.002 | 4.195 | −1.850 | 1.971 |
| TBPZ37 | 7.202 | −1.109 | 0.108 | 9.602 | −3.041 | 5.880 | 5.126 | −0.951 | 1.779 | 5.859 | −1.115 | 0.010 | 4.667 | −1.195 | 2.460 |
| TBPZ38 | 4.596 | −1.574 | 1.121 | 8.762 | −0.815 | 4.21 | 5.222 | −0.698 | 1.828 | 5.400 | −0.971 | 0.001 | 5.375 | −2.176 | 1.014 |
| TBPZ39 | 6.070 | −1.439 | 2.219 | 9.392 | −2.213 | 5.155 | 5.769 | −0.800 | 3.918 | 5.772 | −0.874 | 0 | 4.639 | −1.87 | 1.522 |
| TBPZ40 | 6.090 | −1.967 | 1.929 | 8.590 | −2.055 | 4.1 | 5.214 | −0.842 | 1.778 | 5.514 | −2.298 | 1.184 | 4.822 | −1.851 | 1.535 |
| TBPZ41 | 4.679 | −1.469 | 0.004 | 8.557 | −1.073 | 4.238 | 4.997 | −0.743 | 1.812 | 5.448 | −1.147 | 0.006 | 4.676 | −1.163 | 1.122 |
| TBPZ42 | 6.848 | −1.124 | 2.084 | 9.516 | −1.040 | 4.385 | 5.476 | −1.344 | 2.358 | 6.764 | 1.783 | 1.317 | 6.946 | −1.384 | 1.490 |
| TBPZ43 | 5.582 | −2.315 | 1.677 | 8.831 | −0.898 | 4.325 | 5.462 | −1.872 | 3.436 | 5.171 | −0.661 | 3.177 | 5.013 | −2.468 | 1.121 |
| TBPZ44 | 6.645 | −2.275 | 1.936 | 9.094 | −1.764 | 3.939 | 5.892 | −1.063 | 2.964 | 5.503 | −1.122 | 0.004 | 4.693 | −1.324 | 0 |
| TBPZ45 | 6.378 | −1.607 | 1.110 | 8.557 | −0.955 | 4.336 | 5.230 | −0.769 | 1.783 | 6.371 | −1.899 | 1.195 | 4.903 | −1.763 | 1.523 |
| TBPZP46 | 7.202 | −1.109 | 0.108 | 6.165 | −1.473 | 1.634 | 5.585 | −0.786 | 3.893 | 6.324 | −1.314 | 3.361 | 5.355 | −2.860 | 2.421 |
| TBPZP47 | 5.315 | −2.731 | 0.963 | 8.903 | −1.907 | 5.544 | 5.410 | −0.992 | 1.830 | 5.449 | −0.886 | 1.176 | 3.173 | −0.976 | 0 |
| TBPZP48 | 5.006 | −5.129 | 1.127 | 9.231 | −3.021 | 5.149 | 4.034 | −1.612 | 3.442 | 4.721 | −1.372 | 0.002 | 6.037 | −1.283 | 0.845 |
| TBPZP49 | 6.876 | −3.317 | 0.951 | 8.730 | −2.958 | 4.111 | 5.451 | −1.136 | 1.818 | 5.708 | −1.038 | 0.021 | 4.074 | −3.978 | 0.251 |
| TBPZP50 | 6.309 | −2.914 | 0.007 | 8.787 | −2.397 | 3.629 | 5.312 | −0.998 | 1.802 | 5.374 | −1.282 | 0.002 | 4.069 | −2.916 | 0 |
| TBPZP51 | 7.331 | −1.709 | 1.128 | 9.755 | −2.543 | 3.496 | 5.324 | −1.063 | 1.831 | 7.841 | −1.751 | 1.304 | 8.13 | −1.286 | 1.322 |
| TBPZP52 | 5.470 | −3.384 | 0.063 | 8.598 | −3.204 | 3.198 | 5.494 | −1.324 | 3.039 | 5.632 | −1.046 | 4.503 | 5.727 | −1.639 | 0.743 |
| TBPZP53 | 6.402 | −4.890 | 1.693 | 8.645 | −1.982 | 4.767 | 5.373 | −0.959 | 1.826 | 4.790 | −2.041 | 1.079 | 5.994 | −1.661 | 1.073 |
| TBPZP54 | 6.925 | −2.649 | 6.032 | 5.452 | −2.612 | 3.535 | 4.521 | −1.365 | 3.442 | 5.732 | −1.353 | 1.328 | 5.325 | −1.551 | 0.113 |
| PIO (STD) | 8.396 | −0.983 | 1.023 | 6.683 | −1.814 | 2.537 | 6.261 | −0.828 | 2.212 | 6.232 | −2.171 | 0 | 7.648 | −1.772 | 0.325 |
Fig. 8.
Structure of the Designed Molecule (TSIO8) obtained Highest Binding Score with PDB
Fig. 9.
3D Binding of Molecule TSIO8 with 4 K41
Fig. 10.
2D Binding of Molecule TSIO8 with 4 K41
In conclusion, the present investigation was designed to identify DEGs that may be involved in the progression of T1D. A total of 284 DEGs and 10 hub genes were identified and might be regarded as diagnostic biomarkers and new therapeutic target for T1D. Together, EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN might be effective targets in T1D, but more experimental investigations and clinical trials are needed.
Acknowledgement
I thank Felipe Leal Valentim,INSERM/UPMC, Unité Immunologie-Immunopathologie-Immunothérapie, Paris, France very much, the author who deposited their microarray dataset, GSE123658, into the public GEO database.
Informed consent
No informed consent because this study does not contain human or animals participants.
Authors’ contributions
PG - Methodology and validation. BV - Writing original draft, and review and editing. AT - Formal analysis and validation. CV - Software and investigation. IK - Supervision and resources. The authors read and approved the final manuscript.
Availability of data and materials
The datasets supporting the conclusions of this article are available in the GEO (Gene Expression Omnibus) (https://www.ncbi.nlm.nih.gov/geo/) repository. [(GSE123658) (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE123658)]
Declarations
Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358(9277):221–229. doi: 10.1016/S0140-6736(01)05415-0. [DOI] [PubMed] [Google Scholar]
- 2.Costacou T. The Epidemiology of Cardiovascular Disease in Adults with Type 1 Diabetes. Curr Diabetes Rev. 2017;13(6):520–527. doi: 10.2174/1573399812666160927122643. [DOI] [PubMed] [Google Scholar]
- 3.Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212. doi: 10.2337/diacare.28.1.186. [DOI] [PubMed] [Google Scholar]
- 4.Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 1987;2(8573):1423–1427. doi: 10.1016/s0140-6736(87)91128-7. [DOI] [PubMed] [Google Scholar]
- 5.Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapy of Type 1 Diabetes. Exp Clin Endocrinol Diabetes. 2019;127(S 01):S27–S38. doi: 10.1055/a-0984-5696. [DOI] [PubMed] [Google Scholar]
- 6.Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Understanding type 1 diabetes: etiology and models. Can J Diabetes. 2013;37(4):269–276. doi: 10.1016/j.jcjd.2013.05.001. [DOI] [PubMed] [Google Scholar]
- 7.Pociot F, Lernmark Å. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331–2339. doi: 10.1016/S0140-6736(16)30582-7. [DOI] [PubMed] [Google Scholar]
- 8.Butalia S, Kaplan GG, Khokhar B, Rabi DM. Environmental Risk Factors and Type 1 Diabetes: Past, Present, and Future. Can J Diabetes. 2016;40(6):586–593. doi: 10.1016/j.jcjd.2016.05.002. [DOI] [PubMed] [Google Scholar]
- 9.Nisticò L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996;5(7):1075–1080. doi: 10.1093/hmg/5.7.1075. [DOI] [PubMed] [Google Scholar]
- 10.Wang CY, She JX. SUMO4 and its role in type 1 diabetes pathogenesis. Diabetes Metab Res Rev. 2008;24(2):93–102. doi: 10.1002/dmrr.797. [DOI] [PubMed] [Google Scholar]
- 11.Hussein AG, Mohamed RH, Alghobashy AA. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol. 2012;279(1):42–45. doi: 10.1016/j.cellimm.2012.08.006. [DOI] [PubMed] [Google Scholar]
- 12.Qian C, Guo H, Chen X, Shi A, Li S, Wang X, Pan J, Fang C. Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility. J Diabetes Res. 2018;2018:1614683. doi: 10.1155/2018/1614683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wu X, Zhu X, Wang X, Ma J, Zhu S, Li J, Liu Y. Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin Endocrinol. 2009;71(1):46–49. doi: 10.1111/j.1365-2265.2008.03437.x. [DOI] [PubMed] [Google Scholar]
- 14.Ingaramo PI, Ronco MT, Francés DE, Monti JA, Pisani GB, Ceballos MP, Galleano M, Carrillo MC, Carnovale CE. Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus. Mol Immunol. 2011;48(12–13):1397–1407. doi: 10.1016/j.molimm.2011.03.015. [DOI] [PubMed] [Google Scholar]
- 15.Liu H, Xu R, Kong Q, Liu J, Yu Z, Zhao C. Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus. Biomed Pharmacother. 2017;94:619–626. doi: 10.1016/j.biopha.2017.07.102. [DOI] [PubMed] [Google Scholar]
- 16.Güzel D, Dursun AD, Fıçıcılar H, Tekin D, Tanyeli A, Akat F, Topal Çelikkan F, Sabuncuoğlu B, Baştuğ M. Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. Anatol J Cardiol. 2016;16(2):76–83. doi: 10.5152/akd.2015.5925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Carmann C, Lilienthal E, Weigt-Usinger K, Schmidt-Choudhury A, Hörster I, Kayacelebi AA, Beckmann B, Chobanyan-Jürgens K, Tsikas D, Lücke T. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus. Amino Acids. 2015;47(9):1865–1874. doi: 10.1007/s00726-015-2027-9. [DOI] [PubMed] [Google Scholar]
- 18.Gbr AA, Abdel Baky NA, Mohamed EA, Zaky HS. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway. Naunyn Schmiedebergs Arch Pharmacol. 2020. 10.1007/s00210-020-01979-y. [DOI] [PubMed]
- 19.Zhao LP, Alshiekh S, Zhao M, Carlsson A, Larsson HE, Forsander G, Ivarsson SA, Ludvigsson J, Kockum I, Marcus C, et al. Next-Generation Sequencing Reveals That HLA-DRB3, −DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes. Diabetes. 2016;65(3):710–718. doi: 10.2337/db15-1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mao K, Geng W, Liao Y, Luo P, Zhong H, Ma P, Xu J, Zhang S, Tan Q, Jin Y. Identification of robust genetic signatures associated with lipopolysaccharide-induced acute lung injury onset and astaxanthin therapeutic effects by integrative analysis of RNA sequencing data and GEO datasets. Aging. 2020;12(18):18716–18740. doi: 10.18632/aging.104042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol. 2016;1418:93–110. doi: 10.1007/978-1-4939-3578-9_5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi: 10.1093/bioinformatics/btp616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29. doi: 10.1186/gb-2014-15-2-r29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi: 10.1093/nar/gkv007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Simonne DH, Martini A, Signorile M, Piovano A, Braglia L, Torelli P, Borfecchia E, Ricchiardi G. THORONDOR: a software for fast treatment and analysis of low-energy XAS data. J Synchrotron Radiat. 2020;27(Pt 6):1741–1752. doi: 10.1107/S1600577520011388. [DOI] [PubMed] [Google Scholar]
- 26.Landau W, Niemi J, Nettleton D. Fully Bayesian analysis of RNA-seq counts for the detection of gene expression heterosis. J Am Stat Assoc. 2019;114(526):610–621. doi: 10.1080/01621459.2018.1497496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Solari A, Goeman JJ. Minimally adaptive BH: A tiny but uniform improvement of the procedure of Benjamini and Hochberg. Biom J. 2017;59(4):776–780. doi: 10.1002/bimj.201500253. [DOI] [PubMed] [Google Scholar]
- 28.Maag JLV. gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2. F1000Res. 2018;7:1576. doi: 10.12688/f1000research.16409.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Thomas PD. The Gene Ontology and the Meaning of Biological Function. Methods Mol Biol. 2017;1446:15–24. doi: 10.1007/978-1-4939-3743-1_2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F. May B et al The Reactome Pathway Knowledgebase. Nucleic Acids Res. 2018;46(D1):D649–D655. doi: 10.1093/nar/gkx1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37(Web Server issue):W305–W311. doi: 10.1093/nar/gkp427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Alanis-Lobato G, Andrade-Navarro MA, Schaefer MH. HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res. 2017;45(D1):D408–D414. doi: 10.1093/nar/gkw985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B. Ideker T Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Przulj N, Wigle DA, Jurisica I. Functional topology in a network of protein interactions. Bioinformatics. 2004;20(3):340–348. doi: 10.1093/bioinformatics/btg415. [DOI] [PubMed] [Google Scholar]
- 35.Nguyen TP, Liu WC, Jordán F. Inferring pleiotropy by network analysis: linked diseases in the human PPI network. BMC Syst Biol. 2011;5:179. doi: 10.1186/1752-0509-5-179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Shi Z, Zhang B. Fast network centrality analysis using GPUs. BMC Bioinformatics. 2011;12:149. doi: 10.1186/1471-2105-12-149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Fadhal E, Gamieldien J, Mwambene EC. Protein interaction networks as metric spaces: a novel perspective on distribution of hubs. BMC Syst Biol. 2014;8:6. doi: 10.1186/1752-0509-8-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zaki N, Efimov D, Berengueres J. Protein complex detection using interaction reliability assessment and weighted clustering coefficient. BMC Bioinformatics. 2013;14:163. doi: 10.1186/1471-2105-14-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Fan Y, Xia J. miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context. Methods Mol Biol. 2018;1819:215–233. doi: 10.1007/978-1-4939-8618-7_10. [DOI] [PubMed] [Google Scholar]
- 40.Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234–W241. doi: 10.1093/nar/gkz240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi: 10.1186/1471-2105-12-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 43.Liao C, Sitzmann M, Pugliese A, Nicklaus MC. Software and resources for computational medicinal chemistry. Future Med Chem. 2011;3(8):1057–1085. doi: 10.4155/fmc.11.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gong Z, Xie Z, Qiu J, Wang G. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors. Molecules. 2017;22(11):1865. doi: 10.3390/molecules22111865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Grewal AS, Kharb R, Prasad DN, Dua JS, Lather V. Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators. BMC Chem. 2019;13(1):2. doi: 10.1186/s13065-019-0532-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Salvi GE, Kandylaki M, Troendle A, Persson GR, Lang NP. Experimental gingivitis in type 1 diabetics: a controlled clinical and microbiological study. J Clin Periodontol. 2005;32(3):310–316. doi: 10.1111/j.1600-051X.2005.00682.x. [DOI] [PubMed] [Google Scholar]
- 48.Twetman S, Petersson GH, Bratthall D. Caries risk assessment as a predictor of metabolic control in young Type 1 diabetics. Diabet Med. 2005;22(3):312–315. doi: 10.1111/j.1464-5491.2005.01419.x. [DOI] [PubMed] [Google Scholar]
- 49.Toni M, Hermida J, Toledo E, Goñi MJ, Díez GN. Role of CFH and ARMS2 polymorphisms in retinopathy and coronary artery disease in type 1 diabetes. An Sist Sanit Navar. 2012;35(3):425–432. doi: 10.23938/ASSN.0098. [DOI] [PubMed] [Google Scholar]
- 50.Drobná Z, Del Razo LM, García-Vargas GG, Sánchez-Peña LC, Barrera-Hernández A, Stýblo M, Loomis D. Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico. J Expo Sci Environ Epidemiol. 2013;23(2):151–155. doi: 10.1038/jes.2012.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wang LA, Nguyen DH, Mifflin SW. CRHR2 (Corticotropin-Releasing Hormone Receptor 2) in the Nucleus of the Solitary Tract Contributes to Intermittent Hypoxia-Induced Hypertension. Hypertension. 2018;72(4):994–1001. doi: 10.1161/HYPERTENSIONAHA.118.11497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Garcia-Martínez I, Sánchez-Mora C, Soler Artigas M, et al. Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder. Sci Rep. 2017;7(1):5407. doi: 10.1038/s41598-017-05514-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sala D, Ivanova S, Plana N, et al. Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes. J Clin Invest. 2014;124(5):1914–1927. doi: 10.1172/JCI72327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Keshavarz P, Inoue H, Nakamura N, Yoshikawa T, Tanahashi T, Itakura M. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes. Mol Genet Metab. 2008;93(2):200–209. doi: 10.1016/j.ymgme.2007.08.125. [DOI] [PubMed] [Google Scholar]
- 55.Granados-Riveron JT, Ghosh TK, Pope M, et al. Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet. 2010;19(20):4007–4016. doi: 10.1093/hmg/ddq315. [DOI] [PubMed] [Google Scholar]
- 56.McKenna K, Morris AD, Ryan M, et al. Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus. Am J Physiol Endocrinol Metab. 2000;279(1):E155–E160. doi: 10.1152/ajpendo.2000.279.1.E155. [DOI] [PubMed] [Google Scholar]
- 57.Yue J, Zhu T, Yang J, et al. CircCBFB-mediated miR-28-5p facilitates abdominal aortic aneurysm via LYPD3 and GRIA4. Life Sci. 2020;253:117533. doi: 10.1016/j.lfs.2020.117533. [DOI] [PubMed] [Google Scholar]
- 58.Kochetova OV, Avzaletdinova DS, Korytina GF, Morugova TV, Mustafina OE. The association between eating behavior and polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 genes in people with type 2 diabetes mellitus. Mol Biol Rep. 2020;47(3):2035–2046. doi: 10.1007/s11033-020-05304-x. [DOI] [PubMed] [Google Scholar]
- 59.Jiao X, Zhang D, Hong Q, et al. Netrin-1 works with UNC5B to regulate angiogenesis in diabetic kidney disease. Front Med. 2020;14(3):293–304. doi: 10.1007/s11684-019-0715-7. [DOI] [PubMed] [Google Scholar]
- 60.Ruiz de Azua I, Scarselli M, Rosemond E, et al. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Proc Natl Acad Sci U S A. 2010;107(17):7999–8004. doi: 10.1073/pnas.1003655107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wang P, Qin W, Wang P, et al. Genomic Variants in NEURL, GJA1 and CUX2 Significantly Increase Genetic Susceptibility to Atrial Fibrillation. Sci Rep. 2018;8(1):3297. doi: 10.1038/s41598-018-21611-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Faienza MF, Ventura A, Delvecchio M, et al. High Sclerostin and Dickkopf-1 (DKK-1) Serum Levels in Children and Adolescents With Type 1 Diabetes Mellitus. J Clin Endocrinol Metab. 2017;102(4):1174–1181. doi: 10.1210/jc.2016-2371. [DOI] [PubMed] [Google Scholar]
- 63.Galán M, Kassan M, Choi SK, et al. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension. 2012;60(1):71–80. doi: 10.1161/HYPERTENSIONAHA.112.192500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.García SI, Porto PI, Dieuzeide G, et al. Thyrotropin-releasing hormone receptor (TRHR) gene is associated with essential hypertension. Hypertension. 2001;38(3 Pt 2):683–687. doi: 10.1161/01.hyp.38.3.683. [DOI] [PubMed] [Google Scholar]
- 65.Feng X, Scott A, Wang Y, et al. PTPRT regulates high-fat diet-induced obesity and insulin resistance. PLoS One. 2014;9(6):e100783. doi: 10.1371/journal.pone.0100783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ward-Caviness CK, Neas LM, Blach C, et al. A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic. PLoS One. 2017;12(3):e0173880. doi: 10.1371/journal.pone.0173880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sun J, Wang J, Lu W, et al. MiR-325-3p inhibits renal inflammation and fibrosis by targeting CCL19 in diabetic nephropathy. Clin Exp Pharmacol Physiol. 2020. 10.1111/1440-1681.13371. [DOI] [PubMed]
- 68.Yang Z, Bowles NE, Scherer SE, et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res. 2006;99(6):646–655. doi: 10.1161/01.RES.0000241482.19382.c6. [DOI] [PubMed] [Google Scholar]
- 69.Xu H, Shang Q, Chen H, et al. ITIH4: A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method. Evid Based Complement Alternat Med. 2013;2013:360149. doi: 10.1155/2013/360149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Miyashita A, Arai H, Asada T, et al. GAB2 is not associated with late-onset Alzheimer's disease in Japanese. Eur J Hum Genet. 2009;17(5):682–686. doi: 10.1038/ejhg.2008.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.McCann JA, Xu YQ, Frechette R, Guazzarotti L, Polychronakos C. The insulin-like growth factor-II receptor gene is associated with type 1 diabetes: evidence of a maternal effect. J Clin Endocrinol Metab. 2004;89(11):5700–5706. doi: 10.1210/jc.2004-0553. [DOI] [PubMed] [Google Scholar]
- 72.Sun L, Lin P, Chen Y, et al. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism. Theranostics. 2020;10(12):5581–5599. doi: 10.7150/thno.44687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Fan Y, Li X, Zhang Y, et al. Genetic Variants of TPCN2 Associated with Type 2 Diabetes Risk in the Chinese Population. PLoS One. 2016;11(2):e0149614. doi: 10.1371/journal.pone.0149614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Chan GC, Divers J, Russell GB, et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care. 2018;41(1):178–186. doi: 10.2337/dc17-0820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Hermansson C, Lundqvist A, Wasslavik C, Palmqvist L, Jeppsson A, Hultén LM. Reduced expression of NLRP3 and MEFV in human ischemic heart tissue. Biochem Biophys Res Commun. 2013;430(1):425–428. doi: 10.1016/j.bbrc.2012.11.070. [DOI] [PubMed] [Google Scholar]
- 76.Wang Z, Dai Z, Pan Y, Wu S, Li Z, Zuo C. E3 ubiquitin ligase DTX4 is required for adipogenic differentiation in 3T3-L1 preadipocytes cell line. Biochem Biophys Res Commun. 2017;492(3):419–424. doi: 10.1016/j.bbrc.2017.08.083. [DOI] [PubMed] [Google Scholar]
- 77.Aspit L, Levitas A, Etzion S, Krymko H, Slanovic L, Zarivach R, Etzion Y, Parvari R. CAP2 mutation leads to impaired actin dynamics and associates with supraventricular tachycardia and dilated cardiomyopathy. J Med Genet. 2019;56(4):228–235. doi: 10.1136/jmedgenet-2018-105498. [DOI] [PubMed] [Google Scholar]
- 78.Ismail NA, El Baky AN, Ragab S, Hamed M, Hashish MA, Shehata A. Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes. J Pediatr Endocrinol Metab. 2016;29(6):641–645. doi: 10.1515/jpem-2015-0340. [DOI] [PubMed] [Google Scholar]
- 79.Baptista FI, Pinto MJ, Elvas F, Almeida RD, Ambrósio AF. Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus. PLoS One. 2013;8(6):e65515. doi: 10.1371/journal.pone.0065515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Veith C, Marsh LM, Wygrecka M, Rutschmann K, Seeger W, Weissmann N, Kwapiszewska G. Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. Am J Pathol. 2012;181(5):1621–1633. doi: 10.1016/j.ajpath.2012.07.026. [DOI] [PubMed] [Google Scholar]
- 81.Parackova Z, Vrabcova P, Zentsova I, et al. Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes. Sci Rep. 2020;10(1):493. doi: 10.1038/s41598-020-57507-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Muiya NP, Wakil S, Al-Najai M, et al. A study of the role of GATA2 gene polymorphism in coronary artery disease risk traits. Gene. 2014;544(2):152–158. doi: 10.1016/j.gene.2014.04.064. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets supporting the conclusions of this article are available in the GEO (Gene Expression Omnibus) (https://www.ncbi.nlm.nih.gov/geo/) repository. [(GSE123658) (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE123658)]










